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Aims and Objectives 
Aims  
The overall objectives of this ORALMET study were to understand the role of birth 
modality on the oral microbiota of neonates from birth, and to observe the oral 
microbiota of these infants from birth to 3 years of age (Cohort study/Longitudinal 
study), and to describe the oral microbiota of children with and without caries (Cross 
sectional study). All studies are illustrated in Figure 1.1. 
 
Objectives 
Cohort/Longitudinal study 
1) To determine if birth mode (Spontaneous Vaginal delivery (SVD) v 
C-section (CS) delivery) would have an influence on the 
composition and development of the oral microbiota. 
2) To describe the changes in the oral microbiota from birth to 3 years 
of age among breast fed infants. 
Cross sectional study 
3) Compare the oral microbiota (saliva/dentinal microbiota) of children 
aged less than 5 years with high levels of caries (S-ECC) to caries-
free children (saliva). 
 
 
 
 
 
xix 
 
 
 
 
 
 
 
 
 
Figure 1.1: Study overview-schematic overview of the ORALMET study including 
Cross sectional study & Cohort/Longitudinal study. 
 
 
 
 
 Cross sectional study: 50 
Children < 5 years with 
SECC and 50 Caries free 
children   
Birth: C-section delivery: 
Skin Microbiota Sample 
 
Oral Sample 
(mother) 
Cohort study: Oral 
microbiota of 
Infants followed 
from birth until 3 
years of age 
Birth: Vaginal delivery: 
Vaginal Microbiota Sample 
 
Bioinformatics Analysis 
 
Next Generation Sequencing 
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Aims: 
The specific aims of the two studies (Cohort study & Cross-sectional study). 
 
Cohort/ Longitudinal Study:   
A prospective three-year cohort study was designed to follow the evolution of the 
oral microbiome of neonates from birth to 3 years of age. There were two cohorts: 
one cohort included infants delivered by Spontaneous Vaginal Delivery (SVD) and 
the second included infants delivered by Caesarean Section (CS). In total 100 infants 
would be followed longitudinally from birth to three years of age, collecting the 
salivary oral microbiota of these infants at different time points until 3 years of age 
(1 week, 4 weeks, 8 weeks, 6 months/24 weeks, 1 year, 2 years and 3 years of age). 
At the time of delivery, a saliva sample would be collected from the mother along 
with a skin (CS) or vaginal sample (SVD), dependent on birth mode.  
 
Aims 
1) To describe and compare the microbiota of the different body sites 
of the mother (vagina, skin, oral cavity) to their infants microbiota 
(oral cavity).  
2) To identify if there is any influence on mode of delivery on the oral 
microbiota of the infant within 1 week of birth, at 4 weeks, 8 weeks, 
6 months, 1 year, 2 years and 3 years of age. 
3) To describe the oral microbiota changes over time as the infant 
develops and grows from 1 week to 3 years of age (1 week, 4 weeks, 
8 weeks, 6 months/24 weeks and 1, 2 and 3 years of age). 
xxi 
 
4) To identify if breast feeding has an influence on the oral microbiota 
of the neonate, and also to identify if duration of breast feeding has 
an impact on the oral microbiota. 
 
Cross Sectional Study:  
A cross sectional study was designed to compare the oral microbiota of children 
affected by severe early childhood caries (S-ECC) to that of caries-free children, by 
high-throughput sequencing of 16S rRNA amplicons.  This study aimed to describe 
the oral microbiota (saliva and dentinal microbiota) of children less than 5 years old, 
with high caries levels in their primary dentition (S-ECC) to those that are caries free 
(saliva). 
 
Aims 
1) To describe and compare the salivary microbiota of Irish children with 
caries (S-ECC) to children who are caries-free. 
2) To investigate the dentinal microbiota of deep caries and to identify taxa 
that may be advancing the progression of the disease. 
3) To explore the differences in the oral microbiota of the two groups and to 
investigate potential explanatory variables (including diet analysis). 
The attainment of these aims would lead to the identification of microbiota 
associated with health and disease. While much of the outcome of this project is 
necessarily descriptive, there is a core of hypothesis driven research: 
 
 
 
xxii 
 
Hypotheses to be tested  
- There is no difference in the oral microbiome of children 
a) who are delivered by Caesarean section and vaginally 
b) from birth to 3 years of age 
c) with high caries and those who are caries free 
 
Structure of the Thesis 
This thesis is structured in accordance with the guidelines set out by University 
College Cork. Literature review (Chapter 2) is followed by a Methodology Chapter 
(Chapter 3). The research results are presented in Chapter 4 with discussion of the 
research findings in Chapter 5 and a final discussion in Chapter 6. All work has been 
completed while the candidate has been registered as a PhD student. 
Candidate’s contribution to PhD. 
The role of the candidate is described in this section. The candidate is the first author 
of all manuscripts under review in this thesis (Chapter 4). The candidate provided the 
following contributions: 
•             Concept of ORALMET study  
•             Grant Application 
•             Study design 
•             Patient recruitment 
•             Patient Sampling for both Cross sectional and longitudinal study  
•             Compilation of patient questionnaires 
xxiii 
 
•             Laboratory work 
•             Manuscript preparation 
The concept and study design of the ORALMET study was completed by the PhD 
candidate and assisted by Professor. Paul O’Toole, Professor. Helen Whelton and 
Professor. Martin Kinirons. Bioinformatic support was provided by Hugh Harris and 
David Mullins. Patient recruitment and sample collection was assisted by Carol-
Anne O’Shea, a research nurse on the Infantmet project. All authors contributed 
feedback on manuscripts prior to submission. 
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Thesis Abstract 
The oral cavity harbours a very rich and diverse microbial community. In the last 
decade, the oral microbiota of children and adults has been studied in detail using 
continuously developing DNA sequencing methods. In particular focusing on the 
oral microbiome changes in the presence of diseases such as dental caries, 
periodontal disease and the relationship of the oral microbiome with oral health and 
disease states. The overall aim of these studies was to unravel the complexity of the 
oral ecosystem and the driving forces behind the imbalance of this ecosystem which 
leads to increased risk of disease and poor oral health. The oral microbiota of the 
edentulous neonate and infant is poorly characterised particularly the dynamics of 
the oral microbial changes of the neonate as it grows from birth to an older age. This 
is important as it would give researchers that study the oral health of children a better 
understanding of the foundation of the oral microbiome. An important addition 
would also be to explore the influence feeding modality (breast or formula), 
introduction of solid foods, eruption of teeth, antibiotic intake, fluoridation intake 
and oral hygiene habits all have on the infant oral microbiota. Gaining a better 
understanding of the dynamics and maturation of the oral microbiome of neonates 
from birth is important to identify any microbial factors which increase the risk of 
dental diseases in these children.  
In this ORALMET study, we recorded the oral microbial changes from birth to 2 
years of age of infants (n=382) (year 3 data is not included in this thesis) born via C-
section or Vaginal delivery. Factors included in our analysis of the oral microbiota of 
these infants included breast feeding duration and the influence of the maternal 
microbiota (saliva/skin or vaginal microbiota). We observed that breast feeding 
xxv 
 
duration does not have an effect on the oral microbiota of infants, and birth mode has 
an effect on the oral microbiota of infants up to 4 weeks of age only, but not beyond 
that. The oral microbiota changes in composition are most apparent from 6 months 
of age to 2 years of age, with less microbial changes within the oral cavity from birth 
to 8 weeks of age. The oral microbiota composition is continually changing and 
developing up to 1 year of age and at 2 years of age, illustrating continuous 
maturation, with no evidence of stability by 2 years of age. The second part of the 
ORALMET study (cross-sectional study) compared the oral microbiota of children 
between 3-5 years with S-ECC (n=68) and without caries (n=70). We observed 
distinct microbiota differences in the caries microbiota of children with active ECC, 
and the presence of species in the salivary microbiota of children with active caries, 
but not in the salivary microbiota of children without caries. 
ORALMET is the first in depth longitudinal study of the oral microbiome from birth 
of the infant, together with the influence of the maternal microbiota and also the first 
microbiota study of Irish children with and without caries. Together these studies 
provide us with information of the infant oral microbiome and a better understanding 
of the microbial dynamics within the oral cavity of neonates, infants and children. 
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Study Abstracts 
1. Longitudinal study: Birth to 1 year of age. 
2. Longitudinal study: Birth to 2 years of age. 
3. Cross Sectional Study. 
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Abstract:  
1. Longitudinal Study: Birth to 1 year of age. 
Background 
The oral cavity is a rich and diverse microbial niche. While the microbiology of the 
infant gut has been studied in detail, the acquisition of microbial communities and 
the influence of delivery mode on the oral microbiota of the newborn infant remains 
poorly characterised. Studies of the influence of delivery mode accompanied by 
longitudinal sampling of the infant oral cavity from birth, while assessing 
confounders such as feeding modality, would increase our knowledge of this under 
explored area, and may also facilitate early prediction of the risks of developing oral 
childhood diseases such as severe early childhood caries (S-ECC).  
Methods 
A cohort of pregnant women in their second or early third trimester were enrolled in 
the study (n=81). All infants were born full-term, without complications, by 
Spontaneous vaginal delivery (SVD) or by Caesarean section (CS). At delivery, 
vaginal samples were taken from the mother if the infant was born by SVD, along 
with a saliva sample (n=37). If the infant was delivered by CS, a skin swab was 
taken from the mother within 1 hour of delivery along with a saliva sample (n=37). 
To investigate the role of delivery mode on the oral microbiota of their infants, oral 
saliva samples were taken from the infant within one week of birth, and by 
longitudinal sampling again at week 4, week 8, 6 months and 1 year of age (Total 
samples n=340). We used high-throughput sequencing of V4-V5 region 16S rRNA 
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amplicons to compare the microbiota of all samples from mother (vaginal, skin or 
saliva) and infant (oral/saliva).  
Results 
The vaginal, skin and oral microbiota of the mother taken at birth were significantly 
different (p <0.001) and when compared to the infant oral microbiota at the various 
time points, by two established metrics, Bray Curtis dissimilarity and UniFrac 
distances. The vaginal microbiota had a lower alpha diversity than the skin 
microbiota of the mother, while the infant oral microbiota diversity remained 
relatively stable from birth to 8 weeks of age. Birth mode had a significant effect on 
the oral microbiota composition of the newborn infant within 1 week of age (p 
<0.05), but not at 1 year of age. The influence of the duration of breastfeeding on the 
early infant oral microbiota was not significant, when birth modes were combined or 
separated. 
Conclusions 
We conclude that birth mode does not have an effect on the infant oral microbiota 
from 4 weeks of age, and the oral microbiota of infants continues to mature and 
develop after 8 weeks until 1 year of age.  
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Abstract: 
2. Longitudinal study: Birth to 2 years of age.  
Background 
The human oral microbiome is a diverse and rich environment. While caesarean 
section has been linked with disruption of the microbiome of the infant gut, the 
impact of birth modality (CS v SVD) on the infant oral microbiome has received less 
attention. In addition, how the oral microbial ecosystem develops and matures from 
birth to an older age remains under-explored. In this ORALMET study, we continue 
our investigation to analyse the impact of birth mode on the infant oral microbiota 
and observe the oral microbiota changes from birth until 2 years of age.  
 
Methods 
A cohort of pregnant women in their second or third trimester was enrolled in the 
study. Depending on birth modality of their newborn infant (SVD or CS), a maternal 
vaginal sample or maternal skin sample was collected after birth, together with a 
saliva sample from the mother. Neonates born by Spontaneous vaginal delivery 
(SVD) or Caesarean Section (CS) were then followed longitudinally by sampling of 
the saliva to measure the infant oral microbiota collected at birth (1 week) and at 4 
weeks, 8 weeks, 6 months and 1 year and 2 years of age. We used high-throughput 
sequencing of V4-V5 region 16S rRNA amplicons to assess the microbiota of all 
samples from mother and their infant. 
 
Results 
We found that the neonatal oral microbiota immediately after birth was influenced 
by birth mode, but by 2 years of age there was no effect. The infant oral microbiota 
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at 2 years of age is distinct, as demonstrated by its composition and beta diversity 
separation when compared alongside the earlier ages of the infant oral microbiota. 
 
Conclusion 
We conclude that the infant oral microbiota still continues to undergo change and 
development from 1 year to 2 years of age.   
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Abstract:  
3. Cross sectional study. 
Objectives 
The main objectives of this study were to describe and compare the microbiota of 1) 
deep dentinal lesions of deciduous teeth of children affected with S-ECC and 2) the 
unstimulated saliva of these children and 3) the unstimulated saliva of caries-free 
children, and to compare microbiota compositional differences and diversity of taxa 
in these sampled sites.  
Methods 
We compared the oral microbiota of children affected by severe early childhood 
caries (S-ECC) to that of caries-free children, by high-throughput sequencing of 16S 
rRNA amplicons. We compared the salivary microbiota of those with S-ECC (n=68) 
and without caries (n=70), and also investigated the caries microbiota of deep 
dentinal lesions of those children with S-ECC.  
Results 
Using two established metrics (Bray Curtis dissimilarity and UniFrac distance); we 
found that the caries microbiota was distinct from that of either of the saliva groups 
(caries-free & caries-active) when bacterial abundance was taken into account. 
However, when the comparison was made by measuring only presence and absence 
of bacterial taxa, we found that all three microbiota types separated. While the alpha 
diversity of the caries microbiota was lowest, the diversity difference between the 
caries samples and saliva samples was statistically significant (p<0.001). The major 
phyla of the caries active dentinal microbiota were Firmicutes (median abundance 
value 33.5%) and Bacteroidetes (23.2%), with Neisseria (10.3%) being the most 
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abundant genus, followed by Prevotella (10%). The caries-active salivary microbiota 
was dominated by Proteobacteria (median abundance value 38.2%) and  
Bacteroidetes (27.8%) with the most abundant genus being Neisseria (16.3%), 
followed by Porphyromonas (9.5%). Caries microbiota samples were characterized 
by high relative abundance of Streptococcus mutans, Prevotella, Bifidobacterium 
and Scardovia species  
 
Conclusions  
We identified distinct differences between the caries microbiota and saliva 
microbiota, with separation of both salivary groups (caries-active and caries-free) 
whereby rare taxa are highlighted. 
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Introduction:  
1. Longitudinal study: Birth to 1 year of age. 
The human microbiome is made up of a rich environment of microbes and has been 
described as ‘a forgotten organ’ (O’Hara and Shanahan, 2006). These microbes play 
an important role in modifying human health and disease (Ma et al., 2012; Wade, 
2013; Xu and Gunsolley, 2014). Advances in molecular methods analysing the 
microbiome have allowed us to study various body sites in great depth, with the most 
extensively studied microbiota site in infants being the gut microbiota (Azad et al., 
2013; Hill et al., 2017; Penders et al., 2006). As the infant grows the gut microbiota 
develops and matures from birth until 2 to 3 years of age, to establish a more adult-
like ‘stable’ microbiota compositional state (Blaser, 2014; Yatsunenko et al., 2012). 
In recent years there has been a surge of interest studying the effect of birth mode 
and feeding on the infant microbiota from birth until 2 to 3 years of age, to gain an 
understanding of the importance this period plays in programming the microbiota 
and innate immune system for later life. While the establishment of the gut 
microbiota composition has been demonstrated to be affected by birth mode, 
cessation of breastfeeding and weaning onto solids (Azad et al., 2014, 2013; 
Bergstrom et al., 2014; Bokulich et al., 2016; Grönlund et al., 1999; Hill et al., 2017; 
Huurre et al., 2008; Penders et al., 2006), there are fewer studies demonstrating these 
effects on the oral microbiome of the infant (Boustedt et al., 2015; Dominguez-Bello 
et al., 2010; Lif Holgerson et al., 2011).  
The initial microbial exchanges between mother and infant at birth and shortly 
thereafter are fundamental to the infant microbiota, as these early colonizers play an 
important role in the development of the neonate’s immune system and long term in 
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the activity and function of the microbiota (Mueller et al., 2014; Scholtens et al., 
2012). During vaginal delivery, the newborn infant is colonised by the mothers 
vaginal fluid microbiota and intestinal microbiota, whereas the microbiota of those 
infants born via C-section share a close resemblance to the skin microbiota of the 
mother (Dominguez-Bello et al., 2010; Huurre et al., 2008; Lupp and Finlay, 2005; 
Mueller et al., 2017). C-sectioned delivery has been shown to have an effect on the 
microbiota composition and this change is associated with medical complications 
such as coeliac disease, asthma, autism and obesity (Biasucci et al., 2008; Curran et 
al., 2015; Decker et al., 2010; Kero et al., 2002; Neu and Rushing, 2011). C-
sectioned delivery is often medically necessary due to maternal or fetal 
complications and can be accompanied by antibiotic administration before and after 
birth, which can also impact the microbiota (Bokulich et al., 2016; Gyte et al., 2014; 
Ledger and Blaser, 2013). While the C-section rates worldwide are increasing 
(Vogel et al., 2015) and because of the increased risk of complications associated 
with C-section, there is increased focus investigating the effect birth mode has on the 
newborn microbiota with studies exploring the possibility of re-colonising the 
newborn born by C-section, with swabs of the mothers vaginal fluid, in an effort to 
mitigate any disruption in the loss of these important early microbial colonizers of 
the infant intestine (Dominguez-Bello et al., 2016).  
Birth mode is known to influence the oral microbiota in infants at three months of 
age (Lif Holgerson et al., 2011) and infants born by vaginal delivery have a higher 
oral microbial diversity than C-sectioned infants in the first 6 months post birth 
(Boustedt et al., 2015). A higher abundance of health associated species of 
Streptococcus and Lactobacillus were detected in the oral cavity of vaginally 
delivered infants (Nelun Barfod et al., 2011), while infants delivered by C-section 
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acquired Streptococcus mutans nearly 12 months earlier than vaginally delivered 
infants (Li et al., 2005). The influence of birth mode on the oral microbial 
composition of infants has been demonstrated, however saliva samples were taken 
from infants after birth at mean age of 8.25 months (Barfod et al., 2012), 3 months 
(Lif Holgerson et al., 2011), and at 1, 3 and 6 months (Boustedt et al., 2015) without 
taking vaginal or skin samples from the mother, based on mode of delivery. There 
are some limitations in these studies, particularly with sampling of the infant at only 
one time point (Lif Holgerson et al., 2011; Nelun Barfod et al., 2011), while the 
strength of the study by Boustedt et al. (Boustedt et al., 2015) was increased by 
longitudinal sampling within 2 days of birth to 6 months, which allowed examination 
of change in the oral microbiota over time. Studies investigating the impact of 
feeding modality (breast or formula) on the oral microbiome have also demonstrated 
microbiota compositional changes (Holgerson et al. 2013; Romani Vestman et al. 
2013). Lactobacillus species such as L. grasseri were detected at higher abundance 
in breast fed infants, compared to formula fed infants (Lif Holgerson et al., 2013) 
and these oral lactobacilli have antimicrobial properties and probiotic qualities 
(Vestman et al., 2013). 
 
Despite the increased work studying the oral microbiome of children and adults (Aas 
et al., 2005; Jiang et al., 2013; Lazarevic et al., 2009; Nasidze et al., 2009), there is 
need for more in depth research to investigate the oral microbiota from birth of the 
edentulous neonate, where to our knowledge there are only a few studies using high 
throughput sequencing to examine the neonatal oral microbiota (Cephas et al., 2011; 
Chu et al., 2017; Dominguez-Bello et al., 2010). In addition to this, the use of high 
throughput sequencing is needed to examine the oral microbiota by longitudinal 
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sampling of the neonate from birth through to older age, taking into account factors 
such as eruption of teeth, feeding modality at birth (breast or formula) and 
introduction of solid food. Understanding the oral microbiota at birth, prior to 
eruption of teeth and longitudinal sampling may provide us with vital information on 
the evolution of the oral microbiome, birth mode influence and potential early 
indicators of disease risk (caries) in these infants. 
 
In this prospective study, we employed 16S rRNA gene amplicon Illumina 
sequencing to investigate the microbiota of the mother across different body sites at 
birth (vagina/skin and oral) and the oral microbiota of their infants at birth forming 
mother-infant pairs, followed by longitudinal sampling at five time points until 1 
year of age (1 week, 4 weeks, 8 weeks, 6 months/24 weeks and 1 year of age). All 
infants were from a single geographical area (Cork, Ireland), full-term delivery, 
initially breastfed for 4 weeks minimum and born by either Spontaneous Vaginal 
delivery (SVD) or Caesarean section delivery (CS). The main objectives of this 
study were to describe and compare the microbiota of 1) the different body sites of 
the mother (vagina, skin, oral cavity) with and that of their infant (oral cavity), 2) to 
identify if there is any influence on mode of delivery on the oral microbiota of the 
infant,  3) to identify if breast feeding and the length of breast feeding has an impact 
on the oral microbiota of the infant and finally 4) to describe the oral microbiota 
changes over time as the infant develops and grows from birth to 1 year of age (1 
week, 4 weeks, 8 weeks, 6 months/24 weeks and 1 year of age). 
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Introduction: 
2: Longitudinal study: Birth to 2 years of age. 
Detailed information on the development of the infant oral microbiota from birth to 
an older age is scarce. In this study we extend our previous analysis of the infant oral 
microbiota changes from 1 year of age to 2 years of age, in the same cohort of 
infants. While others studies have discussed the infant oral composition at a mean 
age of 8.25 months (Barfod et al., 2012), 3 month old infants (Lif Holgerson et al., 
2011), and at 1, 3 and 6 months (Boustedt et al., 2015), we are unaware of studies 
investigating the oral microbiota development from birth until 2 years of age, 
together with birth mode influence of the maternal microbiota.  
 
From 6 months of age, solid foods are typically introduced, deciduous teeth on 
average begin to erupt, and oral hygiene practices begin. By 2 years of age, the infant 
is now a toddler and milestones which are under development include walking, 
speech and ability to self feed, while weaning from bottle or breastfeeding has 
typically ceased (CDC, 2016; WHO, 2016). Within the first few years of life, these 
developmental milestones can affect the microbiota of the infant by introduction of 
objects into the mouth, hand contact with floor and outside surfaces especially 
during the crawling and walking stages. 
 
The influences of these factors on the gut microbiota of the infant have been studied 
in great detail (Fallani et al., 2011; Koenig et al., 2011; Laursen et al., 2016, 2017). 
The infant gut microbiota reaches stability similar to an adult- like microbiota by 3 
years of age (Yatsunenko et al., 2012). However, there are limited studies 
investigating the oral microbiota of an infant and if stability in the oral microbiota is 
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reached at a similar age. Other factors which could be potential influencers of the 
infant oral microbiota changes include the introduction of solid foods, development 
of dentition and oral hygiene practices, and is another area which is underexplored 
(Johansson et al., 2010; Lif Holgerson et al., 2015; Milgrom et al., 2000; Zaura et al., 
2014). Studies investigating the oral microbiota of toddlers younger than 3 years of 
age mainly include studies determining the oral microbiota composition of children 
with and without caries (Barfod et al., 2012; Hughes et al., 2012; Kanasi et al., 2010; 
Lif Holgerson et al., 2015; Milgrom et al., 2000; Xu et al., 2014). These studies 
include comparisons between those with caries and without caries. Enabled by 
advanced sequencing methods, there has been analysis of a ‘healthy’ oral 
microbiome of children aged 2-6 years (Kanasi et al., 2010), 3-6 years old (Z. Ling 
et al., 2010),  3-4 years old (Jiang et al., 2016; Ma et al., 2015), 3-7 years old (Jiang 
et al., 2014) and less than  30 months old (Xu et al., 2014), all performed  as cross 
sectional studies to compare against the oral microbiota of children with caries. 
 
Species associated with a ‘healthy’ oral microbiome in children include 
Streptococcus oralis, Haemophilus parainfluenzae, Neisseria species, 
Fusobacterium species (Ma et al., 2015), including Fusobacterium periodonticum 
(Jiang et al., 2016). Genera associated with a ‘healthy’ oral microbiome include 
Fusobacterium, Capnocytophaga, Leptotrichia and Porphyromonas (Xu et al., 
2014). Species richness and diversity has been shown to increase in the oral cavity of 
infants as they age from 3 months to 3 years of age (Lif Holgerson et al., 2015). This 
study by Lif Holgerson et al. (Lif Holgerson et al., 2015) supported previous 
research findings that the oral microbial composition changes in richness and 
diversity with increased age, with increased frequency of anaerobes in the oral cavity 
8 
 
(Könönen et al., 1999). The ‘healthy’ salivary microbiome of children with 
deciduous dentition was found to be composed mainly of Firmicutes, with a higher 
abundance of Proteobacteria (Crielaard et al., 2011). The salivary microbiome at 3 
years of age demonstrated complexity, with the salivary microbiota continuing to 
undergo maturation until adulthood (18 years of age) (Crielaard et al., 2011), unlike 
the intestinal microbiota where stability is already reached by 3 years of age 
(Yatsunenko et al., 2012). The studies noted above  have investigated the oral 
microbiota of children on average between 3-7 years of age, but as mentioned 
previously there are no studies that we are aware of that have assessed the oral 
microbiome of infants from birth until 2 years of age, with their maternal samples 
(saliva/skin/vagina) from birth.  
 
We conducted a large cohort study and employed 16S rRNA gene amplicon Illumina 
sequencing to investigate the microbiota of the mother across different body sites at 
birth (vagina/skin and oral). The development of the infant oral microbiota was 
observed from birth until 2 years of age (at 6 time points), born full-term by separate 
birth modes (CS & SVD). We hypothesised that oral microbiota changes would be 
evident as the infant grows from birth, until two years of age, and the influence of 
birth mode would not be evident by 2 years of age. The main objectives of this study 
were thus to describe the development and changes in the infant oral microbiota 
from birth to 2 years of age and to identify if there was any influence of mode of 
delivery and the maternal microbiota (vagina/skin and saliva) on the oral microbiota 
of the infant at 2 years of age.   
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Introduction:  
  3. Cross sectional study. 
Dental caries is the “single most common chronic disease of childhood” (National 
Call to Action to Promote Oral Health. Rockville, MD: U.S. Department of Health 
and Human Services, Public Health Service, 2003) and affects 60-90% of all school 
children (World Health Organisation, 2012). Severe early childhood caries (S-ECC) 
is an aggressive form of dental caries and is defined by any sign of smooth surface 
caries in children younger than 3 years of age. It is also classified as any smooth 
surface of an antero-posterior deciduous tooth that is decayed, missing (due to 
caries), or filled smooth surfaces in children between 3 and 5 years old, and the 
presence of a dmft index  score of ≥4 (age 3), ≥5 (age 4), or ≥6 (age 5) (American 
Academy of Pediatric Dentistry (AAPD), 2008). 
S-ECC is a destructive and common dental infection (Gussy et al., 2006), and when 
it progresses, it can cause acute pain and sepsis, and potential tooth loss when left 
untreated (Finucane, 2012). Poor dental health in early childhood can influence 
growth and cognitive development by interfering with quality of life, nutrition, 
concentration and school participation (Gussy et al., 2006; Martins-Júnior et al., 
2013). S-ECC can have an impact on the primary dentition (Tanner et al., 2011b) 
and in turn is a risk factor for caries of permanent teeth (Alm et al., 2008; Dülgergil 
and Colak, 2012; Li and Wang, 2002). Because of the young age of the children, S-
ECC is difficult to treat successfully in the dental chair (Almeida et al., 2000; Graves 
et al., 2004; Tanner et al., 2011a). These children frequently require treatment under 
general anaesthesia (Albadri et al., 2006), which increases treatment costs 
(McAuliffe U, Kinirons M, Woods N, 2017), and these affected children are at a 
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higher risk of developing recurrent caries (Almeida et al., 2000; Berkowitz et al., 
2011; Ng et al., 2014). 
Dental caries has been investigated for many years using selective culture-based 
methods, and the role of Streptococcus species and the presence of Lactobacillus 
species have both long being recognized as playing substantial roles in dental caries 
(Beighton, 2005; Borgström et al., 1997; Hughes et al., 2012; Pearce et al., 1995; 
Rosebury, 1932; Van Houte, 1994; Yang et al., 2010). However, recent advances in 
molecular methods have allowed scientists to study the microbiology of oral disease 
with greater power, with technologies (Nyvad et al., 2013) such as 16S rRNA gene 
amplicon sequencing showing that the microbiology of dental caries is much richer 
than previously believed. 
The oral cavity has been shown to harbour more than 700 bacterial taxa, with one 
third of these described as non-culturable in vitro (Paster et al., 2006; Paster and 
Dewhirst, 2009), and two thirds belonging to cultivable species (Dewhirst et al., 
2010). Although there is compositional variation between sample sites taken from 
the oral cavity, a ‘core’ microbiome in health has been identified (Zaura et al., 2009).  
Movement away from this core and the associated alteration in microbiota 
composition and its role in the development of oral disease is a key area of oral 
health research. Such studies have also demonstrated that oral disease is not due to 
an isolated organism such as Streptococcus mutans causing caries, but is more 
polymicrobial in nature (Dewhirst et al., 2010; Gross et al., 2012; Nyvad et al., 2013; 
Paster et al., 2006; Paster and Dewhirst, 2009; Rosebury, 1932; Zaura et al., 2009). 
Studies have identified Scardovia wiggsiae, Bifidobacterium, Veillonella, 
Granulicatetta, Scardovia, Fusobacterium, Prevotella and Actinomyces as potential 
contributors to ECC evidenced by their altered abundance in the caries microbiota 
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(Almeida et al., 2000; Li et al., 2007; Li and Wang, 2002; Z. Ling et al., 2010; 
Nasidze et al., 2009; Nyvad et al., 2013; Obata et al., 2014; Paster et al., 2006; Xu et 
al., 2014).  
To understand the microbiology of dental caries, it is helpful to use the combined 
findings from molecular and culture-based studies (Aas et al., 2008; Corby et al., 
2005; Z. Ling et al., 2010; Munson et al., 2004; Tanner, 2015; Tanner et al., 2011b) 
because molecular methods, when compared to culture-dependent methods have 
been shown to underestimate the proportions of certain phyla such as Actinobacteria  
(Munson et al., 2004; Schulze-Schweifing et al., 2014). Studies have shown 
differences in the oral microbiota in children with caries and those that are caries free 
(Beighton, 2005; Li et al., 2007; Z. Ling et al., 2010; Tanner et al., 2011b). 
Streptococcus mutans is found at higher levels at early stages of caries (Gross et al., 
2010), while Lactobacillus spp. are associated with disease progression of caries and 
Scardovia species have been isolated from dentinal caries and have previously been 
associated with having a role in the advancement of deep caries in S-ECC  (Becker 
et al., 2002; Mantzourani et al., 2009; Munson et al., 2004; Tanner et al., 2011b).  
Limited data are available by molecular methods on the microbiota of advanced deep 
dentinal caries and pulpal infections of deciduous teeth, knowledge of which could 
aid in the development of anti-bacterial medicaments in pulp therapy of these 
affected teeth. Gram-negative species have been identified in deep dentinal caries of 
ECC affected teeth (Aas et al., 2008; Corby et al., 2005), and are present in deep 
pulpal infections of primary teeth (Gomes et al., 2013; Hoshino, 1985; Ruviére et al., 
2007; Tavares et al., 2011; Topcuoglu et al., 2013; Triches et al., 2014). Chalmers 
and colleagues (Chalmers et al., 2015) studied the microbiota of exposed vital pulp 
chambers and carious lesions of deciduous teeth, and found that these vital pulps 
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were dominated by phylum Firmicutes and phylum Actinobacteria. Rôças et al. 
(Rôças et al., 2016) used next-generation sequencing approaches to study the 
microbiota of deep dentinal caries of permanent teeth with irreversible pulpitis, and 
showed that Firmicutes was the most abundant phylum, followed by phyla 
Actinobacteria and Proteobacteria. 
In the present study, we employed 16S rRNA gene amplicon sequencing to compare 
the microbiota of the deep dentinal lesions of S-ECC affected deciduous teeth, and 
saliva of these caries-active children, with the saliva of caries-free children. The 
main objectives were to describe and compare the microbiota of 1) deep dentinal 
lesions of deciduous teeth of children affected with S-ECC and 2) the unstimulated 
saliva of these children and finally, 3) the unstimulated saliva of caries-free children 
and compared compositional differences and diversity of taxa in these sampled sites. 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
 
Chapter 2: Literature Review 
 
The oral microbiome of children in health and disease and the 
maternal influence before, during and after birth on the 
microbiome of the neonate. 
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2.1 Abstract 
The presence of an extra organ ‘the microbiome’ throughout life has been shown 
to have a major influence on human health and response to disease risk. The initial 
microbiota transfer does not begin when we are born, but prior to this, during 
pregnancy when the maternal microbiota can have an impact on the growing fetus 
before seeding the newborn at birth. Until recently, it was believed that the 
environment in utero, which encompasses the growing fetus was sterile, and 
during birth the fetus is first exposed to a wave of microbial contamination. In this 
review I present multiple studies which have examined the microbiota 
compositions of the placenta, vagina and skin and their influences on microbiota 
acquisition of the newborn before and during birth. I also discuss current research 
studies of pregnancy and birth mode impact on the oral microbiota of newborns 
and of edentulous infants. Furthermore, I discuss factors which can influence the 
oral microbiota after birth such as feeding mode (breast feeding or formula 
feeding), antibiotic intake and finally discuss the microbiota associated with 
dental diseases such as Early Childhood Caries (ECC).  
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2.2 Introduction 
The human body is a complex frame of internal and external cells, which make up 
the unique structure of tissues (epithelia, connective tissue, nervous system, and 
muscles) and different organs. There are approximately 79 organs of the human 
body and the human body consists of 10 to 100 trillion microorganisms, (Cani and 
Delzenne, 2011), with the vast majority of these microorganisms residing in the 
gastrointestinal tract (Sender et al., 2016). Previous estimates of bacteria cells to 
human cells were in the order of 10:1, while recent analysis have shown that the 
number of bacterial cells to human cells is  found to be in the same ratio of 1:1, 
with a total weight of about 0.2kg (Sender et al., 2016). The term ‘microbiome’ 
was initially given by Joshua Lederberg  “to signify the ecological community of 
commensal, symbiotic, and pathogenic microorganisms that literally share our 
body space and have been all but ignored as determinants of health and disease” 
(Lederberg and Mccray, 2001), and more recently the ‘microbiome’ has been 
labelled as ‘the forgotten organ’ (O’Hara and Shanahan, 2006).  
With the launch in 2007 of the ‘Human Microbiome Project’ (HMP) by the US 
National Institute of Health (NIH) (Human Microbiome Project Consortium, 
2012; Turnbaugh et al., 2007) there has been increased interest in studying this 
‘superorganism’ within all sites of the human body, both in health and disease. 
The HMP studied two distinct geographic locations in the United States, with 242 
healthy males and females screened, in 15 and 18 body habitats respectively. This 
large study showed that the each body habitat was unique (Human Microbiome 
Project Consortium, 2012) and the bacterial diversity was much more varied than 
previously believed.  
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Following on from this study, there have been a large number of studies 
researching the microbiome with projects focused initially on identifying a 
‘healthy’ microbiome, and secondly studying the role of the microbiome in 
disease (Blaser, 2014; Lloyd-Price et al., 2016). Disturbances of the microbiome 
known as ‘dysbiosis’, has been linked to diseases such as type ІІ  diabetes (Qin et 
al., 2012), obesity (Cani, 2013; Devaraj et al., 2013; Turnbaugh et al., 2006), 
colorectal cancer (Tremaroli and Bäckhed, 2012), inflammatory bowel disease 
(Qin et al., 2010), irritable bowel syndrome (IBS) (Kassinen et al., 2007) and 
dental caries (Jiang et al., 2014).  
The human intestine is intensively studied and is colonised with an estimated 10
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to 10
14
 microorganisms, with the most abundant phyla being Bacteroidetes and 
Firmicutes (Eckburg et al., 2005; Gill et al., 2006). Research has focused on 
looking at the causative factors of disease, with factors such as age, diet and 
antibiotic intake all shown to have an impact on microbial compositional 
(Claesson et al., 2012, 2011; Francino, 2016). Other areas of microbiota research 
include body sites such as the oral cavity (Dewhirst et al., 2010; Zaura et al., 
2014), the placenta (Aagaard et al., 2014; Cao et al., 2014) and the role of the 
birth mode in shaping the microbiome of the developing neonate (Chu et al., 
2017; Dominguez-Bello et al., 2010; Lif Holgerson et al., 2011; Rutayisire et al., 
2016).  With birth mode influencing the neonatal microbiome (Dominguez-Bello 
et al., 2010; Lif Holgerson et al., 2011), each body habitat is distinct in its 
composition (i.e. skin, gut, oral cavity). 
Within the oral cavity there appears to be high microbial diversity, which is to a 
great degree site and individual specific (Aas et al., 2005; Nasidze et al., 2009). 
The Human Oral Microbiome Database currently includes 772 microbial species, 
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with 57% of these species named and 13% unnamed but cultivated 
(www.homd.org). The use of high-throughput sequencing of 16S rRNA 
amplicons and other culture independent methods has generated a deeper 
understanding of the microbiota composition in the oral cavity. In this review the 
placental, amniotic fluid, vaginal, skin microbiome are discussed, along with their 
influences on the growing fetus, and their role during birth. Post birth I discuss the 
oral microbiome development together with the influence of feeding modality 
(breast or formula feeding), antibiotic intake on the oral microbiome of infants. I 
also review the oral microbiome maturation from the newborn edentulous oral 
cavity through to childhood as the deciduous dentition emerge, with a focus on 
health and disease risk factors. While bacteria, viruses, fungi, archaea and 
protozoa are habitants of the oral microbiome (Wade, 2013), viruses, fungi, 
protozoa and archaea will not form part of this review. 
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2.3 Methods for studying the Oral Microbiome 
Research into the microorganisms within the oral cavity began back in 1963, 
when Antoni van Leeuwenhoek examined plaque taken from teeth under the 
microscope. He identified ‘little animals’ representing the first identification of 
oral bacteria (van Leeuwenhoek, 1683). Until the advent of culture independent 
methods in the early 1980s a variety of methods were used to study the microbiota 
composition of the oral cavity. These included culture, microscopy, biochemical 
analysis and immunofluorescence staining (Beighton et al., 2004; Hoshino, 1985; 
Kanasi et al., 2010; Maiden et al., 1997; Nyvad et al., 2013; Paster and Dewhirst, 
2009; Wade, 2011).  Bacterial culture was the main method for studying bacterial 
communities in the oral cavity, with particular focus on dental diseases such as 
dental caries (Beighton and Lynch, 1995; Marchant et al., 2001; Marsh, 1994; 
Rosebury, 1932).  
Before the launch of The Oral Microbiome project, around 280 species were 
identified by culture and with the development of culture independent methods, 
there is now estimated to be around 1000 species in the oral cavity (Dewhirst et 
al., 2010; Olsen, 2015; Paster and Dewhirst, 2009). One study proposed that there 
may be several thousand species in the oral cavity (Keijser et al., 2008), second to 
the colon in complexity (Human Microbiome Project Consortium, 2012). It must 
be taken into account that some species in the oral cavity may be transient in such 
an open environment and some microbes may not be permanent residents. The 
oral microbiota composition includes a diverse range of obligate aerobes and 
facultative and obligate anaerobes (Aas et al., 2005; Paster et al., 2006). Certain 
oral bacteria have strict growth requirements and are slow growing, strict 
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anaerobes and therefore when sample taking and growing these cultures, strict 
procedures must be followed to avoid any bias and a misunderstanding of oral 
microbiome composition (Aas et al., 2005; Paster et al., 2006).  
The development of culture independent methods has supported the identification 
of microbes that may have been missed by culture, through the strict and complex 
growth requirements of certain oral bacteria. As of late 2017, 32% of taxa in the 
oral cavity are uncultivable (www.homd.org) (Chen et al., 2010), and this figure 
would be even lower if we had a better understanding of their strict growth 
requirements. . While anaerobic culture plays a role in detection of microbes 
which instigate and propel dental caries, molecular methods (cloning and 
sequencing analysis) have unfortunately been shown to under represent their 
presence (Munson et al., 2004). This highlights the combined need for dual 
analysis in some studies, in combination with more advanced techniques to fully 
dissect the oral microbiome in health and disease. 
The main methods of molecular identification of bacteria are PCR based methods 
(quantitative PCR), DNA-DNA hybridization methods (16S RNA based 
microarrays) and 16S rRNA amplicon sequencing methods (Paster and Dewhirst, 
2009). The use of high-throughput sequencing of the 16S rRNA gene amplicons, 
which has both conserved parts and variable regions (n=9), with length of around 
1500bp is a major advancement on this technique. These regions are used for 
identification of the bacteria present, using PCR primer sets, which target and 
anneal to these variable regions on the 16S rRNA gene (Claesson et al., 2010; 
Schloss et al., 2011). The most recent platforms after the original 454 
pyrosequencing technology used for sequencing of 16S rRNA amplicons are the 
Illumina MiSeq and HiSeq platforms (Caporaso et al., 2012; Lin Liu et al., 2012).  
20 
 
The most critical step for accurate sequencing of 16S rRNA amplicons is  the 
decision on primer choice (Schloss et al., 2011).  Primer choice is important as 
bias can be introduced by amplifying one area, whilst aiming to get maximum 
coverage of the targeted bacteria, and under amplifying or missing other targets as 
a result of primer design (Claesson et al., 2010; Schloss et al., 2011). A large 
study of 175 primers and 512 primer pairs found that only 10 could be 
recommended as broad range primers (Klindworth et al., 2013) while use of 
primers targeting the V4-V5 hyper variable region has been shown to be most 
comparable, with the use of platforms Illumina MiSeq and HiSeq platforms 
(Fouhy et al., 2016). 
With the availability of increased read length of 300bp using Illumina MiSeq 
sequencing of the amplifiable 16S V1-V3 region, researchers have identified a 
richer and more diverse oral microbiota, using a more time efficient and cost 
effective method (Zheng et al., 2015). A study of periodontal disease in adults 
focussed on the V1-2 and V4 regions of the 16S rRNA gene (Griffen et al., 2012). 
An increasing number of studies are targeting the V3-V4 region, with increased 
read length of up to 460bp using Illumina Miseq sequencing (Zheng et al., 2015). 
The computer analyses for managing the data from the 16S rRNA amplicon gene 
sequencing are done using software including QIIME, Mother, USEARCH, 
SPINGO with statistical analysis completed using R (Allard et al., 2015; Caporaso 
et al., 2010; Schloss et al., 2009; Team RDR, n.d.). 
The HMP examined the microbiome composition of nine intraoral sites (buccal 
mucosa, hard palate, keratinized gingiva, palatine tonsils, saliva, subgingival and 
supragingival plaque, throat and tongue dorsum) from around 200 individuals and  
identified over 600 taxa, with a high diversity within the oral cavity sampling sites 
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(Dewhirst et al., 2010; Human Microbiome Project Consortium, 2012; Zhou et al., 
2013). The large data compiled from this work facilitated the development of the 
Human Oral Microbiome Database (HOMD) (Chen et al., 2010; Dewhirst et al., 
2010). This database was developed in 2010, using 16S rRNA to identify all 
genome sequences (HOMD, www.homd.org) and provides a resource for the 
identified oral taxa which are given a unique Human Oral Taxon (HOT) number, 
along with a taxonomic design for any unnamed oral bacteria (Chen et al., 2010; 
Dewhirst et al., 2010).  
Although there has been many studies examining the oral cavity both in health 
and disease (dental caries, plaque, saliva), using 16S rRNA gene sequencing to 
identify bacteria, the use of meta-transcriptomics (RNA) to assess bacterial 
activity and metabolism of the oral bacteria is limited, unlike the gut samples 
(Jorth et al., 2014; Turnbaugh et al., 2010). Using both methods could be 
complementary to one another in the study of the oral microbiota in health and 
disease states (Jorth et al., 2014). Metagenomic sequencing of the whole 
community DNA by shotgun sequencing avoids the PCR step that may introduce 
bias and sequences the whole pool of microbial genomic DNA in the sample 
which allows one to study specific genes. However this requires specific tools and 
detailed computer analysis to analyse the data and is more expensive (Gilbert et 
al., 2011; O’Toole and Flemer, 2017; Sharpton, 2014). While studies are 
continuing to use these methods to study the oral microbiota, the technology is 
constantly evolving, with studies always striving to adapt to these technical 
improvements and explore the dynamics within the oral cavity. 
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2.4 Pregnancy and microbiome changes in utero on the growing fetus. 
During pregnancy, the body goes through a number of major anatomical, 
physiological, hormonal, and metabolic and biochemical changes. As early as the 
turn of the 20
th
 century (Tissier H, 1900) it was believed that the womb was a 
sterile environment which housed and protected the growing fetus, with the 
newborn first exposed to microbes at birth directly from the mother’s birth canal 
(Funkhouser and Bordenstein, 2013). It was thought that for a healthy pregnancy 
to develop it was essential for the fetus to grow in a sterile environment and the 
presence of bacteria internally was a serious risk to the fetus. If bacteria were to 
enter the body, it was believed that the only way bacteria entered was by 
ascending up from the vagina (Goldenberg et al., 2000). The hypothesis of a fetus 
born germ-free has since been questioned (Perez-Muñoz et al., 2017) with studies 
reporting microbes present in the umbilical cord blood, amniotic fluid (DiGiulio, 
2012; DiGiulio et al., 2008; Mendz et al., 2013), foetal membranes (Steel et al., 
2005) and the placenta (Aagaard et al., 2014).  
Furthermore, the mode of delivery of the infant, C-section or vaginal delivery, has 
an influence on the microbiota of the newborn child (Biasucci et al., 2010; 
Dominguez-Bello et al., 2010). A change from a vaginal delivery to a C-sectioned 
delivery of a newborn has been shown to be hugely influential by disturbing the 
microbiota transfer from mother to infant, and this disturbance is associated with 
medical complications such as coeliac disease, asthma, autism and obesity 
(Biasucci et al., 2008; Curran et al., 2015; Decker et al., 2010; Kero et al., 2002; 
Neu and Rushing, 2011). The discovery of these complications associated with C-
sectioned delivery has increased research on the influence of birth mode on the 
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neonatal microbiota with researchers exploring the area of re-colonising the 
newborn born by C-section, with swabs from the mothers vaginal fluid, in an 
effort to replenish any important early microbes potentially lost by this disruption 
(Dominguez-Bello et al., 2016). In the next section, I discuss early colonisation 
and exchanges between mother and infant during gestation and the influences of 
birth mode, feeding practices and early microbial exchanges on the microbiome of 
the newborn. 
2.4.1 Early colonisation of the fetus.  
The hypothesis that the growing fetus is protected in a sterile environment has 
been challenged by studies examining the stool of infants born to mothers whom 
have been taking probiotics during pregnancy (Rautava et al., 2012a; Schultz et 
al., 2004). Schultz et al. administered probiotics containing Lactobacillus 
rhamnosus to six pregnant mothers and by morphological and molecular analysis, 
the probiotic was found in the stool samples of all 6 infants at 1 and 6 months of 
age (Schultz et al., 2004). Supporting this evidence of vertical transmission from 
mother to the fetus, was a study by Rautava et al. (Rautava et al., 2012a). 
Probiotics Bifidobacterium lactis, Bifidobacterium lactis with Lactobacillus 
rhamnosus GG (LGG) or placebo were administered to 43 mothers during 
pregnancy. The microbial DNA of probiotic origin was identified in the amniotic 
fluid and placenta of these women (Rautava et al., 2012a). The data provided by 
both of these studies and supported by animal models (Jiménez et al., 2008) 
indicate vertical transmission from mother to fetus and shared exchanges between 
the growing fetus and its mother.  
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2.4.2 Placental Microbiome 
The placenta has two main components; the foetal placenta (chorion frondosum),  
and the maternal placenta (Decidua basalis) (Wassenaar  and Panigrahi 2014). The 
placenta connects the growing fetus to the uterine wall, to allow the fetus to 
develop by providing nutrients and oxygen, and removing waste products from 
the fetus via the mother’s blood supply. Studies of the placental organ are limited, 
however since the development of the advanced sequencing of 16S rRNA 
amplicons and the launch of the HMP, there has been surge in researching the 
microbiology of the placenta, its surrounding environments, and the influence of 
these microbial communities on pregnancy outcome. 
A healthy pregnancy was believed to begin with a sterile placenta and sterile 
encasement of the growing fetus, but recent research has suggested the placenta to 
be rich and diverse in its microbiota composition (Aagaard et al., 2014; Stout et 
al., 2013). Microbes have been identified in the placenta and in the foetal 
membrane of both full-term and preterm subjects sampled (Steel et al., 2005; 
Stout et al., 2013). Before the launch of metagenomic studies, a study in 2013 by 
Stout at al. found evidence of bacteria localising in the placental samples. They 
performed a large cross sectional morphological study of 195 pregnant women to 
identify bacteria within samples from the basal plate of the placenta of each 
patient, in term and preterm deliveries (Stout et al. 2013). Stout et al. hypothesized 
that the cells in the basal plate of the placenta, at the maternal foetal interface, 
may be a source of microbes associated with negative pregnancy outcomes. Using 
histopathology and histochemical analysis they found that 27% of the placentas 
studied had evidence of bacteria within the cells of the placenta sampled; both 
gram negative and gram positive with all ranges of morphology. The percentage 
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of intracellular bacteria in found in the placental basal plates of spontaneous 
preterm deliveries before 28 weeks was 54.5%, and was more than double than 
that of term spontaneous deliveries (26.7%). However beyond 28 weeks delivery, 
this difference was not significant (Stout et al., 2013).  
The presence of oral microbes in the placenta were also identified by Steel et al. 
with bacteria evident in over two thirds of foetal membranes sampled after 
preterm premature rupture of membranes (PPROM) or after a preterm labour, 
using Fluorescence in situ hybridisation (FISH) (Steel et al., 2005). Sweeney et al.  
identified a high abundance of Ureaplasma spp. associated with chorioamnionitis 
in both preterm and term placental samples (Sweeney et al., 2016). 
Chorioamnionitis is inflammation of the foetal membranes (amnion and chorion) 
due to an intra-amniotic infection (IAI). Prince et al., found that those preterm 
subjects with severe chorioamnionitis had high abundances of Ureaplasma 
parvum, Fusobacterium nucleatum, and Streptococcus agalactiae within the 
placental membranes (Prince et al., 2016). Using whole genome shotgun 
sequencing, Prince et al. compared the placental membrane microbiome and cord 
blood cytokine levels of term gestations, with and without chorioamnionitis and 
preterm with and without chorioamnionitis. They found increased levels of 
inflammatory cytokines in the cord blood samples of preterm subjects, and high 
levels of oral and urogenital bacteria (Ureaplasma parvum, Fusobacterium 
nucleatum and Streptococcus agalactiae) they hypothesise could be a factor that 
increases risk of preterm birth (Prince et al., 2016).  
Ureaplasma species are the most common pathogens associated with preterm 
birth and have been identified in the amniotic fluid and vagina of patients with 
preterm labours (DiGiulio, 2012; DiGiulio et al., 2015; Kacerovsky et al., 2015; 
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Kasper et al., 2010; Kikhney et al., 2017; Romero et al., 2014b; Yoon et al., 
1998). Using high-throughput sequencing a  study of the placental microbiome by 
Aagaard et al. (Aagaard et al., 2014) characterized the placenta as harbouring a 
‘unique microbiome’. However the presence of a ‘unique’ microbiome in the 
placenta has recently been challenged due to high levels of bacterial 
contamination in the DNA extraction kits (Lauder et al., 2016). (See Table 2.1 for 
summary of placental metagenomic studies). 
Placental biopsies from healthy mothers (n=320) of full-term births were 
examined by 16S ribosomal DNA-based and whole-genome shotgun (WGS) 
metagenomics (Aagaard et al., 2014). The taxa and the genes identified were 
compared to previous microbiome analysis of other body sites (oral, skin, nasal 
airway, vaginal and intestinal microbiomes) from the HMP database (Aagaard et 
al., 2014; Human Microbiome Project Consortium, 2012). This comparison 
demonstrated that the placenta harboured taxa Firmicutes, Proteobacteria, 
Bacteroides and Fusobacteria, and found similarities between these the microbes 
within the placenta to those isolated from the oral cavity (Aagaard et al., 2014; 
Human Microbiome Project Consortium, 2012; The Human Microbiome Project 
Consortium, 2012) . The similarity of the placental microbiome to that of the oral 
cavity further supports the strong link  between the oral microbes of periodontal 
disease with preterm birth, and poor pregnancy outcomes (Ercan et al., 2013; 
Goldenberg et al., 2008; Offenbacher et al., 1998). This suggests spread of 
periodontal pathogenic bacteria to the fetus (Fardini et al., 2010; Han et al., 2006) 
while a blood borne route is the most likely pathway for bacteria to travel to the 
placenta (Goldenberg and Culhane, 2006; Han, 2011; Amanda L Prince et al., 
2014). 
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If these periodontal microbes have the ability to travel in the bloodstream and 
reach the amniotic fluid and placenta of the growing fetus, the question remains as 
to why these oral bacteria are the main causative pathogens to accelerate preterm 
birth, and how these microbes avoid the immune system and target the developing 
fetus. The oral microbe Fusobacterium nucleatum has been located in the 
amniotic fluid (Bearfield et al., 2002) and the placenta (Aagaard et al., 2014; 
Blanc et al., 2015) of pregnant women, and this bacterium has been shown to 
cause increased vascular permeability, allowing for the growth of other 
pathogenic bacteria such as Escherichia coli (Fardini et al., 2010).  
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Table 2.1. Recent microbiome studies investigating the placenta, amniotic fluid, 
vagina, oral microbiome and birth mode influence on the neonatal microbiota. 
 
Study Sampling 
site 
Pregnancy status Outcomes 
(Han et al. 2006) Amniotic 
fluid 
Amniotic fluid Bergeyella spp.  was detected in 
the sub gingival plaque of the 
patient and amniotic fluid but not 
in her vaginal tract. 
(Zhou et al. 2007) Vagina Vaginal communities Caucasian v 
Black women (non-pregnant) 
Vaginal communities different 
among these racial groups: 
lactobacilli lower in black 
women v Caucasians 
(DiGiulio et al. 2008) Amniotic 
fluid 
Amniotic fluid The amniotic cavity of women in 
preterm labour harbours DNA of 
a greater diversity including  
microbes:Sneathia sanguinegens, 
Leptotrichia amnionii and an, 
uncultivated bacterium 
(Ravel et al. 2011) Vagina Non pregnant African-American women have a 
vaginal microbiome more likely 
not dominated by Lactobacillus. 
(Human Microbiome 
Project Consortium 
2012) 
Vagina, skin, 
oral cavity 
and other 
body sites 
Non Pregnant All body sites characterised.  
(Aagaard et al. 2012) Vagina Pregnant Diversity and species richness 
reduced in pregnancy with 
dominance of Lactobacillus. 
(Stout et al., 2013) Placenta Term & preterm Placental basal 
plates 
Intracellular bacteria at higher 
levels in placental basal plate 
associated with preterm 
deliveries. No difference was 
noted between placental basal 
plate of preterm and term 
deliveries. 
(Aagaard et al. 2014) Placenta Pregnant v Human microbiome data 
base (non pregnant) 
Placenta microbiome most 
similar to Oral microbiome 
(containing F. nucleatum) 
(Hyman et al. 2014) Vagina Pregnant; preterm birth Change in microbial composition 
did not correlate with PTB 
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(Romero, Hassan, Gajer, 
Tarca, Fadrosh, Bieda, 
et al. 2014) 
Vagina Pregnant women with Preterm 
births. Case control study. 
The composition of the vaginal 
microbiota changes as pregnancy 
advanced, with differences were 
not noted in those that had a 
spontaneous preterm delivery 
    
(Walther-António et al., 
2014) 
Vagina Pregnant: longitudinal Vaginal microbiome is one of 
low diversity and high stability 
during pregnancy 
(Romero, Hassan, Gajer, 
Tarca, Fadrosh, Nikita, 
et al. 2014) 
Vagina Pregnant and non-pregnant Difference in the stability and 
composition between Non 
Pregnant and Pregnant vaginal 
microbiome. 
(DiGiulio et al. 2015) Vagina, gut, 
saliva 
Pregnant: samples taken before and 
after delivery. Included preterm 
deliveries. Case control study 
Microbiota composition and 
diversity during pregnancy 
remained stable. There was an 
abrupt change in vaginal 
composition after birth, 
(MacIntyre et al. 2015) Vagina Pregnant: longitudinal study: during 
pregnancy 
The vaginal microbiome changes 
dramatically after birth, during 
pregnancy the vaginal 
microbiome shows low diversity. 
(Prince et al. 2016) Placenta Pregnant :preterm Placental microbiome changed 
with the alteration in severity of 
chorioamnionitis, and this in PT 
subjects there was higher 
abundance of urogenital and oral 
bacteria. 
    
(Bokulich et al. 2016) Stool, 
vaginal, rectal 
swab from 
mothers 
During Pregnancy and after birth Birth mode, feeding practice and 
antibiotic intake influence the 
newborns acquisition and 
structure in the first 2 years of 
life. 
 
(Dominguez-Bello et al. 
2016) 
 
Mode of 
delivery 
(vaginal, skin, 
oral 
microbiome 
 
Pregnant: samples taken from 
mother (skin, vaginal, saliva) before  
birth and from newborn infant after 
birth (saliva, fecal) 
 
Birth mode influences the initial 
microbiota of infant between 
multiple sites of infant (skin, 
saliva, fecal). 
 
(Chu et al., 2017) 
 
Mode of 
delivery (at 
delivery and 6 
weeks after 
birth:Nares 
skin, saliva, 
vagina, fecal) 
 
Pregnant women at delivery and 
their newborn at birth and 6 weeks 
after 
 
Microbiota structure in infant 
driven by body site, not by 
delivery 
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2.5 Influence of birth mode and maternal microbiota on the neonatal 
microbiota. 
2.5.1 Vaginal Microbiome 
The vaginal microbiome in pregnancy plays a very important role in both the 
maternal health and also that of the growing fetus health outcomes. In the early 
nineteenth century the presence and importance of Lactobacillus species was 
noticed within vaginal secretions (Thomas, 1928). Thomas described what he saw 
as “a gram positive non-spore forming rod, sometimes quite long and slender, 
with square or very slightly tapering ends occurring singly or in chains” (Thomas, 
1928). 
Studies of the bacteria present in the vagina, similar to other body sites have been 
limited because many taxa are unculturable and certain bacteria remained 
undetected. With recent advances in culture independent approaches, there has 
been a shift and improvement in our understanding of the vaginal microbiome 
both in health and disease, and particularly during pregnancy (Fettweis et al., 
2012a; Huang et al., 2014).( See Table 2.1 for summary of metagenomic studies). 
The HMP along with other studies have identified microbiota variance within the 
sample location points of the vagina itself (lower, upper vagina and cervix) (Kim 
et al., 2009). Other studies are focusing on longitudinal analysis to record this 
diversity within the vagina over time, with a particular focus on any evidence for 
any dynamics within the vaginal microbiota (Fredricks 2011; Xiao et al. 2016). 
Using high-throughput sequencing of 16S rRNA amplicons and whole genome 
shotgun (WGS) sequencing, studies of the vaginal flora of healthy pregnant 
(gravid) and of non-pregnant (non-gravid) women have advanced significantly. 
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These studies have coincided with the increase of research focusing on vaginal 
flora with preterm and PPROM (preterm pregnant rupture of the membranes) 
affected mothers (Fettweis et al., 2012a). In the following sections I discuss the 
vaginal microbiome of non-pregnant (non-gravid) women, and pregnant (gravid) 
women and also discuss the changes within the vaginal flora during pregnancy 
which can lead to preterm births (see Figure 2.1). The importance of the vaginal 
microbiota is highlighted, in particular for women who suffer from pregnancy 
complications as a result of imbalances of their vaginal microbiota.  
 
2.5.1.1 Vaginal Microbiota: Non-gravid 
The vaginal microbiome is unique and undergoes changes in its community from 
birth to puberty to menopause (Hickey et al., 2012). There are changes associated 
with both menstrual cycles and sexual activity and hormones are said to play a 
role in these changes (Brotman et al., 2014; Hickey et al., 2012; Johnson et al., 
1985; Lorenz et al., 2015). The vaginal microbiome was one of the body sites 
examined as part of the Human Microbiome Project (HMP) (Human Microbiome 
Project Consortium, 2012). Following on from this initial work by the HMP was 
the development of ‘The Vaginal Human Microbiome Project’ at Virginia 
Commonwealth University (VCU) (Fettweis et al., 2012a, 2012b). This project 
studied the vaginal microbiome of women and focused on the microbiota changes 
within the vaginal microbiome when exposed to infection or physiological 
conditions such as the menopause (Fettweis et al., 2012a). Similar to the Human 
Oral Microbiome Database (HOMD), a 16S rRNA reference database of taxa 
found in the vaginal microbiome has been developed, along with a method 
developed to classify species present termed STIRRUPS (Species-level Taxon 
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Identification of rDNA Reads using a USEARCH Pipeline Strategy) (Fettweis et 
al., 2012b). 
The HMP established that the vaginal microbiome is of lower diversity compared 
to other body sites such as the oral cavity (Dewhirst et al., 2010; Human 
Microbiome Project Consortium, 2012). The vaginal microbiota is inhabitated by 
more than 200 bacterial species, with a dominance of Lactobacillus which 
outweighs other microbes during the reproductive years of the female. 
Lactobacillus were first cultivated and identified from vaginal secretions in the 
late 19
th
 century, and believed to play a role in protecting the vaginal environment 
from harmful microorganisms (Doderlein, 1928). These bacteria produce lactic 
acid, lowering the pH to an average pH of 4 +/- 0.5 (Tevi-Benissan et al., 1997) 
and producing bacteriocins (Dover et al., 2008) playing a role in protecting the 
vagina, and also protecting the unborn fetus by inhibiting pathogenic bacteria 
growth (Goplerud et al., 1976; Moberg et al., 1978). 
Culture independent methods have identified different five vaginal microbial 
communities evident in healthy non-pregnant women of reproductive age, four of 
which are dominated by one of the following Lactobacillus species: Lactobacillus 
iners, Lactobacillus crispatus, Lactobacillus jensenii, and Lactobacillus gasseri 
(Ravel et al., 2011). The five groups labelled as ‘community state types (CST’s)’ 
(CST I to CST IV). The fifth group is characterised by low levels of Lactobacillus 
species, with increased presence of anaerobic microbes including Prevotella, 
Gardnerella, and Sneathia. The predominant species in a healthy vagina has been 
identified as L. crispatus (Antonio et al., 1999), but with the availability of culture 
independent methods, studies have found L. iners present in very high abundance 
although previously undetectable through culture studies (Falsen et al., 1999; 
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Zhou et al., 2004). Ravel et al. found that L. iners was detectable in nearly 85% of 
396 healthy women sampled, followed by L. crispatus, L. gasseri and L. jensenii 
in descending order. They also detected that women whose lower genital tract 
microbiota was dominated by Lactobacillus, the pH was typically 4–4.5 (Ravel et 
al., 2011). When the genital tract microbiota was not dominated by Lactobacillus, 
the pH was >5.5 (Ravel et al., 2011). The low pH together with high Lactobacillus 
levels have an important role to play in resistance of HIV transmission (Borgdorff 
et al., 2014; Mirmonsef and Spear, 2014). Bacteriocins are antimicrobial peptides, 
produced by Lactobacillus species, causing breakdown of the membranes of 
antagonistic microbes. Lactobacillus species do not cause vaginal irritation and 
have a role to prevent bacterial infections of the vagina such as Bacterial 
Vaginosis (BV) (Dover et al., 2008; Klaenhammer, 1988). 
Bacterial vaginosis (BV) is an infection of the vagina as a result of change in the 
vaginal microbiota composition, which affects millions of women every year, and 
is associated with a two-fold increased risk of preterm delivery (Hillier et al., 
1995; Leitich et al., 2003). BV is associated with a shift from high abundances of 
Lactobacillus species to a more polymicrobial community (Onderdonk et al., 
2016). When Lactobacillus species are in low abundance other anaerobic bacteria 
can thrive in a slightly higher pH (5.3-5.5). Genera such as Prevotella, 
Gardnerella, Sneathia, Corynebacterium, Anaerococcus and anaerobic species 
such as Gardnerella vaginalis and Mycoplasma hominis have been isolated at this 
higher pH level and this finding highlights the important protective role 
Lactobacillus plays (Hillier et al., 1995). BV in non-pregnant women is associated 
with the acquisition of sexually transmitted infections and other chronic health 
problems, while during pregnancy it is associated with increased risk of preterm 
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birth (Hillier et al., 1995; Leitich et al., 2003), preterm premature rupture of 
membranes (PPROMS) and miscarriage (Lamont et al., 2011). Zhou et al, (Zhou 
et al., 2007) found differences in the composition of vaginal communities in 
different racial groups (Caucasian and black women), with Lactobacillus less 
dominant in black women compared to Caucasian women. These findings suggest 
that this vaginal microbiota difference may partly account for the known 
susceptibility of women in these racial groups to bacterial vaginosis (BV) and 
sexually transmitted diseases. Ling et al. (Ling et al., 2010) studied the vaginal 
microbiota diversity and richness of 50 women with BV and compared these to 50 
healthy women. They found that there was a higher number of phylotypes 
associated with BV and three phyla (Bacteroidetes, Actinobacteria and 
Fusobacteria) were strongly associated with BV and with BV, there is an increase 
in richness and diversity, compared to the healthy vaginal communities. (Ling et 
al., 2010; Srinivasan et al., 2012). These BV bacteria are labelled as BV-
associated bacteria (BVAB) (Onderdonk et al., 2016).  
There is supporting evidence to suggest that BV is caused by a change in bacterial 
communities from a Lactobacillus rich community to a more polymicrobial 
community with greater species richness and diversity and a higher abundance of 
anaerobic bacteria (Onderdonk et al., 2016; Srinivasan et al., 2012). What is not 
fully clear is whether these microorganisms associated with BV are opportunistic 
causing an increase in the pH or are pathogenic (Ma et al., 2012).  
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2.5.1.2 Vaginal Microbiota: gravid 
Understanding the diversity and composition of the vaginal microbiome in non-
pregnant women is an important foundation to have before comparing the role of 
the vaginal microbiota in pregnant women, in both health and disease states. 
Studies have found differences between the vaginal microbiome diversity and 
stability in gravid and non-gravid women (Aagaard et al., 2012; Huang et al., 
2014; Prince et al., 2014a; Prince et al., 2014b; Romero et al., 2014b; Walther-
António et al., 2014). Of importance to our understanding of the vaginal 
microbiome is observing these changes and the effect the changes have on the 
imbalance within the vaginal microbiome community, especially when imbalance 
can have a negative impact on the growing fetus during pregnancy. Also, because 
the passage of the newborn through the vaginal birth canal has been shown to 
have an impact on the neonatal microbiome (Dominguez-Bello et al., 2010; 
Grönlund et al., 1999; Penders et al., 2006; Turnbaugh et al., 2009) a detailed 
overview of the vaginal microbiota is discussed, before discussing the role of the 
vaginal microbiota during birth. 
During pregnancy, there are many changes in hormone levels, such as oestrogen 
and progesterone, along with physiological changes in the vaginal epithelium. It is 
thought that oestrogen has a role to play in changing the composition of the 
vaginal microbiome by providing a source of energy for Lactobacillus to increase 
in abundance (MacIntyre et al., 2015). During pregnancy glycogen is deposited 
within the epithelium of the vaginal wall and when oestrogen levels rise this 
glycogen is metabolised to lactic acid, maintaining a low pH (<4.5) (Boskey et al., 
2001). This low pH prevents the growth of other bacteria (Nasioudis et al., 2015), 
while after birth oestrogen levels fall 100-1000 fold within the first week after 
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giving birth (Nott et al., 1976). This illustrates the role Lactobacillus has during 
pregnancy in providing protection to prevent ascending infections, leading to 
preterm birth (Aagaard et al., 2012).  
There have only been a few studies using culture-independent methods to study 
the vaginal microbiome during pregnancy (Aagaard et al., 2012; Romero et al., 
2014c; Verhelst et al., 2004). Some studies have focused on the vaginal 
microbiome of the mother during gestation, close to delivery and after birth 
(DiGiulio et al., 2015; MacIntyre et al., 2015; Romero et al., 2014c). Their 
findings have illustrated the low diversity and high stability of the vaginal 
microbiome during pregnancy (Aagaard et al., 2012; Hyman et al., 2014; Romero 
et al., 2014b) and compositional differences between vaginal sampling site (lower, 
upper vagina and cervix) (Kim et al., 2009). 
It is believed that pregnancy causes a shift in the vaginal microbiota to a 
microbiota of lower diversity and of increased stability dominated by one or two 
Lactobacillus species (Aagaard et al., 2012; Romero et al., 2014c). Aagaard et al. 
(2012) defined a ‘pregnant vaginal microbiome’ at 3 sites; posterior fornix, mid 
vagina & vaginal introitus (Aagaard et al. 2012b). Similar to their methodology 
with their study of the placental microbiome (Aagaard et al. 2014) , Aagaard et 
al., (Aagaard et al. 2012b) demonstrated that the vaginal microbial community 
changed as the growing fetus increased in gestational age and also by closeness to 
the cervix (Prince et al. 2014a; Aagaard et al. 2012b). The microbial communities 
at the preterm stage (<32 weeks) were found to be less diverse and less complex 
than those sampled beyond 32 weeks. During pregnancy, both diversity and 
richness were reduced, with a dominance of Lactobacillus species (L. iners, 
crispatus, jensenii and johnsonii). The increase in Lactobacillus species 
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abundance in gravid subjects furthermore suggests a distinct community in gravid 
versus non-gravid women, and a classification of the vaginal microbiota into 
different community state types (CSTs) as previously described (Ravel et al. 
2011). Walther et al., also showed that during pregnancy microbiota diversity was 
reduced with higher stability and a high abundance of L. crispatus (Walther-
António et al., 2014). Romero et al. found that the vaginal microbiota of pregnant 
women had a higher abundance of Lactobacillus vaginalis, L. crispatus, L. gasseri 
and L. jensenii (Romero et al., 2014c). The dominance of Lactobacillus species 
varies according to ethnic groups with L. gasseri absent in black women, and L. 
jensenii present in Asian and Caucasian women (MacIntyre et al., 2015).  
To investigate the vaginal microbiota changes before and after pregnancy, studies 
have included pre-delivery and post-partum samples, and have identified that after 
birth there is a change and restructuring of the vaginal microbiome community. 
MacIntyre et al. sampled the vaginal microbiome of 42 British women during 
pregnancy and again 6 weeks post birth and found Bacilli dominated during 
pregnancy but after birth, the vaginal microbiome shifted with increased 
Clostridia and Bacteriodia, and decreased Lactobacillus species (MacIntyre et al., 
2015). Huang et al. also identified a change in the microbiota diversity levels  
during the different trimesters and after birth (Huang et al., 2015), while DiGiulio 
et al. illustrated a decrease in Lactobacillus species levels after birth, with an 
increased abundance of anaerobes like Prevotella and Anaerococcus species 
(DiGiulio et al., 2015).  
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2.5.2 Skin Microbiome 
The skin is the largest organ of the body and because of its external exposure, it 
can be colonised by a huge variety of microorganisms, which demonstrate 
differences in colonisation depending on skin site i.e. retroauricular creases, 
antecubital fossa, anterior nares (Human Microbiome Project Consortium, 2012). 
An estimated 1 million bacteria, with hundreds of distinct species, inhabit each 
square centimetre of skin (Grice et al., 2008). The primary role of the skin is to act 
as a physical barrier, protecting the body, by renewing itself every 3-4 weeks. The 
bacterial ecology of the skin can be affected by such factors such as environment, 
immune system, lifestyle and underlying conditions such as diabetes (Grice and 
Segre, 2011).  
Metagenomic analysis has shown that the profile of skin bacteria is different in 
moist areas of the skin (navel, groin, behind the knee, inner elbow) versus dry 
areas of the skin (forearm, buttock, various parts of the arm) (Grice et al., 2009; 
Grice and Segre, 2011). Staphylococcus and Cornebacterium species are most 
abundant in the moist habitats, whereas in dry areas, gram negatives are in 
abundance, and there is a mixed abundance of phyla Proteobacteria, Firmicutes 
and Bacteriodetes (Grice et al., 2008). Studies have found variability within 
habitats and between people (Costello et al., 2009; Grice et al., 2009). 
In utero, the skin of a fetus is surrounded and protected by amniotic fluid, but 
minutes after birth the skin of the newborn is colonised by increased microbial 
numbers by the surrounding  microbe-rich air (Capone et al., 2011; Dominguez-
Bello et al., 2010; Sarkany and Gaylarde, 1968).  As mentioned, delivery mode, 
environment, hospital workers and equipment can influence the bacteria that 
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colonise the infant. Early skin-to-skin contact from mother to infant evokes 
neuron-signals between mother and their newborn infant (Moore et al., 2012) and 
early skin-to-skin contact of a mother and her preterm neonate, has been shown to 
have a positive effect on the oral microbiota development of the neonate, with 
increased Streptococcus levels in infants where skin-to-skin contact was 
undertaken, while levels of Corynebacterium and Pseudomonas were at increased 
levels in the oral cavity of those infants whom did not partake in early skin-to-skin 
contact (Hendricks-Muñoz et al., 2015). During the first few days of life the 
newborn baby comes into contact with many microbes and matures from a skin 
microbiota of high numbers of Staphylococcus species to one of increased 
diversity and composition (Capone et al., 2011).  
It has been shown that vaginally delivered infants are colonised with bacterial 
communities most like the vaginal communities of their mothers, whereas infants 
delivered via C-section have bacterial communities most like their mothers skin 
microbiota (Dominguez-Bello et al., 2010). This influence was observed in the 
first 24 hours, although Capone et al. did not see any clear separation with the 
mode of delivery influence on the microbiota of infants tested, in the youngest 
group of 1-3 months of age (Capone et al., 2011). The authors suggested that the 
skin microbiome in early life is very unstable and evolves over the first year to 
one of increased diversity and perhaps beyond one year of age (Capone et al., 
2011). 
During the first year of life, the skin undergoes maturation and becomes more 
adult-like after one year of age (Nikolovski et al., 2008). The infant skin has a 
thinner epidermis and stratum corneum until at least the second year of life 
(Stamatas et al., 2011). The infant skin and preterm skin differs from adult skin in 
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structure and function, and  these characteristics poses the preterm skin at higher 
risk of pathogen attack (Stamatas et al., 2011, 2010). Infant skin is dominated 
mainly by the phylum Firmicutes, followed by Actinobacteria, Proteobacteria and 
Bacteroidetes (Capone et al., 2011). Adult skin is dominated by Proteobacteria, 
followed by phyla Actinobacteria and Firmicutes (Costello et al., 2009; Grice et 
al., 2009).  
A study of preterm skin illustrated an increased abundance of Firmicutes and 
decreased Proteobacteria compared to term neonates, whom presented with 
increased Staphylococcus, Corynebacterium and Prevotella levels (Pammi et al., 
2017). The high abundance of Staphylococcus species on the skin are believed to 
increase the immunity of the skin, preventing the growth and colonisation of 
pathogenic species (Iwase et al., 2010).  
While birth mode did not seem to affect the diversity of the skin microbiota at 
birth of preterm infants (Salava et al., 2017) and of term infants (Capone et al., 
2011), the influence of birth mode has been identified with C-section infants 
acquiring the maternal skin microbiota including Staphylococcus species 
(Dominguez-Bello et al., 2010). Because of the interruption in vertical transfer of 
vaginally microbiota caused by a C-section delivery, this may lead to a different 
pathway in the succession of bacteria to the newborn infant. As a result, efforts 
and studies are now focused into how one can restore the beneficial maternal 
vaginal microbiota to a C-sectioned delivered infant. One such study 
demonstrated that partial restoration of the maternal vaginal microbes can be 
accomplished artificially by replenishing the newborn born by C-section with 
these vaginal microbes in the first month of life (Dominguez-Bello et al., 2016). 
By studying the skin microbiota newborns, born preterm or full-term, and 
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examining the changes from birth over time this will aid in development of 
beneficial skin probiotics and prebiotics for those with skin conditions or poor 
skin health (Al-Ghazzewi and Tester, 2014; Krutmann, 2009), similar to the 
increased focus aiming to improve gut health with such beneficial bacteria (Neu, 
2014).  Because C-sectioned infants have been shown to have a lower diversity 
within their oral microbiota (Lif Holgerson et al., 2011), it would be important to 
investigate the potential impact the skin microbiota has on the oral microbiota of 
the newborn and infant, in particular if any disturbances would lead to a poorer 
oral health outcome (Barfod et al., 2012; Nelun Barfod et al., 2011). 
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2.5.3 Preterm birth: the role of the oral, placental and vaginal microbiome in 
Preterm birth. 
Preterm births are defined as “babies born alive before 37 weeks of pregnancy are 
completed”. One quarter of preterm births have been linked with a bacterial 
invasion into the amniotic fluid and sac (DiGiulio et al., 2008; Goldenberg et al., 
2008; Romero et al., 2014a). In 2005, the World Health Organisation estimated 
that 12.9 million births worldwide were preterm, and in 2014 this figure rose to an 
estimated 15 million births per year (World Health Organisation report November 
2014). Factors contributing to infants delivering less than 37 weeks gestational 
age are (1) spontaneous labour with intact membranes, (2) preterm premature 
rupture of the membranes (PPROM) and (3) labour induction or caesarean 
delivery due to pregnancy complication such as pre-eclampsia (Bobetsis et al., 
2006; Goldenberg et al., 2008). Preterm birth is the leading cause of infant 
mortality and morbidity and linked to 5 to 18% of pregnancies (Li Liu et al., 
2012; Romero et al., 2014a).  
Bacterial infection is associated with pregnancy complications, along with other 
factors such as diet and excess gestational weight gain (Antony et al., 2015; 
DiGiulio et al., 2008; Donders et al., 2009; Hillier et al., 1995). Studies have 
found a strong link between intrauterine infection and preterm labour. It is thought 
that ascending bacterial infection is a cause of 40-50 % of preterm births (Witkin, 
2015), with other correlations linking oral infection and amniotic/placental 
infection with pregnancy complications, illustrating a bloodborne route for 
bacterial invasion (Fardini et al., 2010; Hill, 1998). 
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Understanding the role of changes in the levels of Lactobacillus species such as 
those found in healthy pregnancy vaginal microbiome (L. iners, crispatus, jensenii 
and johnsonii) (Aagaard et al., 2012) are important in understanding the affect this 
has on the vaginal microbiome and adverse pregnancy outcomes. These decreased 
levels of Lactobacillus species are replaced by high abundance of Streptococcus, 
Staphylococcus, Prevotella, Gardnerella and vaginal candidiasis and is associated 
with preterm births and inflammatory diseases (Holst et al., 1994; Onderdonk et 
al., 2016; Wijgert and Jespers, 2017). This change in the structure of the vaginal 
microbial community has been shown to be linked with preterm birth through 
culture studies (Fredricks et al. 2005; Hillier et al. 1995), but there are few studies 
using metagenomics to illustrate this link.  
Recently, Hyman et al. (2014) looked to investigate if preterm birth was linked 
with the vaginal microbiome during pregnancy (Hyman et al. 2014). They found 
that changes in the vaginal microbiome were linked with preterm birth, and found 
a higher alpha diversity in those born preterm. A higher alpha diversity was also 
found in the vaginal community by Romero et al. (Romero et al., 2014b). Hyman 
et al. (2014) did however find a dominance of Lactobacillus in the vaginal 
communities of all women, with no difference in that of term and preterm 
mothers, but identified Bifidobacterium and Ureaplasma in high abundance in 
two mothers with preterm births.   
To identify the risks posed to mothers of early delivery of their newborn baby, it 
is important to understand the bacterial community in pregnant women during a 
non-complicated pregnancy and in non-pregnant women. Digiulio et al. identified 
very low abundances of Lactobacillus species in the vaginal microbiota of 
mothers whom delivered preterm infants, while overall the diversity  was higher 
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in their vaginal microbiome (DiGiulio et al., 2015). The altered vaginal 
composition early in gestation was a early sign of poor pregnancy outcome for 
these mothers and linked with preterm birth (DiGiulio et al., 2015). Hyman et al., 
demonstrated a link between high alpha diversity in the vaginal microbiome and 
preterm birth (Hyman et al., 2014). Romero et al., did not find such an association 
(Romero et al., 2014c).  
 
Figure 2.1. The Vaginal Microbiota composition of non-pregnant (non-
gravid), pregnant (Gravid) and vaginal microbiome of mothers whom 
delivered preterm neonates. References: (Aagaard et al., 2012; DiGiulio et al., 2015; 
Fettweis et al., 2014; Huang et al., 2014, 2015; Lamont et al., 2011; MacIntyre et al., 2015; 
Romero et al., 2014b; Walther-António et al., 2014) 
 
 
 
 
Gravid: Increased stability, 
decreased diversity. 
Majority Lactobacillus spp. 
(L. vaginalis, L. crispatus, L. 
gasseri and L. jensenii) 
Non-Gravid:  
L. iners, L. crispatus, L. 
jensenii, and L. gasseri 
Preterm: Increased 
L.crispatus. , 
Ureaplasma, 
Gardnerella. 
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It is believed that oral microbes can travel to the placenta and amniotic fluid via a 
blood borne route (Fardini et al., 2010; Han et al., 2006), and these findings have 
challenged the concept of the ‘sterile womb’ (Mueller et al., 2014; Perez-Muñoz 
et al., 2017). The identification of oral bacteria in the amniotic fluid of patients 
with preterm labour (Madianos et al., 2013) and in the placenta of pregnant 
women (Aagaard et al., 2014), have increased the energy of focus to study both 
the placenta and amniotic fluid with the advancement of technologies. Aagaard et 
al. showed that the placenta harbours taxa Firmicutes, Proteobacteria, Bacteroides 
and Fusobacteria, with the bacteria most similar to microbes located in the human 
oral cavity (Aagaard et al., 2014). Using more simplified methods (Histology & 
FISH), two research groups have shown that the placental samples were more 
likely to harbour intracellular bacteria, in women whom have shorter gestations, 
compared to those that have longer full-term gestations (Steel et al., 2005; Stout et 
al., 2013). These intracellular bacteria were at a higher level in preterm deliveries 
(Stout et al., 2013).  
Prince et al. detected a high abundance of oral bacteria in placental membrane 
tissue from preterm subjects with chorioamnionitis (Prince et al., 2016). These 
bacteria included Streptococcus and Fusobacterium species while preterm 
subjects with more severe chorioamnionitis had higher abundances of 
Ureaplasma parvum, Fusobacterium nucleatum, and Streptococcus agalactiae. 
Interestingly, Ureaplasma species were isolated from chorioamnion tissue and 
cord blood samples, and found to be associated with chorioamnionitis (intra-
amniotic infection) in moderate/late preterm and term placenta (Sweeney et al., 
2016).  
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The finding of oral species in the placental samples is in concordance with 
isolation of similar oral species from the amniotic fluid examined (Bearfield et al., 
2002). Han et al. identified Bergeyella species in the amniotic fluid and from the 
subgingival plaque of the same subjects examined, and when the vaginal cavity 
was examined this species was not identified suggesting the transmission from the 
oral cavity to the amniotic fluid (Han et al., 2006). The oral microbe 
Fusobacterium nucleatum has been located in the amniotic fluid (Bearfield et al. 
2002) and in the placenta (Blanc et al. 2015; Aagaard et al. 2014) of pregnant 
women, and this species has been shown to cause increased vascular permeability 
(Fardini et al. 2010).   
There is a longstanding link between periodontal disease and preterm birth 
(Goldenberg and Culhane, 2006) and it is thought that the presence of periodontal 
disease can facilitate the transport of microbes from the periodontal site within 
blood to the placental-fetal interface;  stimulating an inflammatory response 
which can trigger preterm delivery. Gram negative bacteria are the main causes of 
chronic periodontal disease. Bacteria such as Porphyromonas gingivalis, 
Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans 
(Norskov-Lauritsen and Kilian, 2006) are the main culprits, which trigger 
significant amounts of proinflammatory mediators, mainly IL-1β, IL-6, PGE2, 
and TNF-α (Pihlstrom et al., 2005). It is believed that the initiation of an immune 
response to these bacteria in the placenta and fetal circulation may stimulate 
preterm birth or cause structural changes in the placenta, which then leads to early 
birth (Madianos et al., 2013). These periodontal bacteria along with Tannerella 
forsythia, Tannerella denticola, and Capnocytophaga species have been identified 
at higher levels in the saliva of mothers who deliver preterm infants, which 
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suggested a role for these microbes in pregnancy outcome (Chen et al., 2012; Ide 
and Papapanou, 2013; Santa Cruz et al., 2013).  
Animal studies have shown that infections with periodontal pathogens increase 
levels of circulating Interleukin (IL) IL-1β, IL-6, IL-8, IL-17, and TNF-α to 
induce preterm birth (Ren and Du, 2017). Han et al., have identified pro 
inflammatory cytokine (e.g. IL-6) at increased levels in the amniotic fluid of 
preterm mothers, produced as a response to interuterine infection. Elevated levels 
of pro-inflammatory cytokines IL-6, IFN-γ and TNF-α have been observed in the 
umbilical cord blood of preterm subjects compared to full-term subjects (Zhong et 
al., 2016). Contrary to this finding, increased levels of anti-inflammatory 
cytokines (IL-10) were found in the amniotic fluid of preterm subjects, suggesting 
a role in dampening the inflammatory response (Greig et al., 1995).  
The stimulation of an immune response during pregnancy has been suggested to 
act as a protective measure to prevent rejection of the fetus and prepares the fetus 
for life outside of the womb. In addition, antimicrobial peptides (AMPs) are 
released into the amniotic fluid during pregnancy and act as a chemical barrier for 
ascending infections. These AMPs are found in the amniotic membranes in the 
placenta and it is believed that their presence may be the reason why researchers 
have not found viable bacteria in the placentas that they have examined (Perez-
Muñoz et al., 2017).  
We have widened our thinking from the concept of sterility within the womb, to 
infection ascending up from the vagina, to the additional source of haematogenous 
spread of microbes, in particular from the oral cavity. While studies have 
identified differences in abundances of the placental bacterial communities in 
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preterm versus full-term births (Romero et al., 2014c), no significant differences 
were seen between preterm and term placentas using histology staining of 
placental samples in another study (Stout et al., 2013). Avoidance of sampling 
error is critical to prevent any contamination. This is especially important to keep 
in mind when collecting ‘sterile’ samples from an in utero environment is 
extremely difficult, immediately after delivery of a newborn in a busy hospital 
setting. Also there has been evidence of contamination of samples from DNA 
extraction kits, and controls are seen as a necessity alongside samples tested 
(Lauder et al., 2016). Along with using culture, immunological and morphological 
studies, the use of current and advancing technologies in microbiome research are 
needed to validate the microbial signatures in the placenta, oral cavity, amniotic 
fluid and vagina of pregnant women, to help with the understanding of possible 
triggers or risk factors for preterm birth. 
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Figure 2.2. The microbiota compositional differences in each body site of 
mother and infant. The microbiota compositional differences are described for 
each body site of the mother (placenta, amniotic fluid, oral cavity, skin, vagina) 
and of the infant after birth (oral). Birth mode influence and microbiota 
differences between full-term and preterm infants are also illustrated.  
Vagina 
Full-term: Increased 
stability. Majority 
Lactobacillus spp. (L. 
crispatus, L. jensenii, L. 
gasseri and L. 
Vaginalis), Prevotella & 
Sneathia spp, 
Clostridiales, 
Bacteroidales 
Preterm: Decreased 
diversity, Majority L. 
crispatus 
 
Placenta 
Full-term: Proteobacteria, 
(Enterobacter and 
Escherichia/Shigella), 
Propionibacterium, Fusobacterium 
spp. 
Preterm Fusobacterium nucleatum, 
Escherichia coli, Capnocytophaga, 
Streptococcus spp. 
 
Amniotic fluid 
Full-term: Proteobacteria, 
Propionibacterium,Fusobacterium 
nucleatum, Streptococcus spp. 
Preterm Enterococcus , Escherichia 
spp.,Shigella spp.,Leptotrichia spp, 
,Sneathia spp, Streptococcus 
spp.,Bergeyella spp.  and 
Capnocytophaga spp. 
 
 
   Skin 
Full-term: Staphylococcus, 
Corynebacterium and 
Propionibacterium spp 
Preterm: Staphylococcus spp., 
Streptococcus spp, 
Enterococcus spp. 
 
Oral cavity (Infant at birth) 
Full-term: Streptococcus and 
Actinobaculum spp. 
Preterm: Staphylococcus spp., 
Streptococcus spp., Gemella spp. 
 
 
 
Oral cavity (Infant at birth) 
Mode of delivery 
SVD: Greater diversity: Streptococci ((S. 
mitis, S. Salivarius), A. naeslundi, A. 
odontolytics, F. Nucleatum, , 
Streptococcus salivarius, Lactobacillus 
curvata, Lactobacillus salivarius, 
Lactobacillus casei. 
CS : Streptococci ((S. mitis, S. Salivarius), 
Slackia exigua 
 
 
Oral Cavity (Mother) 
Term: Streptococcus spp., Fusobacterium nucleatum, Porphyromonas gingivalis 
Preterm Fusobacterium nucleatum, Bergeyella spp, Streptococcus spp. 
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References: Placenta: (Collado et al., 2016), (Aagaard et al., 2014), (Stout et al., 2013). Amniotic 
fluid:(Collado et al., 2016), (Han et al., 2006), (DiGiulio, 2012; DiGiulio et al., 2008), (Bearfield 
et al., 2002), (Hill, 1998). Oral (mother): (Bearfield et al., 2002), (Dominguez-Bello et al., 2010), 
(Costello et al., 2013). Oral (Infant) :(Boustedt et al., 2015), (Lif Holgerson et al., 2015), (Li et 
al., 2005), (Lif Holgerson et al., 2011), (Holgerson et al. 2013), (Lif Holgerson et al. 2011a), 
(Nelun Barfod et al. 2011b). Skin: (Dominguez-Bello et al., 2010), (Capone et al., 2011), 
(Costello et al., 2013). Vagina:(Aagaard et al., 2012; Dominguez-Bello et al., 2010; Hyman et al., 
2014; MacIntyre et al., 2015; Ravel et al., 2011; Romero et al., 2014b, 2014c; Walther-António et 
al., 2014). 
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2.5.4 Influence of birth mode on the neonatal microbiota 
Birth is a transition from sterile intrauterine life to the extra uterine existence with 
continuous exposure to microorganisms. Mother to infant exchange of microbiota 
plays an essential role in the future of this infant, in terms of immunity and 
metabolic health (Mueller et al., 2014). The first exposure to micro-organisms in 
vaginally delivery infants is during the passage through the birth canal, while with 
Caesarean section (C-section) the micro-organisms are acquired from the skin of 
the parents (Moore et al., 2012) workers and even the medical equipment 
(Adlerberth & Wold., 2009). The initial development and maturation of the 
neonatal microbiome is hugely determined by exchanges at birth, and shortly 
after. Shortly after birth, the population of early colonizers stabilizes, and their 
presence plays a very important role in host defence, and in the development of 
the neonatal immune system, and these early colonisers may play an important 
long term role in the activity and function of the microbiota (Mueller et al., 2014; 
Scholtens et al., 2012). See Figure 2.2. 
The delivery mode has been shown to also have an effect on the bacterial 
composition of the gut and oral cavity of the newborn (Biasucci et al., 2010; 
Dogra et al., 2015; Dominguez-Bello et al., 2010; Lif Holgerson et al., 2011; 
Rutayisire et al., 2016). During vaginal delivery the newborn infant is colonised 
by the mothers vaginal fluid microbiota and intestinal microbiota, whereas the 
microbiota of those infants born via C-section share a close resemblance to the 
skin microbiota of the mother (Dominguez-Bello et al., 2010; Huurre et al., 2008; 
Lupp and Finlay, 2005; Mueller et al., 2017). Up to twenty-four hours after birth, 
infants born via Spontaneous vaginal delivery (SVD) have acquired bacteria most 
similar to their mother’s vaginal community (Lactobacillus, Prevotella and 
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Sneathia species), while C-sectioned infants have acquired bacteria most similar 
to their mother’s skin community microbiota (Staphylococcus, Corynebacterium, 
and Propionibacterium species) (Dominguez-Bello et al., 2010). This study also 
showed that at twenty-four hours after birth, there is no differentiation between 
the microbiota compositions in the following body sites of the newborn: oral 
cavity, skin and intestine. 
The vertical transmission of microbes from mother to neonate is vital in 
developing the newborns immunity and metabolic development, but when vaginal 
delivery cannot occur for medical reasons, C-section delivery is required. There is 
increasing evidence that highlights how altering of interrupting this microbiota 
transmission with C-section delivery at birth may be associated with diseases such 
as coeliac disease (Decker et al., 2010), obesity (Barros et al., 2012; Mueller et al., 
2015), asthma (Kero et al., 2002; Thavagnanam et al., 2008), type 1 diabetes 
(Algert et al., 2009; Cardwell et al., 2008) and allergies (Kristensen and 
Henriksen, 2016). A systematic review has recently supported the concept that C-
section delivery is linked with autism (Curran et al., 2015), and disruption of the 
vertical transmission of beneficial vaginal microbes to the neonate can have a 
negative impact, with strategies developed to diminish this impact (Dominguez-
Bello et al., 2016; Moya-Pérez et al., 2017). 
The effects of birth mode on intestinal bacterial acquisition can be detected in the 
early weeks and also up to the early years of childhood (Dogra et al., 2015; 
Grönlund et al.; Hill et al., 2017; Penders et al., 2006; Salminen et al., 2004). 
Birth mode influence was identified in mouse models after a few days with the gut 
microbiota of the newborn having a high abundance of Lactobacillus from the 
mothers vaginal canal (Pantoja-Feliciano et al., 2013). C-section delivery has been 
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shown to have an effect on the development of newborn gut with lower intestinal 
counts of bacteria and lower diversity in the gut (Azad et al. 2013; Grönlund et al. 
1999). The intestinal microbiota can be affected for the first two years of life 
(Jakobsson et al., 2014). Bifidobacterium species have been found a higher levels 
in the intestinal microbiota of infants born by vaginal delivery (Biasucci et al., 
2010; Fanaro et al., 2003; Scholtens et al., 2012), while Clostridium and 
Lactobacillus species been found at higher levels in the intestinal microbiota of C-
sectioned infants (Rutayisire et al. 2016; Biasucci, Benenati, Morelli, Bessi & 
Gunther Boehm 2008; Penders et al. 2006). Disturbances to the gut microbiota 
was evident up to six months after birth in C-Sectioned infants (Grönlund et al. 
1999) 
In a recent study, the effects of birth mode on the gut microbiota was evident by 
one week of age in newborns (Hill et al., 2017). Hill et al. identified an increase in 
Firmicutes levels and lower abundance of Actinobacteria at one week post birth in 
C-section neonates. They also found that the gut microbiota diversity by 8 weeks 
post birth of infants born via C-section, became more stable and was more similar 
to those infants born via vaginal delivery, and this stability was maintained at 6 
months post birth (Hill et al., 2017).  
While birth mode has an effect on the gut microbiota, the early acquisition of 
certain microbes via mode of delivery, and the timing of this acquisition can have 
an effect on weight gain as early as 18 months of age (Dogra et al., 2015). Within 
the early weeks of life the C-sectioned delivery has been associated with increased 
risk of childhood obesity (Blustein et al., 2013; Li et al., 2014; Mueller et al., 
2017). Interestingly, a high maternal pre-pregnancy weight is also associated with 
differences in the neonatal colonisation of its gut microbiota in vaginally delivered 
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infants but not in those infants born via C-section (Mueller et al., 2016). By 
inoculating newborn infants born by C-section with vaginal fluid from their 
mother, these infants can acquire microbes lost via C-sectional delivery 
(Dominguez-Bello et al., 2016). 
The typical age for introduction of solids and weaning from breastfeeding is 
around 5-6 months. Bergström et al. found changes in the infant gut microbiome 
typically btween 9 to 18 months when breastfeeding stopped, and this was 
followed by an increase in microbiota diversity, with increased levels of 
Lactobacillus, Bifidobacterium and Enterobacteriacae (Bergstrom et al., 2014). 
At 2-3 years of age, the composition of the gut microbiome during infancy 
becomes more stable, and more similar to the adult microbiota (Power et al., 
2014). Yatsunenko et al. reported differences in the composition of the gut 
microbiome depending where they lived (Yatsunenko et al., 2012). However all 
these subjects showed increased diversity with a more adult-like microbiota by 3 
years of age (Yatsunenko et al., 2012). While changes in the intestinal microbiota 
are evident with geographical location, the oral microbiota does not appear to be 
affected by geographical loaction (Nasidze et al., 2009). 
The influence of birth mode on the infant oral microbiota can be seen as early 
three months of age (Lif Holgerson et al., 2011). Infants born via vaginal delivery 
were seen to have more of a similar oral composition to their mothers and a 
greater diversity than C-sectioned infants in the first 6 months post birth (Boustedt 
et al., 2015). A higher abundance of health associated species Streptococcus and 
Lactobacillus were detected in the oral cavity of vaginally delivered infants 
(Nelun Barfod et al., 2011), while infants delivered by C-section acquired 
Streptococcus mutans nearly 12 months earlier than vaginally delivered infants 
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(Li et al., 2005). It is believed that when Streptococcus mutans levels are 
diminished, Streptococcus sanguinis colonises around 9 months of age during a 
discrete "window of infectivity". This colonisation has potential health benefits as 
this species acts as an antagonist to the cariogenic species Streptococcus mutans 
(Caufield et al., 2000, 1993). The influence of birth mode on the newborns oral 
microbiota has been demonstrated with the oral microbial communities of the C-
section and vaginally delivered infants resembling that of their mothers skin and 
vaginal communities respectively (Dominguez-Bello et al., 2010). Contrary to 
these studies, Chu et al. found that the infants gut and oral cavity undergoes 
change during the first 6 weeks of life, and not until 6 weeks does each body site 
show uniqueness (Chu et al., 2017). These changes did not seem to be affected by 
delivery mode (Chu et al., 2017). Studies investigating the influence of birth mode 
on the oral microbiota are limited. Larger cohorts studying the infant oral 
microbiota are required to gain further knowledge of the influence of pregnancy, 
delivery mode, maternal microbiota and early feeding mode on the oral 
microbiota of the newborn. 
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Figure 2.3. Factors influencing the acquisition and development of the infant 
oral microbiota. References: (Lif Holgerson et al., 2013, 2011; Nelun Barfod et al., 2011) 
Breast 
feeding (BF) 
exclusively  
Mixture of 
both BF & 
FF 
Formula 
feeding (FF) 
only 
Before Birth; In utero: 
 
 
Preterm 
birth 
Vaginal Microbiome 
 
Skin 
Microbiome 
 
Haematogenous spread of 
microbes 
 
Amniotic 
fluid 
 
Placenta 
 
Spontaneous 
Vaginal delivery 
(SVD) 
 
Caesarean Section 
(CS) 
 
 
Antibiotics 
 
Ascending 
Infection 
 
    Changes 
Hormonal, 
Immunological 
& Metabolic  
 
Oral Microbiota 
CS: 
Streptococci (S. 
mitis, S. 
Salivarius), 
Slackia exigua 
 
 
Oral Microbiota BF: 
Streptococcus sp. & 
Lactobacillus sp. 
L.gasseri. Actinomyces 
gerencseriae and Streptococcus 
australis 
Svd: L.plantarum, L.plantarum, 
L.gasseri, L.vaginalis 
Gut 
microbiome:Bifiodobacterium 
 
 
Oral Microbiota SVD:  
Greater diversity: 
Streptococci ((S. mitis, S. 
Salivarius), A. naeslundi, 
A. odontolytics, F. 
nucleatum and L. 
salivarius  
Streptococcus salivarius, 
Lactobacillus curvata, 
Lactobacillus salivarius, 
Lactobacillus casei. 
 
 
 
 
Oral Microbiota FF: 
Prevotella 
melaninogenica/histicola 
Kingella spp, Leptotrichia 
buccalis, Haemophilus 
spp. 
Gut microbiome: E.Coli, 
C.difficile 
57 
 
2.6 Antibiotics and feeding mode (breast or formula feeding) and their 
influence on the microbiome of the newborn. 
The human body and its microbiota are obviously affected by both external and 
internal influences. The human body is influenced by the environment, diet, age, 
antibiotic usage, presence of disease, host genetic factors and the immune and 
stress response. The establishment of the microbiota begins at birth, and is 
strongly influenced by birth mode (Bokulich et al., 2016; Dominguez-Bello et al., 
2010; Madan et al., 2016; Song et al., 2013). After birth, antibiotic usage, 
geographic location and feeding mode (formula fed or breast fed) can all have a 
major impact on the developing microbiome. I discuss each of these influences on 
the microbiome of the newborn, focusing on their impact on the oral microbiome.  
2.6.1 Antibiotics: during pregnancy and post birth 
A single dose of antibiotics can disturb the human microbiota with some evidence 
to show that the original microbial ecosystem does not return to normal following 
this course of treatment (Bokulich et al., 2016; Cho et al., 2012; Francino, 2016; 
Zaura et al., 2015). The use of broad spectrum antibiotics reduces bacterial 
diversity in the intestine (Greenwood et al., 2014; Modi et al., 2014), although the 
human microbiome does demonstrate a degree of resilience to antibiotic intake 
(Relman, 2012). If antibiotics are taken early in life, their effect can be disruptive, 
and lead to an increased risk of development of diseases such as obesity, 
inflammatory bowel disease and diabetes later in life (Cho et al., 2012; Cox and 
Blaser, 2014; Shaw et al., 2010). Mueller et al. found that early exposure to 
antibiotics in the second or third trimester in C-sectioned infants, posed these 
children to a 84% higher risk of obesity later in childhood (Mueller et al., 2015). 
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Increased asthma risk is also associated with a lower diversity as a result of 
antibiotic intake (Abrahamsson et al., 2014; Goksör et al., 2013). 
While one study demonstrated recovery of the intestinal microbiota by 89% 
within 60 days after stopping the antibiotic, the microbial community did not 
return to the starting configuration (De La Cochetière et al., 2005). From birth up 
to 3 years of age, the infant microbiota undergoes maturation and increases in 
diversity and stability, and if antibiotics are administered from birth or within 
these early years, the microbiota at this stage is much more vulnerable to 
disruption (Cox and Blaser, 2014).  
Antibiotics may be administered prophylactically to the mother during pregnancy, 
before birth, during a C-section delivery and also after birth during nursing. 
Antibiotics are routinely administered to the mother during pregnancy if the 
mother tested positive with Group B Strep (GBS). GBS can lead to early onset 
neonatal sepsis after premature rupture of membranes with no sign of labour. If 
the mother presents with fever, antibiotics are  administered to prevent any risk of 
infection to the growing fetus (Chapman et al., 2014; de Tejada, 2014; Flenady et 
al., 2013; Wynn, 2016). Newborn infants are more than likely to be given 
antibiotics when born prematurely, and their mother may be administered 
antibiotics during delivery. Broad spectrum antibiotics are commonly 
administered as a prophylactic measure to reduce the risk of infectious diseases 
during C-Section delivery (Smaill and Grivell, 2014). 
Antibiotics account for 80% of all medication prescribed during pregnancy 
(Bookstaver et al., 2015) and these antibiotics when administered during 
pregnancy are termed Intrapartum antimicrobial prophylaxis (IAP). Antibiotics 
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most commonly administered are penicillin and cephalosporin, and both target 
gram positive and gram negative bacteria (Gyte et al., 2014). With over 40% 
women receiving antibiotics during pregnancy there is concern about its overuse 
and its health affects long term (Blaser, 2016; Cho et al., 2012; Ledger and Blaser, 
2013). The long term effect of early antibiotic use during pregnancy and at birth 
has not been studied in great detail, and because of the lack of research, there is 
concern about the long-term consequences of antibiotic use (Kuperman and 
Koren, 2016).  
Mothers that received antibiotics during pregnancy had a different vaginal 
microbiota characterised by an increased abundance of Staphylococcus species 
and potential interruption of transfer of beneficial vaginal microbes which were 
depleted (Stokholm et al., 2014). Infants born to mothers that had received 
antibiotics during pregnancy had perturbations of their gut microbiota and the 
effect was not seen until  10, 30 and 90 days after the birth (Arboleya et al., 2015). 
The preterm infants harboured a reduced abundance in Bacteroidetes and a higher 
abundance of Proteobacteria (mainly Enterobacteriaceae) (Arboleya et al., 2015). 
Increases in Enterobacteriaceae abundance in the gut microbiota have been linked 
with increased risk of diabetes type 1 in children (Soyucen et al., 2014). Early use 
of antibiotics has been shown to decrease the diversity with lower abundances of 
Bifidobacteria, and higher abundances of Enterobacteria and Proteobacteria 
(Fouhy et al., 2012; Greenwood et al., 2014). Interestingly the gut microbiota 
composition at 8 weeks was different to the composition recorded at 4 weeks, 
where Fouhy et al. noted a recovery of the reduced Bifidobacterium numbers 
(Fouhy et al., 2012).  
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While there has been a lot of work exploring the effect of antibiotics on the 
intestinal microbiome, the impact on the oral microbiome has not received as 
much attention. As discussed, the majority of women receiving a C-section 
receive antibiotics prophylactically to prevent per partum infections.  
A study by Holgerson et al. reported differences in the infant oral microbiota 
associated with mode of delivery, but antibiotic intake was not taken into account  
(Lif Holgerson et al., 2011; Smaill and Grivell, 2014). Of the mothers included in 
this study, 15 of the 41 mothers received intravenous antibiotics, and this may 
have had a significant factor based on previous research discussed, but this did not 
form part of the results or discussion (Lif Holgerson et al., 2011). A recent study, 
by Gomez-Arango et al. investigated the effect of intrapartum antibiotic exposure 
on the oral microbiota of the newborn infant (Gomez-Arango et al., 2017). They 
investigated the source of the initial infant oral microbiome from maternal 
placental, oral and gut samples. The neonatal oral microbiota was composed of 
65.35% of microbes of maternal oral microbiome origin, 3.09% of placental 
origin, 31.56% of unknown and 0% of maternal gut origin. Intrapartum antibiotics 
were administered to 64% of all women. The authors found that these antibiotics 
had an effect on the initial oral microbiome. Infants whose mothers were 
administered antibiotics had an oral microbiota with a higher abundance of 
phylum Proteobacteria, while infants whose mothers were not exposed to 
antibiotics had an oral microbiota higher in Streptococcaceae, Gemellaceae and 
order Lactobacillales (Gomez-Arango et al., 2017).  
The increased presence of the phylum Proteobacteria the gut is seen as a marker 
of disease and dysbiosis (Shin et al., 2015). This phylum is most abundant in the 
oral cavity of the deciduous dentition (Crielaard et al., 2011). Streptococcus is 
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viewed as an early colonizer of the oral cavity, with Streptococcus mutans evident 
almost 1 year earlier (17.1 months of age) in C-sectioned infants compared to 
vaginally born infants (Caufield et al., 1993; Li et al., 2005).   
Costello et al. studied the microbiome of the stool, skin and oral saliva samples of 
six low birth weight infants, of which were 5 born prematurely, at days 8, 10, 12, 
15, 18 and 21 days after birth (Costello et al., 2013). All except one preterm infant 
had received antibiotics only during the first week of life and their oral microbiota 
demonstrated high levels of Firmicutes, with high abundance of Staphylococcus 
and Streptococcus. The preterm infant on antibiotics for the duration of sampling 
demonstrated a much higher abundance in the oral microbiome of the genera 
Mycoplasma (a novel Mycoplasma species) and Pseudomonas (P. aeruginosa) in 
comparison to infants whom did not have continued antibiotic treatment (Costello 
et al., 2013). The peaking of these genera between days 15 to 21 coincided with 
antibiotic treatment for suspected necrotizing enterocolitis. The presence of these 
pathogenic microbes in the oral cavity of this infant warrants further study as to its 
health significance and the possible pathogenic role of these microorganisms 
(Costello et al., 2013). While research investigating the oral microbiome post 
antibiotics is limited in infants, in adults when the microbiota of saliva and faecal 
samples were examined from the same adult, at baseline after exposure to 
antibiotic and again at 1, 2, 4 and 12 months post treatment, they found that while 
there was changes in the faecal microbiota composition and oral cavity remained 
stable throughout those time points mentioned (Zaura et al., 2015). 
So overall research investigating the antibiotic effect on the oral cavity in infants 
has received very little focus and with antibiotic use increasing, along with 
antibiotic resistance, increased energy on researching this area is needed.  
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2.6.2 Feeding mode (Breast feeding v Formula feeding) impact on the Oral 
microbiome of the newborn.  
An exclusively breastfeeding infant is seen as the gold standard method for 
feeding the newborn infant. Irelands breast feeding rates are the lowest compared 
to other countries, with 46% breastfeeding on leaving hospital in a recent report 
(HSE: Health Service Breastfeeding Action Plan, 2016). This is compared to rates 
of 90% in Australia and 81% in the United Kingdom (HSE: Health Service 
Breastfeeding Action Plan, 2016; McAndrew et al., 2010; Public Health 
Association of Australia (PHAA), 2010) 
Breast milk is rich in beneficial bacteria that colonise the gut of the newborn, 
increasing diversity of the gut microbiota compared to infants that are formula fed 
(Azad et al., 2013; Fallani et al., 2010). The bacteria of breast milk mainly 
includes species of Lactococcus, Enterococcus and Lactobacillus while there is 
increased interest in the probiotic bacteria isolated from breast milk which 
includes Lactobacillus salivarius, Lactobacillus gasseri and Lactobacillus 
fermentum (Lara-Villoslada et al., 2018; Martín et al., 2007; Olivares et al., 2006). 
Breast milk is made up of Prebiotic oligosaccharides (OS), which stimulate the 
growth and activity of the microbes in the gut to aid with gut health (Vandenplas 
et al., 2014). Oligosaccharides that can be difficult to digest and species 
Bifidobacterium infantis (Yoshida et al., 2012) and Bifidobacterium breve (James 
et al., 2016) are required to help break down these oligosaccharides. The 
oligosaccharide are a source of energy for lactate producing microbes such as 
Bifidobacterium, Streptococcus, Staphylococcus and Enterococcus and these milk 
oligosaccharides prevent growth of pathogenic microbes by acting as decoy 
receptors (Bode, 2012). Bifidobacterium spp. play a role in protecting against 
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pathogens, and keep the immune response active in the epithelial cells of the gut. 
The benefits to the mother and infant have been seen after administering these 
species to mothers while pregnant and to their infants after birth, with prevention 
of allergies in the infant (Enomoto et al., 2014; Mikami et al., 2012, 2009). 
The aim of formula manufacturing companies is to bring artificially made formula 
as close to the gold standards of breast milk, by adding OS such as galacto-
oligosaccharides, fructo-oligosaccharides and/or probiotcs (Vandenplas et al., 
2014). Exclusively breast fed infants have a gut microbiota dominated by 
Bifidobacterium (Bezirtzoglou et al., 2011; Harmsen et al., 2000; Penders et al., 
2006; Power et al., 2014; Tannock et al., 2013; Turroni et al., 2009).  Formula fed 
infants demonstrate a more varied gut microbiota with lower Bifidobacterium 
levels (Coppa et al., 2006).   
It is thought that breastfeeding enhances lactic acid producing bacteria acquired 
from the mothers vaginal microbiota (Coppa et al., 2006). Previous molecular 
studies suggested that the Lactobacillus present in the infant gut were acquired 
from the mothers vaginal canal or direct from breast milk (Martín et al., 2007). 
Recent studies did however find the common gut bacteria Lactobacillus johnsonii 
at higher abundances in the vaginal microbiome of pregnant women than non-
pregnant women, suggesting a role for the vaginal community of the mother in 
shaping the infant gut community (Aagaard et al., 2012). L. johnsonii has been 
suggested to aid with digestion of breast milk and is acquired by the neonate from 
the birth canal during delivery (Abee et al., 1994;Prince et al., 2014). While these 
studies have shown the influence of vaginal delivery on acquiring beneficial 
microbes, a recent study demonstrated the positive effects of breastfeeding 
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exclusively over four months on the gut microbiome of C-sectioned infants (Hill 
et al., 2017).  
Formula supports the infant gut of development in a much more diverse 
microbiota than breast feeding (Azad et al., 2013). Levels of Escherichia coli, 
Clostridium difficile and Bacteroides fragilis are at much lower levels in breast 
fed, compared to formula fed infants (Penders et al., 2006; Yoshioka et al., 1983). 
Formula fed infants have a gut microbiota which comprises Streptococcus, 
Bacteroides, Clostridium, and Bifidobacterium (Bezirtzoglou et al., 2011; 
Harmsen et al., 2000; Yoshioka et al., 1983). Azad et al. studied faecal samples 
taken at 4 months of age from 24 healthy infants and these formula fed infants 
showed an increased species richness and increased levels of Clostridium difficile 
in their gut microbiome (Azad et al., 2013) . While C-section can lower gut 
diversity and richness (Azad et al., 2013), breastfeeding has the ability to modify 
and improve some of these affects (Azad et al., 2016). Allergy risk can be  
reduced further by administration by breastfeeding and by taking probiotics 
during pregnancy (Enomoto et al., 2014; Rautava et al., 2012b).  
Changes in the gut microbiome based on feeding modality have been noted. The 
oral microbiome also demonstrates microbiota influences (Holgerson et al. 2013; 
Romani Vestman et al. 2013).(Summarised in figure 2.3). Both these studies 
found that the oral microbiota varied if the infant was formula fed versus breast 
fed, with Lactobacillus (L. grasseri) detected and at a higher abundance in breast 
fed infants only (Lif Holgerson et al., 2013). Breast fed infants also demonstrate 
oral Lactobacillus by 3 months of age within the oral cavity, which are not found 
in the oral cavity of  formula fed infants (Lif Holgerson et al., 2013). These oral 
Lactobacillus (L. gasseri) have antimicrobial properties and probiotic qualities 
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and are found at much higher levels in the oral cavity of breast fed infants 
(Vestman et al., 2013). L. gasseri attaches itself to epithelial cells and is present in 
saliva, and has strong probiotic benefits by inhibiting growth and attachment of 
pathogens such as Streptococcus mutans (Kotzamanidis et al., 2010; Vestman et 
al., 2013). L. gasseri presence in the vaginal microbiome is variable between 
ethnic groups (MacIntyre et al., 2015). When L. gasseri is present in low 
abundance in the vaginal microbiota of certain ethnic groups, there is a stronger 
need for these mothers to breastfeed, to counteract the poor levels of these species 
which may be acquired during birth.  
While exclusively breastfeeding is recommended up to 6 months of age, studies 
have reported that prolonged breastfeeding is a risk factor for ECC (Chaffee et al., 
2014; Hong et al., 2014; Kato et al., 2015). Two recent systematic reviews and 
meta-analysis however both concluded that breastfeeding can protect against 
dental caries, while both studies recommended that further research is needed in 
children whom are breastfed after 12 months of age (Avila et al., 2015; Tham et 
al., 2015). While breast feeding up to 12 months is not associated with an 
increased risk of caries, a meta-analysis of infants breast fed beyond 12 months 
found that these children were at an increased risk of dental caries (Richards, 
2016). This increased risk of dental caries if breast feeding is continued beyond 12 
months of age may be due to other factors such as dentition, poor oral hygiene, 
frequency of cariogenic food and drink intake and breastfeeding during the night. 
Nocturnal breastfeeding causes increased risk of caries because of the pooling of 
milk and thus milk remains in the mouth for a longer duration to attack the 
dentition and also the protective measure of saliva is depleted as salivary flow is 
lower at night time (Dowd, 1999).  
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There has been controversy for many years as to the cariogenic effects of 
substitute formulas (Bowen et al., 1997), while further studies reported the need 
for further evaluation to assess the cariogenicity of formula (Chaudhary et al., 
2011). There also seems to be lack of evidence supporting the idea that breast 
milk is cariogenic. It has been found that some breast milk components have an 
anti-cariogenic effect, inhibiting growth by production of peptides and by 
interrupting adhesions of Streptococcus mutans (Aimutis, 2004; Wernersson et al., 
2006), supporting the oral health benefit of breast feeding. 
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2.7 The Oral Microbiome. 
2.7.1 The oral microbiome of the newborn edentulous infant from birth to 
childhood. 
The oral microbiota of the newborn infant is initially acquired at birth, from the 
mother, the surrounding hospital environment and its workers, and also from 
parents, siblings and carers (Cephas et al., 2011; Stahringer et al., 2012; Tanner et 
al., 2002). 
In the early months of life, little is known about the arrival of oral microbes. 
During the first few days of life, Pearce et al. found that Streptococcus oralis, 
Streptococcus mitis and Streptococcus salivarius colonize the oral cavity (Pearce 
et al., 1995).  Colonisation by Streptococcus mutans was found to occur at the 
median age of 26 months whilst Streptococcus sanguinis colonised during a 
discrete “window of infectivity” at the median age of 9 months (Caufield et al., 
2000, 1993). A study by Wan et al. (Wan et al., 2001) showed the presence of 
Streptococcus mutans in edentulous infants as young as 3 months of age and also 
demonstrated that preterm infants are 4.4 times more likely to be colonized by 
Streptococcus mutans than are full-term infants (Wan et al., 2003).  
Relatively little is known about the timing of arrival of the key microbes found in 
the oral cavity of children and the key factors involved in the establishment of the 
oral microbiota, unlike the gut microbiota where these phenomena are well 
understood (Claesson et al., 2012, 2010). The seeding of the gut microbiota in 
infants has been shown to be affected by birth mode and feeding practices 
(Dominguez-Bello et al., 2010; Hill et al., 2017; Penders et al., 2006; Song et al., 
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2013), but there is less research looking at the establishment of the oral microbiota 
from birth.  
As mentioned previously, acquiring the oral microbiome by the newborn infant 
begins in the first few seconds of birth. The mode of delivery has an impact on the 
acquiring of oral microbiomes from the vaginal birth canal and from skin of the 
mother when delivered by C-section (Boustedt et al., 2015; Dominguez-Bello et 
al., 2010; Li et al., 2005; Lif Holgerson et al., 2011; Nelun Barfod et al., 2011). 
(See Figure 2.3). 
Examining the saliva samples of 149 infants (SVD n=96; C-section n=53) within 
2 days of birth and again at 1, 3 and 6 months, Boustedt et al. found that birth 
mode had an effect on the saliva microbiota, with a greater diversity in vaginally 
delivered infants (Boustedt et al., 2015). Microbes A. naeslundi, A. odontolytics, 
F. nucleatum and L. salivarius were only found among vaginally delivered infants 
(Boustedt et al., 2015). Dominguez-Bello et al. illustrated the effect birth mode 
has on the neonatal oral microbiota within twenty-four hours after birth, with 
transfer of the mothers vaginal microbiota (Lactobacillus, Prevotella and Sneathia 
species) and skin microbiota (Staphylococcus, Corynebacterium, and 
Propionibacterium species) to the infants oral cavity if delivered vaginally or by 
C-section (Dominguez-Bello et al., 2010).  
Further work supporting the effects the delivery mode has on the oral microbiota 
was published by Lif Holgerson et al., who identified that the influence of birth 
mode on the oral microbiota can be seen as early three months of age (Lif 
Holgerson et al., 2011). Using Human Oral Microbe Identification Microarray 
(HOMIM), they studied the oral biofilm (cheek, tongue, alveolar ridges) in 
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healthy three month old infants. 38 infants were born by C-section and 25 infants 
were delivered vaginally. The vaginally delivered infants had higher numbers of 
taxa, and identification of Slackia exigua in the oral microbiota of C-section 
infants only (Lif Holgerson et al., 2011) warrants further investigation. A higher 
abundance of health associated Streptococcus and Lactobacillus species have been 
found in the oral cavity of vaginally delivered infants (Nelun Barfod et al., 2011). 
Species of high abundance found in vaginally delivered infants included 
Streptococcus salivarius, Lactobacillus curvata, Lactobacillus salivarius, and 
Lactobacillus casei (Nelun Barfod et al., 2011), while Li et al. found the presence 
of Streptococcus mutans in the oral cavity 16 months earlier in C-Sectioned 
delivered infants (Li et al., 2005). 
While those research studies mentioned have shown the influence of delivery 
mode on the oral microbiota. Chu et al. observed the influence of birth mode 
immediately after birth, but this influence on the microbiota of the infant was not 
identified by 6 weeks after birth. At 6 weeks post birth each body site sampled 
demonstrated uniqueness (Chu et al., 2017). They found that the oral cavity was 
mainly composed of Streptococcus, Propionibacterium, Lactobacillus and 
Staphylococcus at birth, but by 6 weeks, there was increased abundance and 
dominance of Streptococcus and Veillonella (Chu et al., 2017). 
There is evidence to suggest that the oral microbiome is dynamic with changes 
arising with the eruption of teeth, and also with the shedding of these primary 
teeth (Xu et al., 2015). Despite this, there are limited research studies using high-
throughput sequencing to focus on the oral microbiome of the edentulous mouth 
of infants and following the oral microbiota of these infants as their teeth emerge 
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(Cephas et al., 2011; Chu et al., 2017; Costello et al., 2013; Dominguez-Bello et 
al., 2010). 
Before teeth emerge the edentulous infant appears to have a higher abundance of 
Streptococcus (62%) in their oral microbiota compared to their mothers or carers 
who have a lower abundance of Streptococcus (20%) (Cephas et al., 2011). These 
adults have a higher microbial diversity compared to the infants, although the 
infants did demonstrate some species richness in the oral microbiota with the 
presence of Streptococcus, Veillonella and Neisseria before teeth emerge (Cephas 
et al., 2011).  From birth to week 6 after birth, Chu et al. found that the genera in 
the oral microbiota changed from mixed composition of Lactobacillus, 
Propionibacterium and Streptococcus to increased abundance of predominance of 
Streptococcus (61%) followed by Veillonella (Chu et al., 2017).  Creilaard et al. 
studied the salivary microbiome of children from ages 3 to 18 years, at different 
stages of teeth eruption and development, between deciduous and permanent 
dentition (Crielaard et al., 2011). They identified that the deciduous dentition had 
a higher proportion of Proteobacteria (Gammaproteobacteria, Moraxellaceae) 
(Crielaard et al., 2011). As the infant increased in age, the levels of Bacteroidetes 
(mainly Prevotella), Veillonellaceae family and Spirochaetes levels increased 
(Crielaard et al., 2011).  
While there is limited research looking at the changes and dynamics over time in a 
young infant from the edentulous oral cavity until the development of deciduous 
dentition and permanent successors, there is more research investigating the oral 
microbiome of adults.  
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Zaura et al. found a ‘core microbiome in health’ in the oral microbiome of adults 
(Zaura et al., 2009). Variability within the oral cavity has been found within and 
among individuals (Huse et al., 2012; Li et al., 2013; Paster et al., 2006; Zhou et 
al., 2013).  The oral cavity microbiota appears to be stable with highest alpha 
diversity, while the niches within the oral cavity (hard palate, buccal mucosa, 
gingival, alveolar ridges, subgingival pockets) all demonstrated differences in 
bacterial richness and diversity (Human Microbiome Project Consortium, 2012). 
The supragingival plaque had the highest richness, with hard palate having the 
lowest (Huse et al., 2012).  Saliva was reported as the niche with the highest alpha 
diversity, but lowest beta diversity, highlighting richness and similarity between 
individuals (Human Microbiome Project Consortium, 2012; Zhou et al., 2013). 
Streptococcus, Prevotella and Veillonella made up 50% of the salivary microflora 
in adults when sampled, while 50% of plaque comprised of 6 genera including 
Streptococcus, Prevotella, Veillonella plus Fusobacterium, Actinomyces, 
Corynebacterium and Rothia (Keijser et al., 2008). 
When the oral microbiome of adults was sampled at different time points and 
sampled,  variability between habitats examined alongside the oral cavity was 
noted (Aas et al., 2005; Nasidze et al., 2009). Individuals showed more variability 
from the same location and did not demonstrate additional variation when from a 
different geographical location (Nasidze et al., 2009). Costello et al. found that all 
body sites demonstrated microbiota stability over time within individuals, but the 
oral cavity was less variable over time in microbiota than other body sites such as 
gut or skin (Costello et al., 2009), thus further highlighting the stability of the oral 
cavity (Zhou et al., 2013).  
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These studies have demonstrated the oral microbiota to be the most stable, 
compared to other body sites and at different time points (Human Microbiome 
Project Consortium, 2012; Lazarevic et al., 2010; Zhou et al., 2013). Temporal 
variability has been demonstrated when tongue samples were examined over time 
(Flores et al., 2014). Together, these studies illustrate the stability of oral cavity, 
but a deeper assessment of variation needs to be examined in detail when it 
occurs. This is important to see what effects this change has on the structure of the 
oral microbiome and also if composition of the oral microbiota is a causative 
factor for this shift. Furthermore, more research is needed to assess the oral 
microbiome of the newborn infant at birth and changes in the oral microbiota 
when teeth emerge and as the oral cavity matures. 
2.7.2 The oral microbiome & dental caries: Early childhood caries (ECC) & 
Severe-early childhood caries (SECC). 
Dental caries is the “single most common chronic disease of childhood” and 
affects 60-90% of all school children, Severe early childhood caries (S-ECC) is an 
aggressive form of dental caries and is defined by any sign of smooth surface 
caries in children younger than 3 years of age. It is also classified as any smooth 
surface of an antero-posterior deciduous tooth that is decayed, missing (due to 
caries), or filled smooth surfaces in children between 3 and 5 years old, and the 
presence of a dmft index  score of ≥4 (age 3), ≥5 (age 4), or ≥6 (age 5) (American 
Academy of Pediatric Dentistry (AAPD), 2008).  
ECC can cause pain, lead to sepsis, potential tooth loss when left untreated, and 
interferes with the child’s quality of life, nutrition, concentration and school 
participation (Finucane, 2012; Gussy et al., 2006; Martins-Júnior et al., 2013). 
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Because of the young age of children when ECC presents, often they are very 
young to undergo any treatment in the dental chair and there is a higher need for 
dental treatment under general anaesthesia (Albadri et al., 2006). Unfortunately, 
more often than not there is an increased risk of recurrent caries at a later stage 
(Almeida et al., 2000; Berkowitz et al., 2011; Ng et al., 2014) with permanent 
teeth often affected and thus the requirement for further treatment (Alm et al., 
2008; Dülgergil and Colak, 2012; Li and Wang, 2002). 
Dental caries has been investigated for many years using selective culture-based 
methods, and the role of Streptococcus and the presence of Lactobacillus have 
both long being recognized as playing substantial roles in dental caries (Beighton, 
2005; Borgström et al., 1997; Corby et al., 2005; Hughes et al., 2012; Pearce et 
al., 1995; Rosebury, 1932; Van Houte, 1994; Yang et al., 2010). Streptococcus 
mutans is seen as the main player in caries progression, with Lactobacillus seen as 
an opportunistic pathogen. Both of these are acidogenic bacteria and thrive on 
carbohydrate substrates by fermenting them and producing acid (Van Houte, 
1994; Yang et al., 2010). Other species associated with caries include non–mutans 
Streptococci, Actinomyces, Bifidobacteria, Veillonella and Scardovia (Becker et 
al., 2002; Ma et al., 2015; Mantzourani et al., 2009; Tanner et al., 2011b). 
While it has been found that the average prevalence by age at which  
Streptococcus mutans infection occurs ranges from 30% in 3 month old infants to 
over 80% in 24 month old children, Caufield et al., found that the median age of 
colonisation by Streptococcus mutans was 26 months, during a discrete “window 
of infectivity” (Caufield et al. 1993). However, a study by (Wan et al., 2001) 
showed the presence of Streptococcus mutans in edentulous infants as young as 3 
months of age.  
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While work has been done to characterise the oral microbiome in health, the main 
focus of other research groups with the use of new advances in sequencing 
technologies is to identify any rare taxa that may be driving dental caries disease, 
such as Early childhood caries (ECC), and its more severe division of Severe-
early childhood caries (SECC). The use of culture studies have long been in use 
before the advent of current sequencing methods (Nyvad et al., 2013; Pearce et al., 
1995; Tanner et al., 2011b). Culture studies have focused on selected bacteria 
groups that are linked to caries, such as Streptococcus, Lactobacillus and 
Veillonella spp. (Loesche and Syed, 1973; Marchant et al., 2001; Van Houte, 
1994). Veillonella species are not acidogenic, but support growth of other 
cariogenic species (Milnes and Bowden, 1985).  
Whilst sequencing methods are constantly evolving, culture still has a role to play 
when there may be several species underrepresented by molecular methods 
(Munson et al., 2004).  Munson et al. found the diversity of species detected by 
culture comparable to molecular methods, but  also reported increased levels of 
Actinobacteria by culture (Munson et al., 2004). Tanner et al. used anaerobic 
culture to identify species Streptococcus mutans, Scardovia wiggsiae, Veillonella 
parvula, Streptococcus cristatus, and Actinomyces gerensceriae as being 
associated with SECC (Tanner et al., 2011b).  Hughes et al. also found by 
anaerobic culture of plaque samples from teeth with ECC, higher Streptococcus 
mutans levels, compared to those teeth that were caries free, with lower levels 
after treatment compared to before (Hughes et al., 2012).  
Differences in the microbiota before and after treatment of the caries has also been 
identified using 16S rRNA microarray and PCR, with identification of ECC 
associated species Slackia exigua and Scardovia wiggsiae. After treatment there 
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was a decrease in S. mutans, Campylobacter gracilis, Campylobacter concisus, 
Campylobacter rectus and S. mitis (Tanner et al., 2011a). Using 454-
pyrosequencing of plaque samples from children with an average age of 20 
months, Xu et al. found that caries active children had plaque microbiota 
composed of Streptococcus and Veillonella, while Leptotrichia, Selenomonas, 
Fusobacterium, Capnocytophaga and Porphyromonas were seen at higher 
abundances in caries free children (Xu et al., 2014).  
The salivary microbiota compositional changes between caries free and caries 
active have also been described in older children between ages 3-4, with mixed 
dentition, but these studies did not find a species specific ‘core’ associated with 
caries or caries free children, with genera Streptococcus, Prevotella, Veillonella, 
Neisseria, Rothia, and Haemophilus in saliva of both groups (Jiang et al., 2016). 
They did identify potential biomarkers of caries associated species Fusobacterium 
periodonticus and Rothia dentocariosa (Jiang et al., 2016), with Crielaard et al., 
identifying Porphyromonas catoniae and Neisseria flavescens associated with 
caries free children (Crielaard et al., 2011).  
The transition from a deciduous dentition to a mixed-dentition, and then to 
permanent dentition, is documented by changes in the oral microbiota. The 
deciduous dentition has high abundances of Proteobacterium, but as the dentition 
profile changes with increased age, Bacteroidetes (Prevotella), Veillonellaceae 
and Spirochaetes all become more abundant (Crielaard et al., 2011).  
Although dominant species associated with caries and with a caries-free oral 
status in children have been noted, it is important to assess the changes that occur 
to drive these bacteria from health to disease states and also to understand at what 
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stages during this process do these bacteria come into fruition. One such study has 
assessed this by examining the different stages of caries progression over time, 
and comparing to those without caries disease progression (Gross et al., 2012). 
With a mean age of 24 months, plaque samples were collected at three stages of 
caries development (intact enamel, white spot lesion and cavitated). They found 
that as lesion progressed, the diversity of the microbiota decreased. An interesting 
finding was that not all caries samples were dominated by S.mutans, but this was 
replaced by S. sobrinus in one subject and by S. vestibularis and S. salivarius in 
the other. Other studies have found that when S.mutans was absent, either 
Bifidobacterium spp. (B. dentium, Scardovia wiggsiae), Veillonella species, 
Leptotrichia species or Lactobacillus species become dominant and are associated 
with caries (Aas et al., 2008; Corby et al., 2005; Gross et al., 2010; Z. Ling et al., 
2010; Luo et al., 2012; Milnes and Bowden, 1985; Tanner et al., 2011b).  
The variation of microbiota based on caries depth (i.e. white spot versus 
cavitation) was supported with Jiang et al. who identified variation with shifts in 
the oral microbiota based on caries depth (Jiang et al., 2014). Deep Caries can 
often progress into the pulp chamber and the bacteria associated with this are a 
subset of those involved in the caries lesion, with fewer taxa identified within the 
pulp, and increased Veillonella species, with Veillonella dispar found in high 
abundance in pulps chambers of vital exposed deep caries lesions (Chalmers et al., 
2015), and these taxa found may be the primary stimulators of caries from dentine 
into pulp. 
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2.8 Conclusion 
In conclusion, it is clear that there is a vast amount of knowledge and microbiota 
research investigating the role of the maternal microbiota (pre and post birth) and 
the influence birth mode has on the newborn microbiota structure.  The role of the 
maternal microbiota during pregnancy (i.e. placental microbiome and sterility in 
utero) was discussed at length in this review, and although analysis of the 
placental microbiota and analysis of preterm birth does not form part of this 
ORALMET study, the impact of the oral microbiota on preterm birth, and the 
identification of microbes in utero, was important to discuss, as this could have a 
potential impact on the oral microbiota of the infants that we studied from birth. 
It is obvious that the influence of birth modality on the gut microbiota of the 
infant has received far more attention than the oral microbiota of the infant in 
recent years. The studies investigating birth mode and feeding modality (breast 
feeding) on the infant microbiota are limited from birth, and thus our knowledge 
of the potential oral health effects are insufficient. This ORALMET study aims to 
alleviate this current lack of knowledge by observing and documenting the oral 
microbiota from birth until 3 years of age. 
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Chapter 3 
 
 
 
Overall Methodology: Clinical recruitment, 
sample collection and Experimental Techniques. 
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3.1. Recruitment & Sample Collection: Cohort Study (Longitudinal Study). 
3.1.1. Recruitment: 
I aimed to target pregnant women who attended the CUMH for antenatal clinics, 
in their second and third trimester. Before the recruitment of subjects, I met with 
the midwives in the CUMH. I gave a presentation on the ORALMET project and 
the aims and objectives of the study. The logistics of the sample collections and 
the need for the midwives to support the study was crucial. The exact timing of 
birth and the need for caesarean section (CS) or spontaneous vaginal delivery 
(SVD)  meant that planning for the spontaneity of birth meant that the sampling 
packs (including the swabs and consent) were attached to each chart and the 
contact number given. All women were informed and consented in the CUMH, 
while awaiting their antenatal visit. Information leaflets were given to mothers to 
take home, and contacted again before any subsequent visits. Appendix 7.5. 
3.1.2. Sample Collection. 
1) Depending on the delivery mode, the swab collection differed for the CS 
and SVD infants.  
2) If SVD, a vaginal swab was taken within one hour of delivery by the 
midwives in the labour ward. 
3) If CS, a skin swab was collected post delivery, with 12 hours. 
4) A saliva swab was taken from the mother also within 12 hours of delivery. 
Pooled unstimulated saliva sample was collected from the floor of the 
mouth with use of a CatchAll™ collection swab, with hard pack for 
storage after collection (Cambio UK) (Turnbaugh et al., 2007). This was 
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rotated in the floor of the mouth for 1-2 minutes, and placed back in the 
collection tube.  
5) The collection of the newborn infant’s saliva was collected within the first 
week of birth. A research nurse travelled to collect this saliva sample if 
living within the 50 km catchment of Cork City area. 
6) An unstimulated saliva sample was collected from the floor of the mouth 
with use of a CatchAll™ collection swab, with hard pack for storage after 
collection (Cambio UK). This was placed on ice and transported to the 
Lab. 
7) The remaining samples at 8 weeks, 24 weeks, 1 year, 2 years and 3 years 
were collected within their own homes by the research nurse and followed 
the same process as of (6). 
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3.2. Recruitment & Sample Collection: Cross-sectional Study. 
The recruitment process and sequence of sample collection is described for both 
the caries-free cohort and the caries-active cohorts. 
3.2.1. Recruitment: Caries-free Cohort. 
1. Crèches were approached in the Cork City area.  Information leaflets and 
consent forms were given to the parent/guardians.  
 Of the 316 primary schools included nationally in the Department of 
Education’s disadvantaged areas scheme, 31 are based in Cork City. 
Nine have been designated ‘disadvantaged’. 
 Core areas of social deprivation in the city are: 
Knocknaheeney/Churchfield; Fairhill/Gurranabraher/Farranree; 
Blackpool/The Glen, Mayfield, Togher and Mahon. 
 The various crèches in the Cork area were identified through Cork City 
Childcare Company Ltd. The Cork City Childcare Company is one of 
33 childcare communities set up around the country under the childcare 
directorate at the office of the Minister for Children.  
 Samples were taken from children less than five years of age. Children 
were selected at random.  
 For the caries group, I aimed to collect saliva and decayed caries tissue 
from the extracted tooth – max 75 samples. 
 For the caries-free group, I aimed to collect saliva only –max 75 
samples. 
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2. After visiting the various crèches, the study aims and objectives were described 
to the parents and a presentation providing all the background information on the 
ORALMET study to the parents and guardians of the children was given. 
Appendix 7.5. 
3. Consent Forms were given to parents/guardians. Consent forms and diet 
analysis forms were both returned within one week. Appendix 7.2 and 7.3. 
4. No Radiographs were taken as part of this study. If any caries was noted during 
the course of sampling, parents were informed and these children were excluded 
from the study. 
 
3.2.2: Sample Collection: Caries-free Cohort. 
1. All children were consented for the study previous to the day of sample 
collection. 
2. A method of Tell-show-do was used to demonstrate how sampling would 
be done. 
3. Each child sat on a crèche chair, with good natural light. 
4. Beginning with the upper right quadrant, and continuing clockwise to the 
upper left quadrant, and then the lower left and then lower right quadrant, 
the dentition were counted, and charted. 
5. Children’s teeth were wiped with a cotton wool roll and sterile gauze 
square to remove plaque and debris prior to examination which was 
carried out under natural light, using a standard size 4 mirror and ball 
ended CPI ‘C’ probe (Whelton et al., 2006).  
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6. The mouth was illuminated with a Promed Penlight, which consists of 
bright concentrated halogen light when natural light was insufficient.     
7. The dmft score was recorded along with the dmfs score. Caries was 
recorded  at the level of cavitation into dentine (cavitation level), using the 
WHO criteria (Whelton et al., 2006; WHO, 1997). The dmft/dmfs was 
measured, and sample collection was performed. All charting and sample 
collection was performed by the PhD Candidate. 
8. Caries-free children did not show clinical evidence of early pre-cavitation 
of caries or white spot lesions and had no history of treatment on any tooth 
surfaces, as defined (Dye et al., 2007). 
9. A pooled unstimulated saliva sample was collected from the floor of the 
mouth with use of a CatchAll™ collection swab, with hard pack for 
storage after collection (Cambio UK) (Turnbaugh et al., 2007). This was 
rotated in the floor of the mouth for 1-2 minutes, and placed back in the 
collection tube.  
 
3.2.3. Recruitment: Caries-Active Cohort. 
All recruitment of children affected by caries was performed at a Cork University 
Hospital Dental Theatre.  
 All children were initially visited their local Health Service Executive 
(HSE) Dental Treatment Centre where clinical examinations were 
performed. 
 The majority of the children referred to General Anaesthetic were of a 
young age, (1- 16 years of age), dentally anxious and presented with dental 
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caries; notably ECC. These children were then placed on a waiting list at 
the Cork University Dental School and Hospital and were scheduled for 
extraction of their carious teeth, under general anaesthetic.  
 All these children referred for general anaesthetic had radiographs taken as 
part of the examination prior to referral. 
 Recruitment and consent were performed on the day of the general 
anaesthetic. Appendix 7.5. 
 
Figure 3.1. Dental Theatre in Cork University Hospital .This is the 
location where all the sample collection of the caries-free cohort was 
performed. 
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3.2.4. Sample Collection: Caries-Active Cohort. 
All children attended the dental theatre fasting at 7 am-8am. All were consented 
and checked by both the dentist and anaesthetist before the general anaesthetic. 
Each child/parent was given the information of the ORALMET study, and 
explained the objectives of the study along with the sampling that would be done. 
The diet analysis was also completed on the day of consent and sample collection. 
A complete dental examination was completed bedside before the child went 
under General anaesthetic. 
1. Each child sat bedside, with good natural light. 
2. Beginning with the upper right quadrant, and continuing clockwise to the upper 
left quadrant, and then the lower left and then lower right quadrant, the dentition 
were counted, and charted. 
3. Children’s teeth were wiped with a cotton wool roll and sterile gauze square to 
remove plaque and debris prior to examination which was carried out under 
natural light; using a standard size 4 mirror and ball ended CPI ‘C’ probe 
(Whelton et al., 2006).  
4. The mouth was illuminated with a Promed Penlight, which consists of bright 
concentrated halogen light when natural light was insufficient.     
5. The dmft score was recorded along with the dmfs score. Caries was recorded at 
the level of cavitation into dentine (cavitation level), using the WHO criteria 
(Whelton et al., 2006; WHO, 1997), with the addition of visible non-cavitated 
dentine caries as referenced by Whelton et al. (Whelton et al., 2006). 
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6. A saliva sample was collected from the floor of the mouth before the general 
anaesthetic. If the child did not comply, a saliva sample was taken while the child 
underwent general anaesthetic. 
7. Pooled unstimulated saliva sample was collected from the floor of the mouth 
with use of a CatchAll™ collection swab, with hard pack for storage after 
collection (Cambio UK) (Turnbaugh et al., 2007). This was rotated in the floor of 
the mouth for 1-2 minutes, and placed back in the collection tube.  
8. The child then underwent general anaesthetic in the dental theatre (figure 3.1). 
9. While the child was anaesthetised, all carious teeth were extracted by a dentist. 
10. These extracted teeth were placed in sterile gauze and individually, dentine 
was excavated from each carious tooth with a sterile spoon excavator and pooled 
in a sterile eppendorf/collection tube. 
 
 
 
 
 
 
 
 
 
87 
 
3.3. Procedure for collection of saliva from each mother/infant.  
1. Explain the procedure  
2. Wash your hands  
3. Put on disposable gloves 
4. Check that the outer packaging has the seal intact. 
5. Break the seal. 
6. Hold the swab at the upper end of the swab, ensuring that the inner shaft is not 
handled. 
7. Insert swab into patient’s mouth, letting it rest on the floor of the mouth 
allowing for soakage of any pooled saliva present. Leave it rest there for 30 sec. 
8. The swab should not be moved around in the mouth during this time. 
9. Then rub the swab on the mothers tongue, roof of mouth and left and right 
buccal mucosa for 10 seconds each 
10. Replace the swab into the swab cover. 
11. Label the sample bottles with Subject Number, Initials, Sample Number, Date 
of Collection and tick. 
12. Remove disposable gloves and wash hands 
13. Immediately after collection, storage tube stored in a cooler bag with ice pack. 
14.  Saliva sample to be frozen (-20
o
C) within two hours of collection. 
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3.4. Laboratory Methodology 
3.4.1. Piloting the Methodology: DNA extraction 
DNA extraction Kits used 
1. Modified Protocol uses Ready-Lyse (tm) Lysozyme Solution (Epicentre, Cat. 
No. R1802M) for overnight incubation and MasterPure DNA Purification Kit 
(Epicentre, Cat. No. MCD85201) (Forsyth Institute, Boston, USA). 
2. MoBio PowerSoil
TM
 DNA Isolation kit. 
Samples were taken from children (saliva and dental caries), infants (saliva) and 
skin (mother) to pilot the DNA extraction protocol in the above kits (1-2). 
Firstly, DNA was extracted using the above kits (1-2), and PCR was completed on 
the extracted DNA. 
Method: 
A. Kit 1: Modified Protocol uses Ready-Lyse(tm) Lysozyme Solution (Epicentre, 
Cat. No. R1802M) for overnight incubation and MasterPure DNA Purification Kit 
(Epicentre, Cat. No. MCD85201) (Forsyth Institute, Boston, USA). 
This Kit was adapted within the Forsyth Institute (http://mim.forsyth.org) 
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Protocol DNA Extraction: 
1. Lysis 
1. Suspend sample in 150µl of TE Buffer. 
2. Add 1µl of Ready-Lyse Lysozyme to each sample. 
3. Incubate at 37ºC overnight. 
4. Add 150µl of 2X T&C Lysis Solution to each sample and pipette up and 
down when adding. 
5. Add 1µlProteinase K to each sample. 
6. Incubate at 65ºC for 30 minutes, vortexing briefly every 5 minutes. 
7. Cool the sample to 37ºC 
8. Place the samples on ice for 3-5 minutes and then proceed to part B. 
 
B. DNA Clean-up 
1. Add 175µl of MPC Protein precipitation reagent to 300µl of lysed 
sample and vortex mix vigorously for 10 seconds. 
2. Pellet the debris by centrifugation at 4ºC for 10 minutes at ≥ 10,000 x g 
in a microcentrifuge Place on ice immediately after centrifugation. 
3. Transfer the supernatant to a clean microcentrifuge tube and discard the 
pellet. 
4. Add 500 µl of isopropanol to the recovered supernatant. Invert the tube 
30-40 times. 
5. Place on ice for 10 minutes. 
6. Pellet the DNA by centrifugation at 4ºC for 10 minutes at ≥ 10,000 x g 
in a microcentrifuge.  
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7. Pour off the isopropanol, being careful not to lose the pellet. Use a 
pipette tip to remove the remaining propanol without dislodging the DNA 
pellet. 
8. Rinse the pellet with 500µl 75% ethanol. Centrifuge briefly if the pellet 
is dislodged. Repeat rinse with additional 500µl 75% ethanol. 
9. Remove residual ethanol. 
10. Resuspend the DNA in 25 µl of TE buffer. 
Protocol amended from Epicentre Masterpure 
TM 
DNA purification kit and 
Epicentre Masterpure 
TM 
Gram positive DNA purification kit. 
Method: 
1. This method was initially used to extract DNA from saliva (fresh, frozen), and 
from dental caries. 
2. Following steps A& B, DNA was quantified using the Nanodrop 1000 (Table 
3.1.) (Thermo Fisher Scientific, Ireland). 
3. DNA was visualised on a 0.8% agarose gel (Figure 3.2). DNA was then stored 
at -80°C. 
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Nanodrop  
Sample Date [DNA] ng/µl 260/280 260/230 
1.Saliva 
swab 
(frozen) 
20.08.2012          207.3 1.74 1.10 
2.Saliva 
fresh 
(spit) 
20.08.2012 245.1 1.55 0.96 
3.Saliva 
frozen 
(swab) 
20.08.2012 208.8 1.83 1.29 
4.Dental 
caries 
(dentine) 
20.08.2012 949.1 1.81 1.28 
5.Saliva 
swab 
(frozen) 
20.08.2012 233.6 1.69 1.20 
6.Saliva 
spit 
frozen 
20.08.2012 178.3 1.70 1.35 
7.Dental 
caries 
(dentine 
20.08.2012 937.1 1.68 1.11 
Table 3.1. Nanodrop Results using the DNA extraction kit A: MasterPure DNA 
Purification Kit 
 
Figure 3.2. DNA was visualised on a 0.8% agarose gel. (Lane 1-7 (Samples 1-
7(as in Table 3.1)) 
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B. Kit 2: MoBio PowerSoilTM DNA Isolation kit. 
Protocol DNA Extraction: 
Extraction of DNA from all samples (vagina, skin and saliva/Oral) was carried out 
with the MO BIO PowerLyzer® 24 homogenizer with some initial optimisation 
for extraction from using a CatchAll™ collection swab, (Cambio UK) rather than 
a soil sample as previously described (Dominguez-Bello et al., 2010).  
The sample (vagina/skin/saliva) was contained in a CatchAll™ collection swab on 
the end of a collection tube.  
NOTE: The only deviation from the MoBio kit protocol was in step 12: The tubes 
are then centrifuged at room temperature for two minutes at 10,000 x g.  
Gloves were worn at all times. 
1. Saliva, skin and vaginal samples taken by the swabs are all stored in hard packs 
(Catch-All™). Aseptically remove the head of the Catch-All™ Sample Collection 
Swab, by pressing to side of the PowerBead Tube. For the dental caries sample, 
0.2 g of dentine samples was weighed and added directly to the PowerBead Tube.  
Tubes were incubated at 65°C for 10 minutes and then shaken horizontally at 
maximum speed for 2 minutes, using the MO BIO vortex adapter. For the dentinal 
caries sample, the sample was vortexed for an additional one minute when the 
dentine did not break-up and mix with the solution. The remainder of the protocol 
was followed as per manufacturer’s instructions.  
2. Gently vortex to mix. In the case all the swab collected specimens, aseptically 
cut the head 1 cm above this swab of the Catch-All™ Sample Collection Swab. 
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The swab end was inserted into the PowerBead tubes, to which 60µl of solution 
C1 had been added. Twist the swab head and press it against the side of the tube, 
in order to wring out as much as possible of the specimen-containing solution. 
3. Check Solution C1. If Solution C1 is precipitated, heat solution to 60°C until 
dissolved before use. 
4. Add 60 µL of Solution C1 and invert several times or vortex briefly. 
5. Secure PowerBead Tubes horizontally using the MO BIO Vortex Adapter tube 
Holder for the vortex (MO BIO Catalog No. 13000-V1) or secure tubes 
horizontally on a flat-bed vortex pad with tape. Vortex at maximum speed for 10 
minutes. 
6. Make sure the PowerBead Tubes rotate freely in your centrifuge without 
rubbing. Centrifuge tubes at 10,000 x g for 30 seconds at room temperature. 
CAUTION: Be sure not to exceed 10,000 x g or tubes may break. 
7. Transfer the supernatant to a clean two ml Collection Tube (provided). Note: 
Expect between 400 to 500 µL of supernatant. Supernatant may still contain some 
sample particles. 
8. Add 250 µL of Solution C2 and vortex for 5 seconds. Incubate at 4°C for five 
minutes. 
9. Centrifuge the tubes at room temperature for one minute at 10,000 x g. 
10. Avoiding the pellet, transfer up to, but no more than, 600 µL of supernatant to 
a clean two mL Collection Tube (provided). 
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11. Add 200 µL of Solution C3 and vortex briefly. Incubate at 4°C for 5 minutes. 
12. Centrifuge the tubes at room temperature for 2 minutes at 10,000 x g. 
13. Avoiding the pellet, transfer up to, but no more than, 750 uL of supernatant 
into a clean 2 mL Collection Tube (provided). 
14. Add 1200 uL of Solution C4 to the supernatant and vortex for 5 seconds. 
15. Load approximately 675 uL onto a Spin Filter and centrifuge at 10,000 x g for 
1 minute at room temperature. Discard the flow through and add an additional 675 
uL of supernatant to the Spin Filter and centrifuge at 10,000 x g for 1 minute at 
room temperature. Load the remaining supernatant onto the spin Filter and 
centrifuge at 10,000 x g for 1 minute at room temperature. 
Note: A total of three loads for each sample processed are required. 
16. Add 500 µL of Solution C5 and centrifuge at room temperature for 30 seconds 
at 10,000 x g. 
17. Discard the flow through. 
18. Centrifuge again at room temperature for 1 minute at 10,000 x g. 
19. Carefully place Spin Filter in a clean 2 mL Collection Tube (provided). Avoid 
splashing any Solution C5 onto the Spin Filter. 
20. Add 100 µL of Solution C6 to the centre of the white filter membrane. 
Alternatively, sterile DNA-Free PCR Grade Water may be used for elution from 
the silica Spin Filter membrane at this step (MO BIO Catalog No. 17000-10). 
21. Centrifuge at room temperature for 30 seconds at 10,000 x g. 
95 
 
22. Discard the Spin Filter. The DNA in the tube is now ready for any 
downstream application. 
DNA was visualised on a 0.8% agarose gel and quantified using the Nanodrop 
1000 (Thermo Fisher Scientific, Ireland). DNA was then stored at -80°C. 
DNA Extraction: 
Samples: Saliva (spit), saliva swab, caries, and skin  
Method: 
1. This method was initially adapted and piloted to extract DNA from above 
samples 
2. DNA was quantified using the Nanodrop 1000 (Table 3.2.) (Thermo Fisher 
Scientific). 
3. DNA was visualised on a 0.8% agarose gel (Figure 2.3). DNA was then stored 
at -80°C. 
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Nanodrop  
Sample Date [DNA] ng/µl 260/280 260/230 
1.Saliva 
Fresh 
(spit) 
21.08.2012          207.3 1.74 1.10 
2.Saliva 
fresh 
(spit) 
21.08.2012 245.1 1.55 0.96 
3.Saliva 
frozen 
(swab) 
21.08.2012 208.8 1.83 1.29 
4.Dental 
caries 
(dentine) 
21.08.2012 949.1 1.81 1.28 
5.Skin 
swab  
21.08.2012 233.6 1.69 1.20 
 
Table 3.2. Nanodrop Results from DNA Extraction kit B: MoBio PowerSoil
TM
 
DNA Isolation kit. 
 
Figure 3.3. DNA visualised on a 0.8% agarose gel .Lanes 1-5 representing 
samples 1-5 as in Table 3.2.  
 
1   2    3    4   5 
97 
 
3.3.2. PCR Amplification of DNA extracted from both kits (1&2). 
PCR Amplification was performed of all samples extracted, using both DNA 
extraction kits. 
PCR amplification: 
Primers used for PCR amplification were the V4 - V5 region primers 520F 
(AYTGGGYDTAAAGNG) and 926R (CCGTCAATTYYTTTRAGTTT).  
The V4 - V5 amplicons for Illumina sequencing were generated using a two-step 
amplification procedure. The first step reaction mix contained 50 μl BIO-X-
ACT™ Short Mix (BIOLINE), 10 μl of 2 nM forward and reverse primers, 50 ng 
genomic DNA, and ddH₂0 to give a final volume of 100 μl.  
Cycling conditions were: an initial 95°C, 5-min denaturation step; 30 cycles of 
95°C for 15s, 42°C for 15s, and 72°C for 30s; and a final 10-min extension at 
72°C. 
PCR products ran on a 2% gel, along with equal negatives (Figure 3.4) 
 
 
 
 
 
 
 
98 
 
Results: 
 
Figure 3.4. Gel Image of PCR products ran on 2% agarose gel. PCR productions 
of Kit 1& Kit 2. 
Both DNA extraction kits were effective as extraction DNA from all samples 
tested. I decided to select the MoBio PowerSoilTM DNA Isolation kit, because of 
the similarity of the study of mother infant pairs by Dominguez-Bello et al. to my 
study design (Dominguez-Bello et al., 2010), and the due to the piloted DNA 
extraction results for each of the samples taken. Furthermore, I continued to use 
the using a CatchAll™ collection swab, (Cambio UK), as used Human 
Microbiome Project, and due to the fact that these swabs could be used for all 
sample sites to be examined (vagina, skin, oral/saliva).  
 
Kit 1: Samples 
1-7 
Kit 2: Samples 
1-5 
Negatives 
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3.5. Studies Methodology: 
1. Longitudinal study: Birth to 1 year of age. 
2. Longitudinal study: Birth to 2 years of age. 
3. Cross Sectional Study. 
3.5.1 Longitudinal study: Birth to 1 year of age. 
Materials and Methods 
3.5.1.1 Study design, ethics and recruitment 
The study design was to recruit a cohort of mother-infant dyads for longitudinal 
sampling (from birth to 1 year of age) as part of the ORALMET study cohort.  
Mothers were approached and recruited antenatally between February 2012 and 
May 2014 at the Cork University Maternity Hospital (CUMH). Ethical approval 
was obtained from the Cork Teaching Hospitals Clinical Research Ethics 
Committee (reference code: ECM 3 (cc) 01/07/14). All mothers were consented 
for the study within 1-2 months prior to their estimated date of delivery, and two 
groups of mother-infants dyads (n=150) were created based on their mode of 
delivery (full-term spontaneous vaginally delivered infants (SVD), and full-term 
Caesarean section delivered infants (CS). True definition of a baby aged 28 days 
or less is defined as a “neonate” and aged 29 days or greater is defined as an 
“infant” (Chu et al., 2017), but in this study, although sampling began at birth, all 
neonates and infants are defined under the same label ‘infant’. Body sites included 
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in sampling were: vagina, skin, oral of the mother and oral of the infant. All SVD 
and CS deliveries were uncomplicated, and all infants were born full-term. 
Inclusion criteria applied to both SVD and CS delivered infants, were that all 
infants were born full-term (>35 weeks gestation), medically healthy, neonates did 
not receive antibiotic treatment, breast feeding for a minimum of 4 weeks post 
partum. Mothers who delivered by CS were all given prophylactic IV antibiotics 
prior to or during the surgery. If antibiotics were administered to the infant during 
the first year of life, this was recorded along with the length of duration of breast 
feeding. The recruitment resulted in the enrolment of 81 mothers into the study, 
after withdrawal of 24 mothers from the study. Skin samples from 37 mothers of 
CS infants were collected, and 37 vaginal samples from SVD delivered infants 
(Supplementary table 4.2). Information about the infants was collected at delivery 
using medical records at CUMH and further data was collected from each 
mother/infant pair, when the infant was one year old. 
3.5.1.2 Sample Collection 
A CatchAll™ collection swab (Cambio UK), with a hard pack for storage after 
collection was used to collect all samples from each of the following body sites: 
vagina, skin and oral cavity (saliva) (Turnbaugh et al., 2007). From the mother, a 
saliva sample was collected and a skin or vaginal sample depending if C-sectioned 
or vaginal delivery respectively. For the SVD delivered infants, using a 
CatchAll™ collection swab, (Cambio UK) the midwife or gynaecologist collected 
mid-vaginal samples from the mother within 1 hour before delivery. For CS 
delivered infants, the mother’s skin (right and left forearm area) was swabbed 
after moistening a CatchAll™ collection swab in sterile water, within 1 hour 
before delivery. For emergency C-sectioned deliveries, the skin swabs were taken 
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within 1 hour after delivery. The vaginal and skin samples were placed 
immediately on dry ice and transported to the laboratory, where they were frozen 
until further analysis and stored at -80°C. Saliva samples from the mother’s oral 
cavity of SVD and CS delivered infants were taken after the infant was born, 
within 1 hour. The saliva sample from the mother’s oral cavity is labelled at 
‘Saliva’ in the results section. CatchAll™ collection swab was used to collect 
pooled unstimulated saliva in the floor of the mouth for 1-2 minutes. This 
unstimulated saliva sample is recognized as a representation of the whole oral 
ecosystem (Aas et al., 2005; Crielaard et al., 2011; Zaura et al., 2009). For the 
infants, a saliva sample was collected using a CatchAll™ collection swab.  The 
saliva sample collected from the infant’s oral cavity at each time point is labelled 
as ‘Oral week 1, Oral week 4 etc’ in the results section. The first saliva sample 
was collected from the newborn infants within 2 days of delivery, before the 
mothers left hospital (n=75). This was repeated again at 4 weeks (n=60), 8 weeks 
(n=59), 24 weeks (6 months) (n=63) and at 1 year (n=83) of age (Supplementary 
table 4.1). All saliva samples were placed immediately on dry ice, transported to 
the laboratory, where they were frozen until further analysis and stored at -80°C. 
3.5.1.3 Sample Extraction and Processing 
Extraction of DNA from all samples (vagina, skin and saliva/Oral) was carried out 
with the MO BIO PowerLyzer® 24 homogenizer with some initial optimisation 
for extraction from using a CatchAll™ collection swab, (Cambio UK) rather than 
a soil sample as previously described (Dominguez-Bello et al., 2010). The sample 
(vagina/skin/saliva) was contained in a CatchAll™ collection swab on the end of 
a collection tube. The tube was cut 1 cm above this swab, and this was inserted 
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into the PowerBead tubes, to which 60µl of solution C1 had been added. Tubes 
were incubated at 65°C for 10 minutes and then shaken horizontally at maximum 
speed for 2 minutes, using the MO BIO vortex adapter. The remainder of the 
protocol was followed as per manufacturer’s instructions. DNA was visualised on 
a 0.8% agarose gel and quantified using the Nanodrop 1000 (Thermo Scientific, 
Ireland). DNA was then stored at -80°C.  
3.5.1.4 16S rRNA gene amplification primers  
Primers used for PCR amplification were the V4 - V5 region primers 520F 
(AYTGGGYDTAAAGNG) and 926R (CCGTCAATTYYTTTRAGTTT) 
(Supplementary table 4.2; Chapter 4). Initial primers for Illumina sequencing 
contain the sequencing primer binding sites, forward or reverse 16S rRNA gene 
specific primer, and a 10nt in-line multiplexing identifier (MID). Dual separate 
MIDs were attached to both ends of the PCR product (Supplementary table 4.2).  
The V4 - V5 amplicons for Illumina sequencing were generated using a two-step 
amplification procedure. The first step reaction mix contained 50 μl BIO-X-
ACT™ Short Mix (BIOLINE), 10 μl of 2 nM forward and reverse primers, 50 ng 
genomic DNA, and ddH₂0 to give a final volume of 100 μl. Cycling conditions 
were: an initial 95°C, 5-min denaturation step; 30 cycles of 95°C for 15s, 42°C for 
15s, and 72°C for 30s; and a final 10-min extension at 72°C. The products were 
purified using SPRI select beads (Beckman Coulter, Indianapolis IN) as per 
manufacturer’s instructions, using a 0.9:1 volume ratio of beads to product. The 
purified PCR products were eluted in 40 μl of ddH₂0. DNA quantity was assessed 
via Quant-iT™ PicoGreen® dsDNA Assay Kit (Invitrogen™). The samples were 
pooled in equimolar amounts and then sequenced by Eurofins Genomics (Eurofins 
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Genetic Services Ltd, I54 Business Park, Valiant Way Wolverhampton WV9 
5GB, UK) using Illumina MiSeq 2x300 bp paired end technology. Nextflex Rapid 
library preparation was carried out by the company to attach bridge adaptors 
necessary for clustering. Sequencing of 16S DNA was carried out on the V4/V5 
region using a Miseq (301 bp paired-end reads). Sequence data were stored on a 
Linux server and backed up on external hard-drives. 
3.5.1.5 Bioinformatic analysis & statistical analysis  
Sequence processing, OTU clustering and taxonomy assignment 
The software flash (v1.2.8), was used to join paired-end reads. Paired-end reads 
with more than 25% incorrect bases in their region of overlap were excluded from 
subsequent steps. Qiime (v1.9.1) was used to extract barcodes 
(extract_barcodes.py) and for demultiplexing (split_libraries_fastq.py).  
The USEARCH (v8.0.1623) pipeline was used for the following steps: de-
replication of reads (identical reads are represented by a single sequence), 
exclusion of reads shorter than 350 bp and longer than 370 bp, exclusion of 
unique reads, chimera filtering, OTU clustering at 97 % identity and calculation of 
representative OTU sequences. Using USEARCH, all reads (including unique 
reads) were then mapped back to the representative OTU sequences to give the 
final OTU read count for each sample. The software fastQC (v0.11.3) was used 
after each filtering step to assess read quality. The sample number after sequence 
processing was 495. 
Part of the mothur (v1.36.1) (Schloss, 2009) pipeline was used to run the RDP 
classifier using a filtered version of the RDP database in order to assign taxonomy 
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down to genus level. The software SPINGO (v1.3) (Allard et al., 2015), was used 
to assign taxonomy at species level. For both mothur/RDP and SPINGO, 
confidence cut-offs of 80% were used. 
Alpha and beta diversity analysis 
Alpha and beta diversity metrics were calculated in Qiime (v1.9.1)(Caporaso et 
al., 2010). To calculate diversity metrics, several additional steps were carried out 
(also in Qiime). The OTU table was rarefied (single_rarefaction.py) at 10,540 
reads (the lowest read count in the dataset). Representative OTU sequences were 
aligned using pyNAST (align_seqs.py) and filtered to remove columns that do not 
contribute to phylogenetic signal (filter_alignment.py). A phylogenetic tree was 
generated using FastTree (make_phylogeny.py). This tree is necessary for 
phylogenetic alpha and beta diversity metrics. The rarefied OTU table was used in 
the calculation of all diversity metrics. 
The following alpha diversity metrics were calculated: chao1, Shannon 
(Shannon’s index), Simpson (Simpson’s index), Observed species (OTU count) 
and Phylogenetic (PD whole tree). The following beta diversity metrics were 
calculated: weighted and un-weighted unifrac distances, and Bray-Curtis 
dissimilarity. 
Statistics and data visualisation 
All statistics and data visualisation were carried out in R (v3.2.3 and v3.4.0) 
(Statistical and Computing, Vienna, 2016). Alpha diversity boxplots were created 
using the package ggplot2. A Mann-Whitney U test was used to test whether 
SVD- and CS-born babies differed significantly for each time point. A Kruskal-
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Wallis test was performed on alpha-diversity metrics for each baby time point, 
followed by Mann-Whitney U pairwise comparisons corrected using the 
Benjamini-Hochberg method (Benjamini and Hochberg, 1995). Dunn test was 
performed for the pairwise comparison of the alpha diversity for the mum samples 
with the baby time points. Principal Coordinate Analysis (PCoA) plots of beta 
diversity metrics were created using the package ade4. Statistical differences in 
beta diversity were tested using the adonis function from the vegan package. 
Taxon abundance barplots were created using the packages reshape2, ggplot2, and 
ggthemes. Taxon abundance was normalised to sample proportions for the 
barplots. Kruskal-Wallis tests and Benjamini Hochberg pairwise tests were used 
to test for statistical difference in particular taxa at different time points. 
Clustering of mum-baby pairs based on beta diversity was performed using the 
hclust function from base R, and the plot created using the rafalib package. The 
heatmaps to investigate clustering of mum-baby pairs and baby time points based 
on genera abundances were created using the metagenomeSeq package in R.  
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3.5.2 Longitudinal study: Birth to 2 years of age. 
Materials and Methods 
3.5.2.1 Study design, ethics and recruitment 
This study included recruitment of a cohort of mother-infant pairs that were 
observed for longitudinal sampling of the infant oral microbiota (saliva) from 
birth to 2 years of age.  Mothers were recruited antenatally in their second or early 
third trimester, between February 2012 and May 2014 at the Cork University 
Maternity Hospital (CUMH), and all mothers were consented for the study around 
2 months before their estimated date of delivery. Ethical approval was obtained 
from the Cork Teaching Hospitals Clinical Research Ethics Committee (reference 
code: ECM 3 (cc) 01/07/14). In total we aimed to recruit two groups of mother-
infants pairs (n=150) based on their mode of delivery (SVD or CS). The maternal 
sampling sites included vagina if SVD delivered neonate or skin if CS delivery, 
together with oral saliva sample from all mothers. The inclusion criteria were that 
all deliveries were uncomplicated, that all infants were born full-term (>35 weeks 
gestation), medically healthy, neonates did not receive antibiotic treatment, and 
were exclusively breast fed for a minimum of 4 weeks. Mothers that delivered 
neonates by CS were all given IV prophylactic antibiotics prior to the surgery and 
if any antibiotics were administered to the infant during the first year of life, this 
was recorded. We recruited 81 mothers into the study, after withdrawal of 24 
mothers from the study, with 37 skin samples and 37 vaginal samples from CS 
and SVD delivered infants (Supplementary table 4.6.). We collected 382 oral 
samples between week 1 and 2 years of age (table 4.5), with a total of n=42 
infants aged year 2, and of these 18 were CS infants and 24 were SVD infants. 
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3.5.2.2 Sample Collection 
To collect all the samples from each of the body sites (vagina, skin and oral cavity 
(saliva)) we used a CatchAll™ collection swab (Cambio UK), with a hard pack 
for storage (Turnbaugh et al., 2007). From all mothers, a saliva sample was 
collected within 1 hour of delivery and a skin or vaginal sample depending on 
delivery mode. For the SVD delivered infants, the midwife or gynaecologist 
collected mid-vaginal samples from the mother within 1 hour before delivery 
using a CatchAll™ collection swab, (Cambio UK). For CS delivered infants, the 
mother’s skin (right and left forearm area) was swabbed after moistening a 
CatchAll™ collection swab in sterile water, within 1 hour before delivery. For 
emergency C-sectioned deliveries, the skin swabs were taken within 1 hour after 
delivery. All samples were immediately placed on dry ice and transported to the 
laboratory, where they were frozen at -80°C until further analysis. For the infants, 
a saliva sample was collected using a CatchAll™ collection swab.  The saliva 
sample collected from the infant’s oral cavity at each age as the infant increased in 
age labelled as ‘Oral week 1, Oral week 4 etc’. The first saliva sample was 
collected from the newborn infants within 2 days of delivery, before the mothers 
left hospital (n=75). This was repeated again at 4 weeks (n=60), 8 weeks (n=59), 
24 weeks (6 months) (n=63), 1 year (n=83) and 2 years of age (n=42) 
(Supplementary table 4.6). All saliva samples were placed immediately on dry ice, 
transported to the laboratory, where they were frozen until further analysis and 
stored at -80°C. All saliva samples were collected by the candidate when within 
the hospital, or by the research nurse on the Infantmet study. All saliva samples 
from 4 weeks to 2 years of age were collected in the home of the infant by the 
research nurse, together with a stool sample (Infantmet study). 
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3.5.2.3 Sample Extraction and Processing 
Extraction of DNA from all samples (vagina, skin and saliva) was carried out with 
the MO BIO PowerLyzer® 24 homogenizer with some initial optimisation for 
extraction from using a CatchAll™ collection swab, (Cambio UK) rather than a 
soil sample as previously described (Dominguez-Bello et al., 2010). The tube was 
cut 1 cm above this swab, which contained the sample, and this was inserted into 
the PowerBead tubes, to which 60µl of solution C1 had been added. Tubes were 
incubated at 65°C for 10 minutes and then shaken horizontally at maximum speed 
for 2 minutes, using the MO BIO vortex adapter. The remainder of the protocol 
was followed as per manufacturer’s instructions. DNA was visualised on a 0.8% 
agarose gel and quantified using the Nanodrop 1000 (Thermo Scientific, Ireland). 
DNA was then stored at -80°C.  
 
16S rRNA gene amplification primers  
Primers used for PCR amplification were the V4 - V5 region primers 520F 
(AYTGGGYDTAAAGNG) and 926R (CCGTCAATTYYTTTRAGTTT) 
(Supplementary table 4.2; Chapter 4). Initial primers for Illumina sequencing 
contain the sequencing primer binding sites, forward or reverse 16S rRNA gene 
specific primer, and a 10nt in-line multiplexing identifier (MID). Dual separate 
MIDs were attached to both ends of the PCR product (Supplementary table 4.2).  
The V4 - V5 amplicons for Illumina sequencing were generated using a two-step 
amplification procedure. The first step reaction mix contained 50 μl BIO-X-
ACT™ Short Mix (BIOLINE), 10 μl of 2 nM forward and reverse primers, 50 ng 
genomic DNA, and ddH₂0 to give a final volume of 100 μl. Cycling conditions 
were: an initial 95°C, 5-min denaturation step; 30 cycles of 95°C for 15s, 42°C for 
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15s, and 72°C for 30s; and a final 10-min extension at 72°C. The products were 
purified using SPRI select beads (Beckman Coulter, Indianapolis IN) as per 
manufacturer’s instructions, using a 0.9:1 volume ratio of beads to product. The 
purified PCR products were eluted in 40 μl of ddH₂0. DNA quantity was assessed 
via Quant-iT™ PicoGreen® dsDNA Assay Kit (Invitrogen™). The samples were 
pooled in equimolar amounts and then sequenced by Eurofins Genomics (Eurofins 
Genetic Services Ltd, I54 Business Park, Valiant Way Wolverhampton WV9 
5GB, UK) using Illumina MiSeq 2x300 bp paired end technology. Nextflex Rapid 
library preparation was carried out by the company to attach bridge adaptors 
necessary for clustering. Sequencing of 16S DNA was carried out on the V4/V5 
region using a Miseq (301 bp paired-end reads). Sequence data were stored on a 
Linux server and backed up on external hard-drives. 
 
3.5.2.4 Bioinformatic analysis & Statistical analysis. 
 
Sequence processing, OTU clustering and taxonomy assignment 
The software flash (v1.2.8), was used to join paired-end reads. Paired-end reads 
with more than 25% incorrect bases in their region of overlap were excluded from 
subsequent steps. Qiime (v1.9.1) was used to extract barcodes 
(extract_barcodes.py) and for demultiplexing (split_libraries_fastq.py).  
 
The USEARCH (v8.0.1623) pipeline was used for the following steps: de-
replication of reads (identical reads are represented by a single sequence), 
exclusion of reads shorter than 350 bp and longer than 370 bp, exclusion of 
unique reads, chimera filtering, OTU clustering at 97 % identity and calculation of 
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representative OTU sequences. Using USEARCH, all reads (including unique 
reads) were then mapped back to the representative OTU sequences to give the 
final OTU read count for each sample. The software fastQC (v0.11.3) was used 
after each filtering step to assess read quality. The sample number after sequence 
processing was 537. 
 
Part of the mothur (v1.36.1) (Schloss, 2009) pipeline was used to run the RDP 
classifier using a filtered version of the RDP database in order to assign taxonomy 
down to genus level. The software SPINGO (v1.3) (Allard et al., 2015), was used 
to assign taxonomy at species level. For both mothur/RDP and SPINGO, 
confidence cut-offs of 80% were used. 
 
Alpha and beta diversity analysis 
Alpha and beta diversity metrics were calculated in Qiime (v1.9.1)(Caporaso et 
al., 2010). To calculate diversity metrics, several additional steps were carried out 
(also in Qiime). The OTU table was rarefied (single_rarefaction.py) at 10,540 
reads (the lowest read count in the dataset). Representative OTU sequences were 
aligned using pyNAST (align_seqs.py) and filtered to remove columns that do not 
contribute to phylogenetic signal (filter_alignment.py). A phylogenetic tree was 
generated using FastTree (make_phylogeny.py). This tree is necessary for 
phylogenetic alpha and beta diversity metrics. The rarefied OTU table was used in 
the calculation of all diversity metrics. The following alpha diversity metrics were 
calculated: chao1, Shannon (Shannon’s index), Simpson (Simpson’s index), 
Observed species (OTU count) and Phylogenetic (PD whole tree). The following 
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beta diversity metrics were calculated: weighted and un-weighted unifrac 
distances, and Bray-Curtis dissimilarity. 
 
Statistics and data visualisation 
All statistics and data visualisation were carried out in R (v3.2.3 and v3.4.0) 
(Statistical and Computing, Vienna, 2016). Alpha diversity boxplots were created 
using the package ggplot2 and a Mann-Whitney U test was used to test whether 
the infant oral microbiota of SVD- and CS-born babies differed significantly at 
each age of the infant and a Dunn test was performed for the pairwise comparison 
of the alpha diversity for the maternal samples and the infant ages over time. A 
Kruskal-Wallis test was performed on alpha-diversity metrics for each baby time 
point (week 1 to 2 years of age), followed by Mann-Whitney U pairwise 
comparisons corrected using the Benjamini-Hochberg method (Benjamini and 
Hochberg, 1995). Principal Coordinate Analysis (PCoA) plots of beta diversity 
metrics were created using the package ade4. Statistical differences in beta 
diversity were tested using the adonis function from the vegan package. Taxon 
abundance barplots were created using the packages reshape2, ggplot2, and 
ggthemes. Taxon abundance was normalised to sample proportions for the 
barplots. Kruskal-Wallis tests and Benjamini Hochberg pairwise tests were used 
to test for statistical difference in particular taxa at different time points. The 
heatmaps generated to investigate clustering of the maternal samples and all of the 
infant oral microbiota samples at each time point were created using the 
metagenomeSeq package in R.  
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3.5.3 Cross-sectional study 
Materials and Methods 
3.5.3.1 Study design, ethics and recruitment 
The study design was to recruit two cohorts of children under the age of 60 
months. These two groups were categorized into those with S-ECC (caries-
active), and a caries-free cohort, all medically healthy. In total, we recruited 68 
caries-active and 70 caries-free children. The deep dentinal lesion microbiota were 
labelled as Caries-active cavity (CAC) and the salivary microbiota of these caries-
active children labelled as Caries-active saliva (CAS), while the saliva of the 
caries-free children were labelled as Caries-free saliva (CFS). Of the caries-active, 
all were S-ECC affected deciduous teeth, and the CAC and CAS are paired 
samples, each from the same subject. Ethical approval was obtained from the 
Teaching Hospitals Clinical Research Ethics Committee for the recruitment and 
sampling of these cohorts of children. Ethical approval reference: ECM 3 (cc) 
01/07/14. 
Recruiting of the children affected by S-ECC was performed at a Hospital Dental 
Treatment Centre. All children were referred to the Hospital Dental Treatment 
Centre where clinical examinations were performed and they were then scheduled 
for extraction of their carious teeth, under general anaesthetic. All these children 
referred to the Hospital Dental Treatment Centre for general anaesthetic had 
radiographs taken as part of the examination prior to referral. The caries-free 
cohort was recruited from various crèches, where a paediatric dentist travelled to 
each of the crèches and examined the children’s teeth. 
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Inclusion criteria applied to both caries-free and caries-affected groups were that 
they were medically healthy, had no antibiotic intake in the 3 months prior to 
sampling, and were under the age of 60 months.  
3.5.3.2 Diet and Lifestyle data collection   
Before undergoing the dental examination, informed consent was obtained from 
the parent/guardians of the children. We also collected habitual dietary data using 
a validated Food Frequency Questionnaire (FFQ) (Claesson et al., 2012) which 
was provided to each parent/guardian, to record food intake. A detailed 
questionnaire was given to each parent/guardian. Data collected included 
antibiotic treatment history, general medical history and dental history, 
fluoridation status of home (well/public water), feeding practices in infancy, birth 
mode, and oral health related quality of life.  
3.5.3.3 Oral Examination 
Oral examinations for both caries-free and caries-active groups were performed 
by a trained Paediatric dentist. Children in crèches and in the Hospital Dental 
Treatment Centre were examined in a quite area with their parents present. 
Children’s teeth were wiped with a cotton wool roll and sterile gauze square to 
remove plaque and debris prior to examination which was carried out under 
natural light, using a standard size 4 mirror and ball ended CPI ‘C’ probe 
(Whelton et al., 2006). The mouth was illuminated with a Promed Penlight, which 
consists of bright concentrated halogen light when natural light was insufficient.    
For the caries-active group, caries was recorded at the level of cavitation into 
dentine (cavitation level), using the WHO criteria (Whelton et al., 2006; WHO, 
1997), with the addition of visible non cavitated dentine caries as referenced by 
114 
 
Whelton et al. (Whelton et al., 2006).  The dmft score was recorded along with the 
dmfs score, and sample collection performed. For the caries-free group, caries was 
recorded  at the level of cavitation into dentine (cavitation level), using the WHO 
criteria (Whelton et al., 2006; WHO, 1997). The dmft/dmfs was measured, and 
sample collection was performed. Caries-free children did not show clinical 
evidence of early pre-cavitation of caries or white spot lesions and had no history 
of treatment on any tooth surfaces, as defined (Dye et al., 2007).  
3.5.3.4 Sampling 
The same trained paediatric dentist took all samples after the teeth were examined. 
All children were instructed not to brush their teeth the evening and the morning 
before sampling. A CatchAll™ collection swab, with hard pack for storage after 
collection was used (Cambio UK) (Turnbaugh et al., 2007). For the caries-active 
S-ECC group, both a carious lesion sample and a saliva sample were taken. After 
a full dental examination, and pre-general anaesthetic, the CatchAll™ collection 
swab was used to collect pooled unstimulated saliva in the floor of the mouth for 
1-2 minutes. This unstimulated saliva sample is recognized as a representation of 
the whole oral ecosystem (Aas et al., 2005; Crielaard et al., 2011; Zaura et al., 
2009). The swab was placed back in the collection tube, and stored at -80°C. To 
sample the carious lesions, while the child was under general anaesthetic, the 
carious deciduous tooth was extracted and under isolation, the tooth was irrigated 
with saline.  Under care, by a paediatric dentist, the superficial carious dentin was 
excavated with a sterile spoon excavator and the next layer of deep dentinal caries 
was excavated using a new separate sterile spoon excavator and the sample was 
pooled in a sterile 1.5-ml micro-centrifuge tube with 1 ml of TE buffer (50Mm 
Tris-HCL, 1Mm EDTA). The samples were placed in a sterile 1.5-ml micro-
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centrifuge tube and transported to the laboratory, where they were frozen until 
further analysis and stored at -80°C. For the caries-free group, after a full dental 
examination, the CatchAll™ collection swab was used to collect pooled 
unstimulated saliva in the floor of the mouth for 1-2 minutes. The swab was 
placed back in the collection tube, and stored at -80°C. 
3.5.3.5 DNA Extraction 
Extraction of DNA from all samples was carried out with the MO BIO 
PowerLyzer® 24 homogenizer following some initial optimisation for extraction 
from an oral catch-all swab rather than a soil sample as previously described 
(Dominguez-Bello et al., 2010). The saliva sample was contained in a catch-all 
swab in the end of a collection tube. The tube was cut 1 cm above this swab, and 
this was inserted into the PowerBead tubes, to which 60µl of solution C1 had been 
added. Tubes were incubated at 65°C for 10 minutes and then shaken horizontally 
at maximum speed for 2 minutes, using the MO BIO vortex adapter. The 
remainder of the protocol was followed as per manufacturer’s instructions. For the 
caries sample, the tubes were incubated at 65 °C for 10 minutes and then shaken 
horizontally at maximum speed for 4 minutes, using the MO BIO vortex adapter.  
The remainder of the protocol was followed as per manufacturer’s instructions. 
DNA was visualised on a 0.8% agarose gel and quantified using the Nanodrop 
1000 (Thermo Scientific, Ireland). DNA was then stored at -80°C.  
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3.5.3.6 16S rRNA gene amplification primers  
Primers used for PCR amplification were the V4 - V5 region primers 520F 
(AYTGGGYDTAAAGNG) and 926R (CCGTCAATTYYTTTRAGTTT) 
(Supplementary table 4.2). Initial primers for Illumina sequencing contain the 
sequencing primer binding sites, forward or reverse 16S rRNA gene specific 
primer, and a 10nt in-line multiplexing identifier (MID). Dual separate MIDs were 
attached to both ends of the PCR product.   
The V4 - V5 amplicons for Illumina sequencing were generated using a two-step 
amplification procedure. The first step reaction mix contained 50 μl BIO-X-
ACT™ Short Mix (BIOLINE), 10 μl of 2 nM forward and reverse primers, 50 ng 
genomic DNA, and ddH₂0 to give a final volume of 100 μl. Cycling conditions 
were: an initial 95°C, 5-min denaturation step; 30 cycles of 95°C for 15s, 42°C for 
15s, and 72°C for 30s; and a final 10-min extension at 72°C. The products were 
purified using SPRIselect beads (Beckman Coulter, Indianapolis IN) as per 
manufacturer’s instructions, using a 0.9:1 volume ratio of beads to product. The 
purified PCR products were eluted in 40 μl of ddH₂0. DNA quantity was assessed 
via Quant-iT™ PicoGreen® dsDNA Assay Kit (Invitrogen™). The samples were 
pooled in equimolar amounts and then sequenced by Eurofins Genomics (Eurofins 
Genetic Services Ltd, I54 Business Park, Valiant way Wolverhampton WV9 5GB, 
UK) using Illumina MiSeq 2x300 bp paired end technology. Nextflex Rapid 
library preparation was carried out by the company to attach bridge adaptors 
necessary for clustering. Sequencing of 16S DNA was carried out on the V4/V5 
region using a Miseq (301 bp paired-end reads). Sequence data were stored on a 
Linux server and backed up on external hard-drives. 
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3.5.3.7 Bioinformatic analysis and Statistical analysis 
Sequence processing, OTU clustering and taxonomy assignment 
The software, flash (v1.2.8), was used to join paired-end reads. Paired-end reads 
with more than 25% incorrect bases in their region of overlap were excluded from 
subsequent steps. Qiime (v1.9.1) was used to extract barcodes 
(extract_barcodes.py) and for demultiplexing (split_libraries_fastq.py).  
The USEARCH (v8.0.1623) pipeline was used for the following steps: de-
replication of reads (identical reads are represented by a single sequence), 
exclusion of reads shorter than 350 bp and longer than 370 bp, exclusion of 
unique reads, chimera filtering, OTU clustering at 97% identity and calculation of 
representative OTU sequences. Using USEARCH, all reads (including unique 
reads) were then mapped back to the representative OTU sequences to give the 
final OTU read count for each sample. The software fastQC (v0.11.3) was used 
after each filtering step to assess read quality. The median read count for the 
samples after sequence processing was 44,400. The sample number after sequence 
processing was 206. 
Part of the mothur (v1.36.1) (Schloss, 2009) pipeline was used to run the RDP 
classifier using a filtered version of the RDP database in order to assign taxonomy 
down to genus level. The software SPINGO (v1.3) (Allard et al., 2015), was used 
to assign taxonomy at species level. For both mothur/RDP and SPINGO, 
confidence cut-offs of 80% were used. 
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Alpha and beta diversity analysis 
Alpha and beta diversity metrics were calculated in Qiime (v1.9.1)(Caporaso et 
al., 2010). To calculate diversity metrics, several additional steps were carried out 
(also in Qiime). The OTU table was rarefied (single_rarefaction.py) at 10,540 
reads (the lowest read count in the dataset). Representative OTU sequences were 
aligned using pyNAST (align_seqs.py) and filtered to remove columns that do not 
contribute to phylogenetic signal (filter_alignment.py). A phylogenetic tree was 
generated using FastTree (make_phylogeny.py). This tree is necessary for 
phylogenetic alpha and beta diversity metrics. The rarefied OTU table was used in 
the calculation of all diversity metrics. 
The following alpha diversity metrics were calculated: chao1, Shannon 
(Shannon’s index), Simpson (Simpson’s index), Observed species (OTU count) 
and Phylogenetic (PD whole tree). The following beta diversity metrics were 
calculated: weighted and un-weighted unifrac distances, and Bray-Curtis 
dissimilarity. 
Statistics and data visualisation 
All statistics and data visualisation were carried out in R (v3.2.3) (Statistical and 
Computing, Vienna, 2016). Paired Mann-Whitney tests were used to compare 
microbiota of saliva samples (CAS) (n=68) with that of caries samples (CAC) 
(n=68) taken from the caries group. Both CAC and CAS are paired, both samples 
from the same subject. Un-paired Mann-Whitney tests were used to compare the 
saliva and caries samples from the caries group with a control group of caries-free 
saliva (CFS) (n=70) of caries-free individuals. Benjamini and Hochberg 
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correction (Benjamini and Hochberg, 1995) was used to adjust p-values for 
multiple testing. 
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Chapter 4 
 
Results 
1. Longitudinal study: Birth to 1 year of age. 
2. Longitudinal study: Birth to 2 years of age. 
3. Cross Sectional Study. 
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Results 
 
 4.1. Longitudinal study: Birth to 1 year of 
age. 
 
 
This chapter has been submitted for peer review in ‘Journal 
of Dental Research’.  
 
Entitled: 
‘The influence of birth mode and breastfeeding duration on 
the emerging neonatal oral microbiota from birth to 1 year of 
age, a cohort study.’ 
Authors: Eimear Hurley, Hugh M.B. Harris, David Mullins, Maurice P.J Barrett, 
Carol Anne O’Shea, Martin Kinirons, Helen Whelton, C. Anthony Ryan, 
Catherine Stanton, Paul W. O’Toole.  
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4.1 Results  
4.1.1 The oral microbiota of the infant is similar at weeks 1, 4 and 8 but 
becomes more distinct by 1 year of age. 
To investigate the relatedness of the microbiome composition between samples 
including the maternal vagina, skin and their oral cavity (saliva) to their infants 
from week 1 to 1 year of age (at the following time points: 1 week, 4 weeks, 8 
weeks, 6 months and 1 year) we generated PCoA (principle co-ordinate) plots 
showing relatedness by two established metrics, Bray Curtis dissimilarity, and 
UniFrac distances. The Bray Curtis plot (Fig. 4.1A), weighted unifrac (Fig. 4.1B) 
and unweighted unifrac (Fig. 4.1C) both demonstrate substantial overlap between 
each group, indicating similarity in the general composition of the microbial taxa. 
However, using PerMANOVA to compare the microbiota of the mother (vagina, 
skin and oral), with the oral microbiota of the infants at different time points, we 
found statistically significant differences between each group, as measured by 
each metric (p <0.001) (Table 4.1). 
There is sharing of taxa between maternal microbiota (skin/vaginal) and infant 
oral microbiota independent of birth modality (SVD/CS). The Bray Curtis (Fig. 
4.1A) and weighted UniFrac (Fig. 4.1B) demonstrate overlap between the earlier 
ages of the infant (week 1, week 4, week 8) along with the vagina of the mother in 
the weighted PCoA, demonstrating similarity in the composition of microbial taxa 
at this early age. The closeness and overlap of these early oral microbiota samples 
from the infant with the skin and vaginal samples from the mother illustrate 
sharing of taxa independent of birth mode with obvious sharing of taxa of the 
week 1 and week 4 infant oral microbiota with mothers vagina and skin 
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microbiota. While weighted UniFrac is sensitive to the differences in the 
presence/absence and abundance/proportions of OTUs, there is evidence of tight 
clustering of week 1, week 4 and week 8 infant oral microbiota samples along 
with less clustering together with 6 months and 1 year samples, demonstrating 
that at an early age (week 1 to week 8) the abundance of certain OTUs is shared 
between samples, but not as strongly as the infant increases in age, with 
separation of the 6 months and 1 year infant microbiota into their own distinct 
clusters. This longitudinal sampling of the oral microbiota of the infant 
demonstrates similarity of the infant oral microbiota in the first 8 weeks, and then 
change in the microbial oral community structure over time until 1 year, where the 
infant oral microbiota community becomes more distinct.  
 
Plotting datasets using the second UniFrac metric, unweighted UniFrac distances 
(Fig. 4.1C), illustrates tight clustering again of the earlier age time points of the 
oral microbiota of the infant (week 1, week 4 and week 8), with less overlap with 
the increased age (6 months and 1 year). This index measures the presence and 
absence of taxa only and does not take taxon abundance into account. By this 
method there is evidence of clustering of week 1, 4 and 8 of the oral microbiota of 
the infant, indicating sharing of rare taxa, while year 1 has minimal overlap with 
these earlier age time points, indicating less sharing of rare taxa between early and 
later stages of age. This is further supported by the oral microbiota of infants at 6 
months, positioned between week 1 to week 8 and year 1, thus highlighting a 
gradual change in the microbial composition from week 8 to 6 months and finally 
to 1 year of age, where the microbiota appears more distinct (Fig. 4.1C). 
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Table  4.1. Significance values of Bray Curtis dissimilarity and UniFrac distances 
metrics. Significance was calculated using permutational multivariate analysis of 
variance (PerMANOVA). p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). 
A.  
B.  
axis 1 axis 2 PERMANOVA
un-weighted unifrac 18.4 6.7 p<0.001
weighted unifrac 39.2 11 p<0.001
Bray-Curtis 18.5 9.2 p<0.001
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               C.  
Fig. 4.1 Principle Coordinates Analyses (PCoAs) on Spearman distance 
matrices of samples from mother (saliva, skin & vagina) & from infant oral 
at 5 time points (week 1, 4, 8, 6 months and 1 year). A. Bray Curtis 
dissimilarity, B. UniFrac Weighted & C. Unweighted UniFrac between the 5 
groups (mother saliva/oral, skin & vaginal & infant oral week 1,4,8,6 months and 
1 year).  A. Plot of principle co-ordinates using Bray-Curtis dissimilarity. Points 
are coloured according to group and ellipses describe the distribution of points for 
each group. Percentage variation explained: PCA 1 (18.5%) and PCA 2 (9.2%). B. 
Plot of principle co-ordinates using weighted unifrac distance. Points are 
coloured according to group and ellipses describe the distribution of points for 
each group. Percentage variation explained: PCA 1 (39.2%) and PCA 2 (11%). C. 
Plot of principle co-ordinates using un-weighted unifrac distance. Points are 
coloured according to group and ellipses describe the distribution of points for 
each group. Percentage variation explained: PCA 1 (18.4%) and PCA 2 (6.7%). 
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4.4.2 The oral microbiota of the infant is influenced by delivery mode at 1 
week of age, but not at 1 year of age. 
We investigated the influence of birth mode (SVD v CS) on the oral microbiota 
composition of the newborn infant and significance was calculated using 
permutational multivariate analysis of variance (PerMANOVA) (Table 4.2). The 
results were presented by PCoA (principle co-ordinates) plots (Fig. 4.2). The beta 
diversity of the infant oral microbiota at 1 week of age was shown to be affected 
by birth mode (SVD or CS). The impact of birth mode on the infant oral 
microbiota at 1 week of age was statistically significant (p < 0.05). With increased 
age of the infant, we did not find any significant impact of birth mode on the 
infant oral microbiota composition (Table 4.2). Visually, the overlap/clustering 
between SVD and CS becomes tighter with older age, with nearly complete 
overlap by 6 months and 1 year, illustrating homogeneity of the oral microbiota 
within the oral cavity by birth modes. 
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Fig. 4.2 PCoA (principle co-ordinates) plots each demonstrating the effect of 
birth mode (SVD v CS) on oral microbiota composition of the infant at 
different ages (week 1, 4, 8, 6 months and 1 year). Significance was calculated 
using permutational multivariate analysis of variance (PerMANOVA) (Table 4.2). 
 
Time point PerMANOVA p-value 
1 Week 0.047* 
4 Weeks 0.31 
8 Weeks 0.1 
6 Months 0.324 
1 Year 0.329 
Table 4.2.  Significance values for the difference between SVD and CS at each 
time point. Significance was calculated using permutational multivariate analysis 
of variance (PerMANOVA). p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). 
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4.1.3 Diversity of the oral microbiota remains relatively stable up to 6 months 
of age. 
To study the diversity of the microbiota from all samples, we calculated a series 
of alpha (α) diversity metrics: the Chao index, phylogenetic diversity (PD whole 
tree), observed species (OTU count), the Simpson index and the Shannon index 
(Fig.4.3). Alpha diversity is a measure of the diversity within a sample. The Chao 
diversity (Fig. 4.3A) which calculates species diversity within the sample and 
observed species (OTU count) index, which measures OTUs observed in a sample 
(Fig. 4.3B), both illustrated that the α-diversity of the year 1 oral microbiota was 
lowest and the α-diversity of the oral microbiota decreased steadily over time 
from week 1 to year 1. However the two remaining indices measuring α-diversity; 
phylogenetic diversity (Fig. 4.3C) and Shannon diversity (Fig. 4.3D), demonstrate 
that the diversity of the oral microbiota remains stable with increasing age.  
All metrics illustrated that of the samples analysed the skin microbiota diversity 
was highest, with high abundance of Propionibacterium, Streptococcus and 
Corneybacterium, and the diversity of the vaginal microbiota was lower than the 
skin microbiota, composed mainly of genera Streptococcus, Haemophilus, 
Neisseria and Lactobacillus, while both the maternal  skin and vaginal microbiota 
demonstrate compositional differences (p <0.001). While the mother’s skin 
diversity can vary by sample site location, skin diversity is high due to its open 
environment (Costello et al., 2013; Grice et al., 2008; Grice and Segre, 2011), 
while Lactobacillus species can dominate the vaginal microbiota of the mother, 
and makes up the majority of the composition, and the vaginal microbiota 
diversity was previously found to be the lowest compared to skin and oral of 
adults sampled (Li et al., 2012; Zhou et al., 2013). Interestingly, considering the 
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Chao diversity, there were no microbiota differences between the maternal skin 
microbiota and oral of the infant at 1 week of age, and the maternal vaginal 
microbiota and infant at 1 week of age, but as the infant increases in age, the 
microbiota difference increased in significance between the oral cavity of the 
infant from 6 months of age, to the maternal microbiota of the vagina and skin at 
birth (p <0.0001). This illustrates similarity of the maternal skin and vaginal 
microbiota at birth to the infant oral microbiota at week 1, 4 and 8 weeks and not 
until 6 months and beyond does the oral microbiota of the infant appear to acquire 
its own distinct composition, with less influence of the maternal microbiota. 
 
When species diversity was measured by Chao diversity, we observed that the 
maternal oral microbiota and the infant oral microbiota at week 1 of age are 
different (p < 0.005), while at 1 year of age the α-diversity difference between 
these two samples is still significantly different (Fig. 4.3A). By the other α-
diversity measures, the phylogenetic diversity measurement illustrated similar 
findings at week 1 (p <0.05), while OTU count showed difference in diversity of 
significance from 8 weeks (p <0.05). These results demonstrate that at a younger 
age, the differences in microbiota diversity between mother’s saliva and infant 
saliva is less than at an older age, highlighting some relatedness at an early age 
between the oral microbiota of mother and infant. 
 
The composition of the oral microbiota of the infant does not appear to change 
between week 1 and 8 weeks of age when measured using Chao diversity and 
Shannon diversity. At phylum level, Firmicutes abundances at week 1 and week 8 
are similar with relative abundances at week 1 (82.3%) , week 4 (87.3%) and at 8 
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weeks (81.1%). Only after 8 weeks are changes in composition evident (p <0.05) 
(Chao diversity), with Firmicutes levels beginning to decrease from 6 months 
(60.2%) until 1 year (33.7%). From 6 months to 1 year, as the relative abundances 
of  Firmicutes decreases within the oral cavity this coincides with an increase in 
phyla at 1 year of age Proteobacteria (25.6%) and Bacteroidetes (16.7%). 
Similarly, as measured by the Shannon index (Fig. 4.3D) oral microbiota diversity 
differences are apparent from 6 months of age, with oral microbiota differences 
evident between 6 months and 1, 4 and 8 weeks (p <0.0001) and 6 months and 1 
year (p < 0.05). These metrics demonstrate that the diversity of the oral 
microbiota remains relatively stable from week 1 to 8 weeks of age and it is not 
until the infant reaches 6 months of age and 1 year of age do we see significant 
changes in the diversity of the infant oral microbiota.  
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A.  
B.  
C.   
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D.  
Fig.4.3. Alpha diversity comparisons of the 5 groups (mother saliva, skin & 
vaginal & infant oral week 1, 4, 8, 6 months and 1 year). 
A. Boxplot of chao1 diversity in the three groups. B. Boxplot of observed species 
in the eight groups. C. Boxplot of Phylogenetic diversity in the eight groups. D. 
Boxplot of Shannon diversity in the eight groups. Outliers are represented by 
black points.  
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4.1.4 The diversity of the oral microbiota of the infant is influenced by birth 
mode at 1 week of age, but not beyond 1 week of age. 
To investigate the influence of birth mode on the oral microbiota composition as 
the infant increases in age, infant oral microbiota data was separated based on 
birth mode (SVD or CS) at the various time points (week 1, week 4, 6 months and 
1 year). Alpha diversity was used to measure the overall diversity of the 
community present in the sample. Four indices were used (Fig. 4.4). The alpha 
diversity as represented by Shannon diversity index, of the infant oral microbiota 
at 1 week of age was influenced by birth modality (p-value <0.037), but at an 
older age, there was no influence of birth mode on the oral microbiota of the 
infant. Shannon diversity index takes the abundance of species into account, and 
in this case this index indicates that the diversity of the infant oral microbiota at 
week 1 is lower in SVD infants, compared to CS infants, and therefore the species 
abundance is richer in CS infant oral microbiota. 
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B  
C          
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D  
Fig. 4.4. Alpha Diversity measurement of the influence of mode of delivery 
(SVD v CS) on the infant oral microbiota at various time points (week 1, 
week 4, 6 months and 1 year). A. Boxplot of the chao1 diversity, observed 
species, Phylogenetic diversity and Shannon diversity in the two groups (SVD & 
CS) at week 1. B. Boxplot of the chao1 diversity, observed species, Phylogenetic 
diversity and Shannon diversity in the two groups (SVD & CS) at week 4. C. 
Boxplot of the chao1 diversity, observed species, Phylogenetic diversity and 
Shannon diversity in the two groups (SVD & CS) at 6 months. D. Boxplot of the 
chao1 diversity, observed species, Phylogenetic diversity and Shannon diversity 
in the two groups (SVD & CS) at 1 year. Outliers are represented by black points.  
  
 
 
 
 
136 
 
4.1.5 The infant oral microbiota clusters by differential taxon abundance 
from week 1 to 8 weeks, with separation of year 1 infant oral microbiota. 
The abundance levels in different microbiota datasets (skin/vaginal/saliva) was 
graphically demonstrated by hierarchical clustering and the similarity between 
these samples was represented by vertical and horizontal dendrograms 
incorporating a “heatmap” colour scale to convey abundance levels at genus and 
species level (Fig. 4.5, 4.6). In this analysis, we compared the abundance levels of 
the taxa in the maternal (skin/vagina/saliva) datasets along with the infant oral 
microbiota datasets at the various ages. In figure 4.7, as illustrated by hierarchical 
clustering we compared the microbiota datasets from mother (saliva) and infant 
oral microbiota pairs, at genus level and clustering of mother-infant pairs were 
presented on a cluster dendogram (Supplementary figure 4.1). 
The abundance of bacterial taxa at genus level, of the maternal 
(skin/vagina/saliva) datasets along with the infant oral microbiota datasets at the 
various ages is illustrated in figure 4.5. There is evidence of two main branches in 
the horizontal dendogram above the colour bar. The first branch illustrates 
clustering of samples, mainly of oral origin from the infant at weeks 1, 4, 8 and 6 
months, with a very high abundance of the genera Streptococcus (Fig 4.5: labelled 
1). Interestingly, the year 1 oral samples from the infant appear clustered to the 
right, together with some 6 month infant oral samples, with 6 month samples seen 
as a transition between the early infant oral microbiota (week 1 to week 8) to later 
ages of 1 year (Fig. 4.5: labelled 2). The genera that are abundant in year 1 infant 
oral microbiota include Neisseria, Haemophilius, Porphyromonas and 
Streptococcus. At 1 year of age, there are more diverse genera present, compared 
to 1 week of age of the infant, where the diversity is less, and only a few genera 
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dominate, such as Streptococcus. Although we do not see a distinct trend where 
the oral microbiota cluster based on increased age of the infant, we do however 
see that at the early ages of the infant, week 1 to week 8, there is tighter 
clustering, compared to the later stages where 6 months to closer to 1 year of age. 
This trend is supported by our alpha diversity measures (Fig. 4.3), where from 6 
months the difference in diversity becomes more significant than the earlier time 
points. 
The maternal saliva microbiota data appear to be distributed throughout the 
horizontal dendogram, with small areas of tight clustering, highlighting its high 
diversity, with increased abundances of genera Streptococcus, Neisseria, 
Haemophilus and Prevotella. The maternal skin and vaginal microbiota cluster at 
one point (Fig. 4.5: labelled 3). There are high abundances of genus Streptococcus 
numbers in both samples, with the genera Lactobacillus in high abundances in the 
vaginal samples only.  The genera associated with the skin samples are more 
variable, with higher diversity, including Propionibacterium, Haemophilus, and 
Staphylococcus. 
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Fig. 4.5. Hierarchical clustering of microbiota data at bacterial Genus level. 
Abundances are colour-coded according to the colour key on the top left with grey 
representing a value of zero. Euclidean distance and complete linkage were used 
to cluster the rows and columns of the heatmap. The colour bar on side of the 
heatmap corresponds to sample type. Each genus with a mean ≥ 0.5% across all 
samples was included. All taxa present at less than 1% in all groups are excluded 
from the heatmap.  
 
We included in this analysis all samples with at least one species present with a 
median value ≥ 0.5% across all samples, and this is presented in figure 4.6. There 
was no obvious clear separation between each group of samples evident. We did 
however notice tight clustering of some samples, such as vaginal samples with 
high abundances of Lactobacillus iners (Fig. 4.6: labelled 1), skin samples with 
high abundance of Propionibacterium acnes (Fig. 4.6: labelled 2) and oral saliva 
samples with high abundances of Rothia mucilaginosa, Haemophilius 
parainfluenzae and Haemophilius haemolyticus (Fig. 4.6: labelled 3).   
 
1 2 3 
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Fig. 4.6. Hierarchical clustering of microbiota data at bacterial species level. 
Abundances are colour-coded according to the colour key on the top left with grey 
representing a value of zero. Euclidean distance and complete linkage were used 
to cluster the rows and columns of the heatmap. The colour bar on top of the 
heatmap is coloured according to sample type. All taxa present with at least one 
species with a median value ≥ 0.5% across all samples are included.  
 
 
 
 
 
 
 
 
 
 
3 
1 
2 
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We compared the saliva microbiota of the mother with the the infant oral 
microbiota and bacterial taxon abundance were illustrated on a vertical and 
horizontal dendrograms (Fig. 4.7). This analysis did not identify individual 
mother to infant pairs clustering together (Supplementary figure 4.1), but did 
identify clustering of maternal saliva microbiota and infant oral microbiota as 
separate groups.  One subset of mothers illustrated a high abundance of genera 
Selenomonas, Oribacterium and Tanerella, (Fig. 4.7. labelled 1), and a lower 
abundance of genera such as Ruminococcus, Escherichia/Shigella. Infant sample 
clustering was evident, with genera such as Selenomonas, Onbacterium, and 
Megasphaera in higher abundance (Fig. 4.7: labelled 2). 
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Fig. 4.7. Hierarchical clustering of microbiota data between maternal saliva 
microbiota and infant oral microbiota at bacterial Genus level. Abundances 
are colour-coded according to the colour key on the top left with red representing 
a value of zero. Euclidean distance and complete linkage were used to cluster the 
rows and columns of the heatmap. The colour bar on side of the heatmap 
corresponds to sample type (green =mother, yellow=infant).  All taxa present at 
less than 1% in all three groups are excluded from the heatmap. 
 
 
 
 
 
 
 
1 
2 
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4.1.6 Broad and fine detail compositional differences distinguish between 
maternal and infant microbiota datasets. 
We assessed all samples in each group (mother: skin, vagina & oral/saliva; Infant 
Oral at week 1, 4, 8, 6 months & 1 year) for their compositional differences at 
Phylum, Genus and species level. The relative abundances of each group is 
presented at each level (Fig. 4.8) and their abundances and any significant 
differences between groups. The mothers oral saliva is dominated by Firmicutes, 
followed by Proteobacteria and Bacteroidetes. The skin and vagina both have a 
mixed composition also dominated by Firmicutes, while the mothers skin has 
increased Proteobacteria and Actinobacteria, and both body sites are statistically 
different in their microbiota composition (p <0.001) (Fig. 4.8A). 
 
At phylum level (Fig. 4.8A), the composition of the oral microbiota between week 
1 and 1 year is different (p <0.001), while only from 6 months do we see the 
significance begin to emerge. The infant oral saliva microbiota is dominated from 
birth to 6 months by Firmicutes and is relatively stable in its abundance from 
week 1 to 6 months (Fig. 4.8A). Firmicutes levels between week 1 and week 8 are 
similar with relative abundances at week 1 (82.3%), week 4 (87.3%) and at 8 
weeks (81.1%). Only after 8 weeks does the abundance of Firmicutes begin to 
decrease, from 6 months (60.2%) until 1 year (33.7%), and this coincides with an 
increase in abundances of Proteobacteria at 1 year (25.6% ) (p <0.0001)  and 
Bacteroidetes (16.7%).  These changes from 6 months to 1 year may be due to the 
influence of tooth eruption and introduction of solid foods which typically occurs 
at this time. 
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As expected,  at genus level, the dominant genera of the infant oral microbiota at 
1 week of age was Streptococcus, with Streptococcus levels gradually increasing 
in abundance, from week 1 (53.8%) to week 4 (67.6%) and week 8 (67.5%) (Fig. 
4.8B).  However, beyond 8 weeks, this trend ceases, with decreasing levels of 
Streptococcus at 6 months (42.8%) and again at 1 year of age (23.1%). When 
Streptococcus levels begin to decrease, this is counteracted by increased 
abundances by year 1 of genera such as Neisseria (10.3%), Porphyromonas 
(3.96%), Rothia (3.68%) and Haemophillus (3.87%).   
 
By 1 year of age, the infant microbiota is different to the microbiota at a younger 
age (p <0.001) and there was increased presence of genera such as Streptococcus, 
Porphyromonas, Neisseria and Haemophilus. Although the microbial composition 
within the oral microbiota of an infant aged year 1 is composed of genera similar 
to the mother’s microbiota, their microbial composition is different (p <0.001) 
(Fig. 4.8). From week 1 to year 1, species that dominate the oral microbiota 
include Rothia mucilaginosa, Haemophilius haemolyticus, Haemophilius 
parainfluenzae, Porphyromonas catoniae, Veillonella dispar, Lactobacillus iners 
and Prevotella melaninogenica.  
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A.  
 
B.  
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 C.  
Fig. 4.8. Broad and fine detail compositional differences at Genus, phylum 
and species level.  
A. Microbiota composition at phylum level. Percentages for each taxon represent 
the median abundance values for the sample types. B. Barplot of percentage 
abundance at genus level. Percentages for each taxon represent the median values 
for the groups. C: Barplot of percentage abundance at species level. Percentages 
for each taxon represent the median values for the groups.  
 
The bacterial composition of the mothers skin includes Propionibacterium, 
Streptococcus and Corneybacterium, and the species present include 
Propionibacterium acnes, Haemophilus parainfluenzae/haempolticus and Rothia 
mucilaginosa. The vaginal microbiota composition is made up mainly of the 
genera Streptococcus, Haemophilus, Neisseria and Lactobacillus, and species 
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Lactobacillus iners is the main Lactobacillus species identified in the vaginal 
microbiota of the mother, and makes up the majority of the composition, followed 
by Gardnerella vaginalis (Fig. 4.8C). The influence of birth mode on the oral 
microbiota from these maternal body sites (skin/vagina) is evident within 1 week 
of age only but not beyond (Fig 4.2). Lactobacillus iners is present at week 1 and 
surprisingly increases in abundances by week 4 in the infants oral microbiota 
highlighting the potential transfer from mother (vaginal) to infant, along with 
species Propionibacterium acnes from maternal skin. To assess the effect of birth 
mode on the oral microbiota composition of the infant, we divided the oral 
microbiota of infants by birth mode (Figure 4.9). At phylum level, for both CS 
and SVD delivered infants, there is a similar pattern in the phylum composition 
over time (Fig.4.9A), while at genus level, at week 1, infants born by SVD appear 
to have lower levels of Streptococcus, Gemella and more Porphyromonas and 
Prevotella than CS infants at week 1.  
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A.  
 
B.  
 
Fig. 4.9. Comparison of the microbiota composition of infants born by 
different birth modes (SVD & CS) across five time-points from one week to 1 
year of age.  
 
A. Microbiota composition at phylum level. Percentages for each taxon represent 
the median abundance values for the sample types. B. Barplot of percentage 
abundance at genus level. Percentages for each taxon represent the median values 
for the groups. Graph includes data for genera found at >1% average in total 
population. Genera found at <1% were grouped as “other”. 
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4.1.7 Breast feeding duration did not influence the oral microbiota of the 
infant. 
Metadata were collected for each infant from birth until 1 year of age including 
duration of exclusive breastfeeding. Two categories were recorded: less than 4 
months and greater than 4 months duration of breastfeeding (Table 4.3). this data 
was recorded by during the home-visits to the Mother and Infant at 4 weeks, 8 
weeks, 6 months etc. Significance of microbiota composition comparison was 
calculated using permutational multivariate analysis of variance (PerMANOVA) 
(Table 4.4) and presented by PCoA (principle co-ordinates) plots (Fig. 4.10). No 
differences in the oral microbiota of the infants were detected when separated by 
birth mode (SVD & CS) and the duration of breast feeding (Fig. 4.10).  When 
infant microbiota data of both birth modes were combined, the duration of breast 
feeding did not influence the infant oral microbiota (Fig. 4.10C). Thus, this 
analysis indicates that breastfeeding, less than or greater than 4 months does not 
influence the oral microbiota of infants, independent of birth mode. 
     Breast Feeding Duration 
Birth Mode >  4 months < 4 months 
CS     18                   4 
SVD 18 4 
Table  4.3. Total sample number of exclusively breast fed infants included in the 
analysis whom breast fed for greater or less than 4 months. 
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Birth Mode PerMANOVA  
p-value 
CS 0.246 
SVD 0.359 
Combined (SVD & CS) 0.23 
Table 4.4. Significance values (p-values) calculated using permutational 
multivariate analysis of variance (PerMANOVA) for the difference between ‘less 
than 4 months breast feeding’ and ‘greater than 4 months breast feeding’ for SVD 
and CS infants. Both groups (CS & SVD) were combined and tested against 
duration of breast feeding.   
 
       
Fig. 4.10. Beta diversity PCoA (principle co-ordinates) plots (Bray Curtis) 
illustrating the influence of breast feeding duration on the oral microbiota of 
Spontaneous vaginally delivered (SVD) and C-sectioned (CS) infants. A. 
Spontaneous vaginally delivered infants (SVD). B. Caesarean sectioned infants 
(CS). In blue are infants that were breastfed for less than 4 months. In red are 
infants that were breast fed exclusively for longer than 4 months.  
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                            C.  
C. Beta diversity PCoA (principle co-ordinates) plots (Bray Curtis) 
illustrating influence of breast feeding duration on the oral microbiota of 
Combined (CS & SVD) infants. 
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4.1.8 Supplementary Material  
            Total number of samples 
Vaginal                    37 
Skin             37 
Oral: Mother            81 
                        CS         SVD             
 Oral: Infant   
  1 Week         41           34 
             
            75 
  4 Weeks       31          29             60 
  8 Weeks       33          26             59 
  6 Months      37         26             63 
  1 Year          43          40             83 
Supplementary table 4.1. Total number of samples collected in this study from 
mother at birth and from infant at the various time points. 
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Supplementary table 4.2: Complete list of oligonucleotides used for PCR 
amplification. 
 
 
 
Oligoname Barcode Linker Forward Primer (520F) Whole Forward Primer Length (bp)
V4F_7 AACCGGAA AA AYTGGGYDTAAAGNG AACCGGAAAAAYTGGGYDTAAAGNG 25
V4F_78 ACACTGTG AA AYTGGGYDTAAAGNG ACACTGTGAAAYTGGGYDTAAAGNG 25
V4F_139 ACGATCCA AA AYTGGGYDTAAAGNG ACGATCCAAAAYTGGGYDTAAAGNG 25
V4F_272 AGGTACGA AA AYTGGGYDTAAAGNG AGGTACGAAAAYTGGGYDTAAAGNG 25
V4F_494 CATCGTTC AA AYTGGGYDTAAAGNG CATCGTTCAAAYTGGGYDTAAAGNG 25
V4F_632 CGTATTGG AA AYTGGGYDTAAAGNG CGTATTGGAAAYTGGGYDTAAAGNG 25
V4F_693 CTCTACAC AA AYTGGGYDTAAAGNG CTCTACACAAAYTGGGYDTAAAGNG 25
V4F_948 GCTACGTA AA AYTGGGYDTAAAGNG GCTACGTAAAAYTGGGYDTAAAGNG 25
V4F_1062 GTAGTGGA AA AYTGGGYDTAAAGNG GTAGTGGAAAAYTGGGYDTAAAGNG 25
V4F_1116 GTGTCAGT AA AYTGGGYDTAAAGNG GTGTCAGTAAAYTGGGYDTAAAGNG 25
V4F_1178 TACGAAGG AA AYTGGGYDTAAAGNG TACGAAGGAAAYTGGGYDTAAAGNG 25
V4F_1247 TCAGCACA AA AYTGGGYDTAAAGNG TCAGCACAAAAYTGGGYDTAAAGNG 25
V4F_1430 TGGAGTTC AA AYTGGGYDTAAAGNG TGGAGTTCAAAYTGGGYDTAAAGNG 25
Oligoname Barcode Linker Reverse Primer (926R) Whole Reverse Primer Length (bp)
V5R_22 AACGGCTT TT CCGTCAATTYYTTTRAGTTT AACGGCTTTTCCGTCAATTYYTTTRAGTTT 30
V5R_125 ACCTTGCT TT CCGTCAATTYYTTTRAGTTT ACCTTGCTTTCCGTCAATTYYTTTRAGTTT 30
V5R_341 ATCGAACC TT CCGTCAATTYYTTTRAGTTT ATCGAACCTTCCGTCAATTYYTTTRAGTTT 30
V5R_452 CAGAACTC TT CCGTCAATTYYTTTRAGTTT CAGAACTCTTCCGTCAATTYYTTTRAGTTT 30
V5R_555 CCTACGAA TT CCGTCAATTYYTTTRAGTTT CCTACGAATTCCGTCAATTYYTTTRAGTTT 30
V5R_592 CGATATGC TT CCGTCAATTYYTTTRAGTTT CGATATGCTTCCGTCAATTYYTTTRAGTTT 30
V5R_889 GATGCAAG TT CCGTCAATTYYTTTRAGTTT GATGCAAGTTCCGTCAATTYYTTTRAGTTT 30
V5R_992 GGATGGTA TT CCGTCAATTYYTTTRAGTTT GGATGGTATTCCGTCAATTYYTTTRAGTTT 30
V5R_1108 GTGATCTG TT CCGTCAATTYYTTTRAGTTT GTGATCTGTTCCGTCAATTYYTTTRAGTTT 30
V5R_1234 TCACCTGT TT CCGTCAATTYYTTTRAGTTT TCACCTGTTTCCGTCAATTYYTTTRAGTTT 30
V5R_1463 TGTCTCAC TT CCGTCAATTYYTTTRAGTTT TGTCTCACTTCCGTCAATTYYTTTRAGTTT 30
V5R_1526 TTGCGCTT TT CCGTCAATTYYTTTRAGTTT TTGCGCTTTTCCGTCAATTYYTTTRAGTTT 30
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Supplementary figure 4.1. Cluster dendogram of maternal saliva microbiota data 
and infant oral microbiota data. 
 
 
Alpha diversity 
metric 
1 Week   
N=75 
4 Weeks   
N=60 
8 Weeks   
N=59 
6 Months   
N=63 
1 Year   
N=83 
p-value 
overall 
chao1 1076 
[948;1188]  
1031 
[888;1146]  
1025 
[913;1110]  
 842 
[773;995]   
 819 
[715;901]   
<0.001 
PD wholetree 26.2 
[23.2;29.6] 
24.7 
[22.9;27.8] 
25.3 
[23.0;27.4] 
24.7 
[23.2;26.8] 
24.5 
[23.1;26.9] 
0.047 
Simpson 0.96 
[0.95;0.97] 
0.96 
[0.95;0.97] 
0.96 
[0.95;0.97] 
0.96 
[0.94;0.97] 
0.96 
[0.94;0.97] 
0.98 
Shannon 6.52 
[6.13;6.82] 
6.53 
[6.25;6.80] 
6.50 
[6.15;6.63] 
6.35 
[5.88;6.78] 
6.34 
[5.87;6.68] 
0.162 
observed species  516 
[472;593]   
 504 
[455;556]   
 492 
[465;521]   
 479 
[440;524]   
 473 
[432;517]   
<0.001 
       
 
Alpha diversity 
metric 
1 Week vs. 4 
Weeks 
1 Week vs. 8 
Weeks 
1 Week vs. 6 
Months 
1 Week vs. 1 
Year 
chao1 0.136 0.117 <0.001 <0.001 
PD wholetree 0.159 0.159 0.14 0.139 
Simpson 0.976 0.976 0.976 0.976 
Shannon 0.774 0.605 0.538 0.241 
observed species 0.356 0.061 0.021 0.002 
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Alpha diversity metric 4 Weeks vs. 8 
Weeks 
4 Weeks vs. 6 
Months 
4 Weeks vs. 1 
Year 
chao1 0.941 <0.001 <0.001 
PD wholetree 0.881 0.98 0.881 
Simpson 0.976 0.976 0.976 
Shannon 0.774 0.774 0.395 
observed species 0.43 0.14 0.038 
 
Alpha diversity 
metric 
8 Weeks vs. 6 Months 8 Weeks vs. 1 Year 
chao1 <0.001 <0.001 
PD wholetree 0.765 0.728 
Simpson 0.976 0.976 
Shannon 0.774 0.486 
observed species 0.451 0.138 
 
 
Alpha diversity metric 6 Months vs. 1 
Year 
6 Months vs. 2 
Years 
1 Year vs. 2 Years 
chao1 0.015 0.005 0.235 
PD wholetree 0.881 0.213 0.159 
Simpson 0.976 0.976 0.976 
Shannon 0.605 0.605 0.774 
observed species 0.516 0.451 0.703 
 
Supplementary table 4.3: Alpha diversity stats (p-values) between each time 
point of the infant oral microbiota. 
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Genera 
1 Week vs. 
4 Weeks 
1 Week vs. 
8 Weeks 
1 Week vs. 6 
Months 
1 Week 
vs. 1 Year 
Streptococcus 0.076 0.023 0.245       <0.001       
Unclassified 0.248 0.14 0.193       <0.001       
Neisseria 0.54 0.826 <0.001       <0.001       
Haemophilus 0.358 0.217 0.017       <0.001       
Gemella 0.543 0.091 0.069 0.018 
Rothia 0.668 0.012 <0.001       <0.001       
Porphyromonas 0.866 0.22 <0.001       <0.001       
Prevotella 0.597 0.074 <0.001       <0.001       
Lactobacillus 0.439 0.35 <0.001       <0.001       
Capnocytophaga 0.133 0.893 0.007       <0.001       
Staphylococcus 0.512 0.003 <0.001       <0.001       
Leptotrichia 0.326 0.424 <0.001       <0.001       
Veillonella 0.328 0.002 <0.001       <0.001       
Actinomyces 0.543 0.004 <0.001       <0.001       
Bifidobacterium 0.492 0.076 0.615       <0.001       
Granulicatella 0.292 0.06 <0.001       <0.001       
Abiotrophia 0.3 0.365 0.032       <0.001       
Fusobacterium 0.956 0.462 <0.001       <0.001       
Streptobacillus 0.087 0.002 <0.001       <0.001       
Corynebacterium 0.323 0.272 0.002 0.117 
Propionibacterium 0.26 0.2 0.022       <0.001       
Lachnoanaerobaculum 0.701 0.039 <0.001       <0.001       
Oribacterium 0.456 0.694 <0.001       <0.001       
Supplementary table 4.4: Genera difference and associated p-values between 
week 1 and older age. 
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Genera 8 Weeks vs. 6 
Months 
8 Weeks vs. 
1 Year 
6 Months 
vs. 1 Year 
Streptococcus <0.001 <0.001 <0.001 
Unclassified 0.001 <0.001 0.045 
Neisseria <0.001 <0.001 <0.001 
Haemophilus <0.001 <0.001 0.014 
Gemella 0.888 0.483 0.483 
Rothia 0.38 0.03 0.18 
Porphyromonas <0.001 <0.001 0.001 
Prevotella 0.006 <0.001 0.009 
Lactobacillus <0.001 <0.001 0.001 
Capnocytophaga 0.009 <0.001 <0.001 
Staphylococcus 0.018 <0.001 0.001 
Leptotrichia <0.001 <0.001 <0.001 
Veillonella 0.328 0.736 0.215 
Actinomyces 0.005 <0.001 0.44 
Bifidobacterium 0.031 <0.001 <0.001 
Granulicatella <0.001 <0.001 0.932 
Abiotrophia 0.005 <0.001 <0.001 
Fusobacterium <0.001 <0.001 <0.001 
Streptobacillus <0.001 <0.001 <0.001 
Corynebacterium 0.089 0.654 0.117 
Propionibacterium 0.26 0.002 0.022 
Lachnoanaerobaculum <0.001 <0.001 0.005 
Oribacterium <0.001 <0.001 <0.001 
Supplementary table 4.5: Genera difference and associated p-values between 8 
weeks and 6 months and 1 year of age. 
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Results:  
 
4.2. Longitudinal study: Birth to 2 years of 
age. 
 
 
 
The infant oral microbiota demonstrates 
continued change in microbial composition from 
birth to 2 years of age.  
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4.2. Results  
 Numbers of samples 
 Age of Infant    CS SVD Total 
  1 Week    41   34 75 
  4 Weeks   31 29 60 
  8 Weeks   33  26 59 
  6 Months  37  26 63 
  1 Year    43  40 83 
  2 Years   18   24 42 
Table 4.5. Number of oral samples collected in this study at each of the various 
infant ages. 
 
4.2.1 The oral microbiota of infants at 2 years of age is distinct and is not 
altered by birth mode. 
PCoA (principle co-ordinates) plots were generated including the year 1 infant 
oral microbiota data and the maternal microbiota data (vagina, skin, oral) using 
the beta diversity measures: Bray Curtis dissimilarity and UniFrac distances 
metrics (Fig 4.11), which measure diversity between samples. Following on from 
the year 1 analysis, we found that with increased age, the oral microbiota of the 
infant became more distinct, demonstrated by separate clustering, with minimal 
overlap at year 1 and year 2 on the Bray Curtis plot (Fig. 4.11A), weighted unifrac 
(Fig. 4.11B) and unweighted unifrac (Fig. 4.11C). While the early time points 
overlap (week 1, 4 & 8), there is a transition from 6 months to year 1 and year 2 
oral microbiota. The year 2 oral microbiota of the infant demonstrates sharing of 
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taxa with the year 1 oral microbiota and saliva of the mother in Bray Curtis and 
weighted analysis (Fig. 4.11A, B). However in the unweighted analysis (Fig. 
4.11C), where rare taxa are measured, rather than abundance, the year 2 infant 
oral microbiota demonstrates less relatedness. Using Permutational Multivariate 
Analysis of Variance (PerMANOVA) analysis we found statistical differences 
between the abundance of each group at OTU level, as measured by each metric 
(p <0.001) (Table 4.6). The separation of the year 2 infant oral microbiota from 
the earlier ages, highlights differences in beta diversity between samples at 2 
years of age, and signifies development in the oral microbiota from 8 weeks of 
age. 
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A.  
B.  
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C.  
 
Fig.4.11. Principle Coordinates Analyses (PCoAs) on Spearman distance 
matrices of samples from mother (saliva, skin & vagina) & from infant oral 
at 6 time points (week 1, week 4, week 8, 6 months, 1 year and 2 years).  
A. Bray Curtis dissimilarity, B. UniFrac Weighted & C. Unweighted UniFrac 
between the 5 groups (mother saliva/oral, skin & vaginal & infant oral week 
1,week 4, week 8, 6 months, 1 year and 2 years).  A. Plot of principle co-ordinates 
using Bray-Curtis dissimilarity. Points are coloured according to group and 
ellipses describe the distribution of points for each group. Percentage variation 
explained: PCA 1 (18.5%) and PCA 2 (9.2%). B. Plot of principle co-ordinates 
using weighted unifrac distance. Points are coloured according to group and 
ellipses describe the distribution of points for each group. Percentage variation 
explained: PCA 1 (42.4%) and PCA 2 (10%). C. Plot of principle co-ordinates 
using un-weighted unifrac distance. Points are coloured according to group and 
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ellipses describe the distribution of points for each group. Percentage variation 
explained: PCA 1 (8.4%) and PCA 2 (6.7%). 
 
 
 
 
 
 
 
Table 4.6. Significance values of Bray Curtis dissimilarity and UniFrac distances 
metrics. Significance was calculated using permutational multivariate analysis of 
variance (PerMANOVA). p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
X-axis  Y-axis PerMANOVA 
P-value 
Unweighted UniFrac 8.4 6.7 0.001** 
Weighted UniFrac 42.4 10 0.001** 
Bray-Curtis 18.5 9.2 0.001** 
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4.2.2 Birth mode does not impact on the infant oral microbiota by 2 years of 
age. 
To assess the affect of birth mode on the infant oral microbiota, we compared the 
infant oral microbiota by age and birth mode (CS & SVD), with significance 
calculated by PerMANOVA. This analysis indicated that there was a significant 
difference by birth mode in the infant oral microbiota at week 1 ((p < 0.05 (*)), 
but not at 2 years of age, (p =0.502).   
 
 
Fig. 4.12. PCoA (principle co-ordinates) plots, each demonstrating the effect 
of birth mode (SVD v CS) on oral microbiota composition of the infant at 
different ages (week 1, week 4, week 8, 6 months, 1 year and 2 years). 
A.Week 1 SVD v CS; B. Week 4 SVD v CS; C.Week 8; D. 6 months (week 24); 
E. 1 year; F. 2 years. Significance was calculated using permutational multivariate 
analysis of variance (PerMANOVA) (Table 4.7). 
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Timepoint PerMANOVA  
p-value 
1 Week 0.047* 
4 Weeks 0.336 
8 Weeks 0.077 
6 Months 0.347 
1 Year 0.314 
2 Years 0.502 
Table 4.7.  Significance values for the comparison of the oral microbiota data 
difference between SVD and CS at each age of the infant. Significance was 
calculated using permutational multivariate analysis of variance (PerMANOVA). 
p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). 
 
4.2.3 Species richness and diversity of the infant oral microbiota at 2 years of 
age are lower than at an early age. 
The alpha diversity measurement of species richness was lower at 2 years of age 
and was accompanied by microbiota composition changes from the early age data 
when measured by Chao diversity and OTU count (Observed species). 
Significance was measured using the Mann-Whitney U test (p <0.001), while the 
Phylogenetic diversity showed lower significance (p < 0.05) (Table 4.8). The 
Chao diversity, which measures species richness within the infant oral microbiota, 
demonstrated that the oral microbiota diversity from week 1 to 2 years of age 
decreased as the infant increased in age. The differences in diversity between 
week 1 and week 8 infant oral microbiota and the year 2 infant oral microbiota 
was higher (p <0.001) than when the year 2 oral microbiota compared to the 6 
months infant oral microbiota (p <0.01). While we identified these differences in 
diversity between the year 2 oral microbiota and at 1 week to 6 months of age, no 
difference in the diversity was found between the year 1 and year 2 infant oral 
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microbiota (p value = 0.235) demonstrating some relative stability with increased 
age.  
 
 
Fig.4.13. Alpha diversity comparisons of the oral microbiota of infants from 
week 1, week 4, 8 weeks, 6 months, 1 year and 2 years). Boxplots of Chao1 
diversity, Phylogenetic diversity, Simpson diversity, Shannon diversity and 
Observed species in the infant oral microbiota with increased age. Outliers are 
represented by black points.  
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Alpha diversity 
metric 
p-value 
1 Week vs 
2 Years 
p-value 
8 Weeks vs 
2 Years 
p-value 
6 Months 
vs 2 Years 
p-value 
1 Year vs 
2 Years 
p-value 
overall 
chao1       <0.001               <0.001        0.005 0.235 <0.001** 
PD_whole_tree 0.722 0.463 0.213 0.159 0.047* 
Simpson 0.976 0.976 0.976 0.976 0.98 
Shannon 0.241 0.486 0.605 0.774 0.162 
observed_species 0.009 0.181 0.451 0.703 <0.001** 
Table 4.8. Alpha diversity metrics each demonstrating individual P-values using 
the Mann-Whitney U test at each time point of the infant oral microbiota. 
Significant differences between groups are shown by the following notation: p < 
0.05 (*), p < 0.01 (**) and p < 0.001 (***). 
 
By alpha diversity measures (chao1 diversity, observed species, Phylogenetic 
diversity, Simpson diversity, and Shannon diversity), we calculated the diversity 
of the oral microbiota datasets from infants at different ages, separated by birth 
mode (Fig. 4.14). It was found by Shannon diversity that birth mode had an 
significant influence on the diversity of the infant oral microbiota at 1 and 4 
weeks of age (p <0.05), but not by 2 years of age (Fig. 4.14) (Table 4.9).  
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Fig 4.14. Comparison of Alpha Diversity measurement of the infant oral 
microbiota as a function of mode of delivery (SVD v CS) at various infant 
ages (week 1, week 4, 6 months, 1 year and 2 years). A. Boxplots of the chao1 
diversity, observed species, Phylogenetic diversity, Simpson diversity, Shannon 
diversity, Observed species in the two groups (SVD & CS) at week 1, 4 weeks, 8 
weeks, 6 months, 1 year and 2 years, separated by birth mode (SVD or CS). 
Outliers are represented by black points.  
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Table 4.9. Alpha diversity comparisons and accompanying P-values using the 
Mann-Whitney U test on whether SVD differs from CS at each time point of the 
infant oral microbiota. Significant differences between groups are shown by the 
following notation: p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). 
 
 
 
 
 
 
 1 Week 4 Weeks 8 Weeks 
chao1 0.259266 0.233729 0.725472 
PD whole tree 0.343536 0.216761 0.541395 
Simpson 0.147782 0.067716 0.625151 
Shannon            0.037*          0.022286* 0.830745 
observed species 0.17648 0.106851 0.836693 
           6 Months 1 Year 2 Years 
chao1 0.706215 0.912915 0.611223 
PD whole tree 0.615251 0.722269 0.252732 
Simpson 0.219237 0.590785 0.959459 
Shannon 0.264049 0.376689 0.721968 
observed species 0.538987 0.887654 0.702975 
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4.2.4 Clear separation of the infant oral microbiota at 2 years of age. 
The relatedness of microbiota datasets by bacterial taxon abundance of the infant 
oral microbiota datasets at different ages at genus level were represented by a 
vertical and horizontal dendrogram (Fig. 4.15). The infant oral microbiota at week 
1, week 4 and week 8 demonstrates clustering with high abundances of 
Streptococcus, Gemella and Haemophilus. However the strongest clustering 
occurs at 2 years of age when the infant oral microbiota harbours a distinct oral 
microbiota, with high abundances of Neisseria (16.4%), Haemophilius (5.24%) 
and Streptococcus (11.2%) and very low abundances of Lactobacillus, 
Anaeroccoccus, Staphylococcus (0-0.01%). While we noted some fluctuations in 
abundances of the infant oral microbiota between week 1 and 2 years of age 
(p<0.001), only a minority of genera are different between year 1 and year 2 of 
age and include genera Streptococcus, Gemella, Capnocytophaga and 
Staphylococcus (p <0.001). 
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Fig. 4.15. Hierarchical clustering of microbiota data from birth to 2 years at 
bacterial Genus level. Abundances are colour-coded according to the colour key 
on the top left with grey representing a value of zero. Euclidean distance and 
complete linkage were used to cluster the rows and columns of the heatmap. The 
colour bar on side of the heatmap corresponds to sample type. Each genus with a 
mean >/= 0.5% across all samples were included. All taxa present at less than 1 % 
in all groups are excluded from the heatmap.  
 
 
 
 
 
 
171 
 
4.2.5 Compositional analysis of the infant oral microbiota at 2 years of age. 
The infant oral microbiota composition is different across all major phyla between 
week 1 and 1 year and 2 years of age (p <0.001).  While the phyla profiles appear 
relatively similar/stable from week 1 to week 8, compositional changes begin 
from 6 months onwards. The only phylum that is not statistically different in 
abundance between 6 months and 2 years of age is Actinobacteria. Between year 
1 and year 2, the only two phyla that are statistically differentially abundant 
include Firmicutes and Proteobacteria (p< 0.001). Firmicute levels decrease over 
time from week 1 (82.3%) to year 2 (21.1%), while Proteobacteria levels increase 
(3.98% at week 1 to 36.7% at year 2). Bacteroidetes (16.7%-17.7%), 
Actinobacteria (6.24-6.08%) and Fusobacteria (6.58-7.13%) remain consistent in 
abundances between year 1 and year 2, while Firmicutes decrease from year 1 
(33.7%) to year 2 (21.1%) and Proteobacteria increase from year 1 (25.6%) to 
year 2 (36.7%). Thus at phylum level, from 1 year of age to 2 years of age there is 
evidence of some stability arising in the composition at phylum level (Fig 4.16A) 
with less change within the oral cavity of the infant. 
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A.  
B.  
Fig. 4.16. Broad and fine detail compositional differences at phlyum and 
genus level.  
A. Microbiota composition at phylum level. Percentages for each taxon represent 
the median abundance values for the sample types. B. Barplot of percentage 
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abundance at genus level. Percentages for each taxon represent the median values 
for the groups.  
 
There are compositional differences at genus level between the infant oral 
microbiota at week 1 to 2 years of age (p<0.001) (Fig. 4.17). The composition 
changes associated in this timeframe include genera Streptococcus, Neisseria, 
Gemella, Capnocytophaga, Staphylococcus (p<0.001) and less changes with 
genera Porphyromonas, Leptoctrichia, Veillonella and Fusobacteria (p<0.01). 
Genera that remain similar and not significantly different in abundances between 
year 1 and year 2 oral microbiota include Haemophilius, Rothia, Prevotella, 
Lactobacillus, Actinomyces, Propionibacterium and Oribacterium. While no 
differences in alpha diversity (within samples) were noted between year 1 and 
year 2 (Table 4.8), we did see diffrences of significance with beta diversity 
measures. Beta diversity measures the diversity between samples and 
demonstrated significant differences between the infant oral microbiota at 2 years 
of age and the earlier ages of the infant (Fig. 4.15) (PerMANOVA: p<0.001). This 
separation between the year 1 and year 2 oral microbiota, along with the earlier 
ages of the infant (week 1, 4, 8) highlights developmental changes within the oral 
microbiota between from week 1 to 2 years of age. We therefore sought to 
identify differentially abundant taxa that must drive separation on these PCoAs 
between the infant oral microbiome at year 1 and year 2 (Fig. 4.11).  
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Fig. 4.17. Compositional differences at Genus level of the infant oral 
microbiota at week 1, 1 year and 2 years of age. Barplot of percentage 
abundance at genus level. Percentages for each taxon represent the median values 
for the groups.  
 
The abundances levels of Streptococccus decrease dramatically from week 1 to 
year 2 of age, along with levels of Gemella, Lactobacillus and Staphylococcus 
(p<0.001) while genera such as Haemophilius, Prevotella, Neisseria and 
Fusobacterium increase dramatically. Between 1 year of age and 2 years of age, 
genera which decrease from 1 year to 2 years are highlighted in green, and those 
that decreased from 1 year to 2 years of age are highlighted in red (Table 4.10)  
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Genera %Rel.Abundance 
 
1 Year    
N=83 
 
 
 
2 Years    
N=42 
p-value 
 
1 Year vs 2 
Years 
Streptococcus 23.1 [16.1;29.5] 11.2 [7.36;17.8] <0.001 
Unclassified 20.5 [14.0;28.6] 21.9 [18.3;25.0] 0.503 
Neisseria 10.3 [5.84;17.5] 16.4 [12.2;24.4] 0.002 
Haemophilus 3.87 [2.45;6.77] 5.24 [2.93;7.92] 0.251 
Gemella 2.18 [1.43;3.59] 1.26 [0.86;1.86] <0.001 
Rothia 3.68 [1.87;8.33] 2.55 [1.25;6.12] 0.161 
Porphyromonas 3.96 [2.13;7.02] 6.50 [4.31;8.75] 0.008 
Prevotella 1.22 [0.65;2.36] 1.33 [0.87;2.54] 0.661 
Lactobacillus 0.00 [0.00;0.01] 0.00 [0.00;0.02] 0.637 
Capnocytophaga 0.87 [0.29;3.25] 3.76 [2.21;11.7] <0.001 
Staphylococcus 0.05 [0.02;0.10] 0.01 [0.00;0.04] <0.001 
Leptotrichia 1.85 [0.59;3.96] 3.09 [1.77;6.02] 0.005 
Veillonella 1.27 [0.70;2.23] 0.74 [0.29;1.45] 0.005 
Actinomyces 1.49 [0.72;2.38] 1.23 [0.87;2.02] 0.543 
Bifidobacterium 0.01 [0.00;0.02] 0.01 [0.00;0.05] 0.042 
Granulicatella 2.15 [1.20;3.02] 1.58 [1.05;2.27] 0.06 
Abiotrophia 0.49 [0.20;1.23] 1.84 [0.85;3.53] <0.001 
Fusobacterium 0.33 [0.16;0.86] 0.67 [0.35;1.24] 0.009 
Streptobacillus 1.01 [0.29;2.25] 0.76 [0.36;2.12] 0.734 
Corynebacterium 0.03 [0.01;0.12] 0.31 [0.07;0.56] <0.001 
Propionibacterium 0.01 [0.00;0.03] 0.01 [0.00;0.02] 0.371 
Lachnoanaerobaculum 0.23 [0.13;0.57] 0.31 [0.22;0.78] 0.07 
Oribacterium 0.15 [0.06;0.50] 0.15 [0.08;0.47] 0.774 
Table 4.10. Average relative abundances (%) of genera present at 1 year and 
2 years of age and the P-Values of statistical difference between the two time 
points. Highlighted in red are the names of genera that significantly increase in 
relative abundances from year 1 to year 2, while in green are the names of genera 
that significantly decrease in abundances from year 1 to year 2; both of which 
demonstrate statistical differences. 
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Compositional changes at species level are evident (Fig 4.18) between year 1 and 
year 2 infant saliva. The species that dominate the infant oral saliva at 1 and 2 
years of age include Haemophilius haemolyticus, Haemophilius parainfluenza, 
Rothia mucialoginosa and Porphyromonas catoniae, while species which increase 
in abundances at 2 years of age include Capnocytophaga sputigena, 
Capnocytophaga gingivalis, Leptotrichia buccalis, Neisseria oralis, Tannerella 
forsythia and Veillonella dispar. 
 
 
 
Fig. 4.18. Compositional differences at species level in the infant oral 
microbiota at week 1,  year 1 and 2 years of age. Barplot of percentage 
0% 
10% 
20% 
30% 
40% 
50% 
60% 
70% 
80% 
90% 
100% 
week_1_baby_saliva year_1_baby_saliva year_2_baby_saliva 
Tannerella_forsythia 
Leptotrichia_wadei 
Capnocytophaga_gingivalis 
Neisseria_oralis 
Ruminococcus_bromii 
Selenomonas_sputigena 
Leptotrichia_buccalis 
Capnocytophaga_ochracea 
Selenomonas_noxia 
Anaerostipes_hadrus 
Ruminococcus_obeum 
Gardnerella_vaginalis 
Scardovia_wiggsiae 
Capnocytophaga_granulosa 
Propionibacterium_acnes 
Prevotella_histicola 
Leptotrichia_hongkongensis 
Bacteroides_dorei 
Streptococcus_sanguinis 
Streptobacillus_moniliformis 
Escherichia/Shigella_coli 
Granulicatella_elegans 
Lautropia_mirabilis 
Capnocytophaga_leadbetteri 
Capnocytophaga_sputigena 
Prevotella_melaninogenica 
Abiotrophia_defectiva 
Faecalibacterium_prausnitzii 
Actinomyces_odontolyticus 
Streptococcus_mutans 
Veillonella_dispar 
Porphyromonas_catoniae 
Lactobacillus_iners 
Rothia_mucilaginosa 
Haemophilus_parainfluenzae 
Haemophilus_haemolyticus 
177 
 
abundance at species level. Percentages for each taxon represent the median 
values for the groups.  
 
To assess the effect of birth mode on the oral microbiota of the infant we 
seperated the oral microbiota of infants by birth mode, and assessed the phlya and 
genera at each time point the oral microbiota of the infant was examined (Figure 
4.19). At phylum level and genus level,  for both CS and SVD delivered infants, 
there was no obvious impact of birth mode on the oral microbiota composition at  
2 years of age, in contrast to previous observation of birth mode impact being 
evident at the early ages of the infant oral microbiota. 
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A.  
 
 
   B .  
 
Fig.4.19. Comparison of the microbiota composition of infants born by 
different birth modes (SVD & CS) across six time-points from one week to 2 
years of age.  
 
A. Microbiota composition at phylum level. Percentages for each taxon represent 
the median abundance values for the sample types. B. Barplot of percentage 
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abundance at genus level. Percentages for each taxon represent the median values 
for the groups. Genera shown are those found at >1% average in total population. 
Genera found at <1% were grouped as “other”. 
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4.2.6. Supplementary Material 
 
            Total 
Vaginal                    37 
Skin             37 
Oral: Mother            81 
                        CS         SVD             
 Oral: Infant   
  1 Week         41           34 
             
            75 
  4 Weeks       31          29             60 
  8 Weeks       33          26             59 
  6 Months      37         26             63 
  1 Year          43          40             83 
  2 Years        18         24             42 
Supplementary table 4.6. Total number of samples collected in this study from 
mother at birth and from infant at the various ages. 
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Alpha diversity 
metric 
1 Week    
N=75 
4 Weeks   N=60 8 Weeks    
N=59 
chao1 1076 
[948;1188]  
1031 [888;1146]  1025 [913;1110]  
PD_whole_tree 26.2 [23.2;29.6] 24.7 [22.9;27.8] 25.3 [23.0;27.4] 
Simpson 0.96 [0.95;0.97] 0.96 [0.95;0.97] 0.96 [0.95;0.97] 
Shannon 6.52 [6.13;6.82] 6.53 [6.25;6.80] 6.50 [6.15;6.63] 
observed_species  516 [472;593]    504 [455;556]    492 [465;521]   
 
Alpha diversity 
metric 
6 Months   N=63 1 Year   N=83 2 Years   N=42 p-value 
overall 
chao1  842 [773;995]    819 [715;901]    795 [681;868]   <0.001** 
PD_whole_tree 24.7 [23.2;26.8] 24.5 [23.1;26.9] 26.3 [23.9;27.9] 0.047* 
Simpson 0.96 [0.94;0.97] 0.96 [0.94;0.97] 0.96 [0.94;0.97] 0.98 
Shannon 6.35 [5.88;6.78] 6.34 [5.87;6.68] 6.28 [5.89;6.69] 0.162 
observed_species  479 [440;524]    473 [432;517]    488 [420;512]   <0.001** 
Supplementary table 4.7. Alpha diversity metrics for each time point with OTU 
counts and overall P-values using the Mann-Whitney U test. Significant 
differences between groups are shown by the following notation: p < 0.05 (*), p < 
0.01 (**) and p < 0.001 (***). 
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Results:  
 
4.3 Cross Sectional study. 
 
This chapter has been submitted for peer review in ‘Journal 
of Dental Research’. 
 
Entitled: 
‘Comparison of the salivary and dentinal microbiome of 
children with severe-early childhood caries to the salivary 
microbiome of caries-free children.’ 
Authors: Eimear Hurley, Maurice P.J Barrett, Martin Kinirons, Helen Whelton,  
C. Anthony Ryan, Catherine Stanton, Hugh M.B. Harris
  and Paul W. O’Toole.  
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4.3. Results  
 
4.3.1 A distinct microbiota in caries lesions but not saliva in children with S-
ECC. 
Given that S-ECC is such an acute disease, it seemed possible that it resulted from 
a global microbiota change in the oral cavity. To investigate the relatedness of 
microbiome composition in CAC (caries-active caries), CAS (caries-active saliva) 
and CFS (caries-free saliva), we generated PCoA (principle co-ordinates) plots 
showing relatedness by two established metrics, Bray Curtis dissimilarity, and 
UniFrac distances. The Bray Curtis plot (Fig.4.20A) shows separation of the 
caries lesion samples (CAC) and the two saliva sample types (CFS & CAS) based 
on PCoA axes 1 and 2. The microbiota of the two saliva groups (CAS & CFS) 
considerably overlap, indicating a similarity in the general composition of 
microbial taxa. For weighted UniFrac, (Fig.4.20B) the caries microbiota group is 
again separated from the two saliva microbiota groups, with only minimal overlap 
of some samples. Combined with the Bray Curtis analysis, this shows 
convincingly that there is no major separation between the microbiota of caries-
active saliva (CAS) and caries-free saliva (CFS) groups, even though this metric is 
very sensitive to the differences in the presence/absence and abundance of 
OTUs/samples. 
Plotting the second UniFrac metric, unweighted UniFrac distances (Fig.4.20C), 
illustrates separation between the three groups (CAC, CAS & CFS). This index 
measures the presence and absence of taxa only and does not adjust the distance 
metric according to taxon abundance, so unlike weighted analysis, it reflects the 
184 
 
contribution of rare taxa (that get overwhelmed in a weighted analysis). When 
presence/absence of taxa is the dominant parameter used to calculate distance, 
separation between all three groups occurs. The CAS microbiota was closer to the 
CAC microbiota than the CFS microbiota, suggesting rare taxa are shared 
between the former two samples. 
A.   
               B.      
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        C.  
Fig.4.20. PCoA (principle co-ordinates) plots showing relatedness by two 
established metrics, Bray Curtis dissimilarity, and UniFrac distances, while 
unweighted UniFrac illustrates separation between the three groups (CAC, 
CAS & CFS).   
A. Plot of principle co-ordinates using Bray-Curtis dissimilarity. Points are 
coloured according to group and ellipses describe the distribution of points for 
each group. Percentage variation explained: PCA 1 (22.3 %) and PCA 2 (7.7 %). 
B. Plot of principle co-ordinates using weighted unifrac distance. Points are 
coloured according to group and ellipses describe the distribution of points for 
each group. Percentage variation explained: PCA 1 (45 %) and PCA 2 (11.7 %). 
C. Plot of principle co-ordinates using un-weighted unifrac distance. Points are 
coloured according to group and ellipses describe the distribution of points for 
each group. Percentage variation explained: PCA 1 (16.6 %) and PCA 2 (4.9 %) 
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4.3.2 Microbiota diversity in caries lesions is lower than that of saliva from 
children with or without S-ECC. 
To study the diversity of the microbiota from the caries lesions (CAC) and saliva 
samples of both caries-free children (CFS) and caries-active children (CAS), we 
determined a series of alpha diversity metrics: the Chao index, phylogenetic 
diversity (PD whole tree), observed species (OTU count), the Simpson index and 
the Shannon index (Fig.4.21). All metrics illustrate that the diversity of caries 
microbiota was the lowest of these sample types. The difference in the diversity 
values of the caries samples and saliva samples was significant (p<0.001). The 
Chao diversity measurement, as illustrated in Fig.4.21A, estimates the number of 
species from observed data, and the diversity of the low abundance taxa, and 
according to this metric, the CFS versus CAS comparison was significantly 
different with a p-value of <0.05. All other alpha diversity comparisons 
(Fig.4.21.B,C,D) indicated that the diversity difference between the caries 
samples and saliva samples was significant (p<0.001). 
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. A.  
B.  
C.  
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D.  
Fig 4.21. Pairwise alpha diversity comparisons of saliva and caries 
microbiota. 
A. Boxplot of chao1 diversity in the three groups. Outliers are represented by 
black points. Significant differences between groups are shown by arrows and the 
following notation: p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). B. Boxplot of 
observed species in the three groups. Outliers are represented by black points. 
Significant differences between groups are shown by arrows and the following 
notation: p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). C. Boxplot of 
Phylogenetic diversity in the three groups. Outliers are represented by black 
points. Significant differences between groups are shown by arrows and the 
following notation: p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). D. Boxplot of 
Shannon diversity in the three groups. Outliers are represented by black points. 
Significant differences between groups are shown by arrows and the following 
notation: p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). 
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4.3.3 Habitual diet is not significantly different in children with or without S-
ECC.  
Diet can have a profound impact on oral health and caries risk. We found no 
significant differences when we compared the habitual intake of each food group 
from the FFQ data derived from the caries-active and caries-free subjects. No food 
group was consumed at significantly different frequency when we tested either for 
unequal presence/absence of food groups in the diet using the Fisher's test, or 
different frequencies of food groups in the diet using the Mann-Whitney test. Any 
trends were not supported by significant p-values (<0.05).  
 
4.3.4 Differentially abundant taxa in CAC compared to saliva microbiota of 
both CAS & CFS 
Differential bacterial taxon abundance in compared microbiota datasets may be 
graphically demonstrated by hierarchical clustering, whereby samples are grouped 
based on similarity of the taxa in their microbiota. These relatedness levels 
between samples, and their constituent microbial taxa, are represented by vertical 
and horizontal dendrograms incorporating a “heatmap” colour scale to convey 
abundance levels.  Fig.4.22 illustrates the abundance of bacterial taxa at family 
level. The three groups are split into two main branches visible in the horizontal 
dendrogram above the colour bar in Fig.4.22. CAC clusters on one branch (red 
bar) and the two saliva groups (CAS in green & CFS in blue) cluster on the other. 
There is clustering of the CAS and the CFS within this branch, showing 
considerable similarity between the two groups at family level. When compared 
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against the patient metadata, there was no obvious variable that convincingly 
separates CAS from CFS (data not shown).  
The microbiota of the CAC samples was characterized by high relative abundance 
of Prevotellaceae, Veillonellaceae, Bifidobacteriacae and Streptococcaceae, and 
by low relative abundance of Corynebacteriaceae, Carnobacteriaceae, 
Aerococcaceae and Micrococcaceae. Both saliva sample types (CAS & CFS) 
showed higher abundances than caries samples of Leptotrichiaceae, 
Porphyromonadaceae and Flavobacteriaceae and of Neisseriaceae and 
Pasteurellaceae, while illustrating a very low abundance compared to CAC of 
Spirochaetaceae, Bifidobacteriaceae and Lactobacillaceae.  
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Fig. 4.22. Hierarchical clustering of microbiota data at bacterial family level. 
Abundances are colour-coded according to the colour key on the top left with grey 
representing a value of zero. Euclidean distance and complete linkage were used 
to cluster the rows and columns of the heatmap. The colour bar on top of the 
heatmap corresponds to sample type: CAC red, CAS green and CFS blue. All taxa 
present at less than 1 % in all three groups are excluded from the heatmap.  
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A more nuanced picture emerges when differentially abundant taxa were analysed 
at genus level (Fig.4.23). The samples again separate laterally into caries versus 
saliva (with both caries-active and caries-free clustering together). The microbiota 
content appears to be split vertically in two groups of differentially abundant 
genera as revealed by the dendogram on the Y-axis based on bacterial abundance. 
The top branch is divided, with CAS and CAC showing higher abundance of 
Streptococcus and Prevotella, and with Neisseria at a higher abundance in both. 
In the saliva samples (CAS & CFS), Leptotrichia, Porphyromonas and 
Haemophilus are in higher abundance, with Leptotrichia at higher abundance in 
CFS than CAS.  
The lower branch shows clear low-abundance of the genera Lactobacillus, 
Treponema, Scardovia and Parascardovia in the CFS & CAS. (Fig.4.23), while 
low abundance taxa in CAC are Gemella and Granulicatella.   
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Fig.4.23. Hierarchical clustering of microbiota data at bacterial genus level. 
Abundances are colour-coded according to the colour key on the top left with grey 
representing a value of zero. Euclidean distance and complete linkage were used 
to cluster the rows and columns of the heatmap. The colour bar on top of the 
heatmap is coloured according to sample type: CAC red, CAS green and CFS 
blue. All taxa present at less than 1 % in all three groups are excluded from the 
heatmap.  
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When we included samples in the analysis with at least one species with a median 
value of ≥0.5%, we identified fewer outliers, with only one CAS sample within 
the CAC branch, and two CAC within the second branch of the saliva samples. 
There was clearer separation of the samples, with CAC on the first branch, with 
high abundance of Streptococcus mutans, compared to the saliva samples. The 
two saliva samples split into two branch points, with CFS illustrating clustering 
within the first branch, with higher abundance of Tannerella forsythia, 
Capnocytophaga gingivalis, and Leptotrichia buccalis. Species with a clear low 
abundance in the majority of saliva samples included Scardovia wiggsiae, 
Parascardovia denticolens, Prevotella denticola and Prevotella oris, where these 
were present at higher abundance in CAC. 
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Fig.4.24. Hierarchical clustering of microbiota data at bacterial species level.  
Abundances are colour-coded according to the colour key on the top left with grey 
representing a value of zero. Euclidean distance and complete linkage were used 
to cluster the rows and columns of the heatmap. The colour bar on top of the 
heatmap is coloured according to sample type: CAC red, CAS green and CFS 
blue. All taxa present with at least one species with a median value  ≥ 0.5 % in all 
three groups are included. 
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4.3.5 Broad and fine detail compositional differences distinguish caries 
microbiota from paired and healthy control saliva samples. 
At phylum level (Fig.4.25), the CAC microbiota is dominated by the Firmicutes 
(median abundance value 33.45%), while the CAS microbiota was dominated by 
Proteobacteria (median abundance value 38.18%;  p <0.0001). At phylum level, 
both the CAS and CFS microbiota composition is quite similar (Fig.4.24A) , with 
the main phylum difference between saliva of CAS versus CFS children being 
Fusobacteria. Its abundance has a median value of 13.4% in the saliva microbiota 
of CFS children, but 7.37% in CAS (p <0.0001). Both the CAS and CFS microbiota 
are dominated by Proteobacteria at 38.2% and 36.1% respectively. 
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C.  
Fig.4.25. Broad and fine detail compositional differences at Genus, phylum 
and species level.  
A. Microbiota composition at phylum level. Percentages for each taxon represent 
the median abundance values for the sample types. B. Barplot of percentage 
abundance at genus level. Percentages for each taxon represent the median values 
for the groups. C: Barplot of percentage abundance at species level. Percentages 
for each taxon represent the median values for the groups.  
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Excluding the “other” and “unassigned” categories, the three microbiota types 
(CAC, CFS & CAS) are dominated by taxa Neisseria, Capnocytophaga, 
Porphyromonas, Streptococcus, Prevotella, Leptotrichia, and Haemophilus. 
Streptococcus, Neisseria, Prevotella, Capnocytophaga, dominate the CAC sample 
microbiota and at lower levels, taxa Scardovia, Parascardovia, Selenomonas and 
Lactobacillus. CAC sample microbiota include numerous species of higher 
relative abundance: Streptococcus mutans, Alloprevotella denticola, Prevotella 
histicola, Scardovia wiggsiae, Parascardovia denticolens, Prevotella tannerae 
and Bifidobacterium dentium. 
The CFS microbiota composition differs significantly from the saliva of CAS 
group by the presence of the following microbial genera: Leptotrichia, 
Bifidobacterium, Corynebacterium, Alloprevotella, Cardiobacterium and 
Veillonella (p<0.0001). The abundance of all six genera was significantly higher 
in CFS (p<0.0001). The CAS microbiota was dominated by Neisseria, 
Porphyromonas, Streptococcus and Haemophilus, and species included 
Streptococcus mutans, Prevotella histicola, Prevotella melaninogenica, 
Porphyromonas catoniae and Prevotella salivae.  CFS samples were dominated 
by Leptotrichia, Capnocytophaga, Neisseria, Haemophilus, Streptococcus and 
Porphyromonas at genus level, while at species level, the CFS group include 
species Haemophilus haemolyticus, Haemophilus parainfluenzae, Rothia 
mucilaginosa, Porphyromonas catoniae and Streptococcus sanguinis.  
Microbial taxa showing statistically significant differential abundance between 
CFS and CAS children included Streptococcus mutans, Haemophilus 
parainfluenzae, Prevotella histicola, Leptotrichia buccalis, Veillonella dispar, 
Alloprevotella tannerae and Prevotella salivae. Interestingly, Streptococcus 
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mutans, Prevotella histicola and Veillonella dispar were present at higher 
abundance in CAS than the saliva of CFS.  
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Chapter 5 
 
 
 
Discussion 
1. Longitudinal study: Birth to 1 year of age. 
2. Longitudinal study: Birth to 2 years of age. 
3. Cross Sectional Study. 
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5.1. Discussion:  
1. Longitudinal study: Birth to 1 year of age. 
In this large cohort study we investigated the oral microbiota of infants from birth 
to 1 year of age in infants that were born full-term, via by Spontaneous vaginal 
delivery (SVD) or by Caesarean section (CS). All infants were initially breastfed 
for a minimum of 4 weeks and the oral microbiota of these infants were sampled 
at five time points in the first year of life (1 week, 4 weeks, 8 weeks, 6 months 
and 1 year of age).  
At birth, we found that the mother’s skin, vagina and oral microbiota communities 
are distinct, and for each body habitat (vagina, skin, oral) they demonstrate a 
unique composition (Fig. 4.1). The diversity of the vaginal microbiota was lower 
than the skin microbiota of the mother as measured by alpha diversity metrics 
(Fig. 4.3), similar to previous observations (Li et al., 2012; Zhou et al., 2013). 
This low diversity within the vaginal samples is most likely due to the dominance 
of genus Lactobacillus with Lactobacillus iners and Gardnerella vaginalis in high 
abundances, as represented by CST III and CST IV  (Romero et al., 2014c). These 
species have been previously identified in the vaginal microbiota of healthy 
women of reproductive age (Ravel et al., 2011; Zhou et al., 2007, 2004) and of 
pregnant women (Romero et al., 2014c) particularily in the last trimester 
(Walther-António et al., 2014). 
 
In agreement with previous studies (Chu et al., 2017; Dominguez-Bello et al., 
2010), we found that birth mode had an influence on the neonatal oral microbiota 
for a short window after birth.  We found that the oral microbiome of the infant 
was influenced by birth mode within 1 week of age only, but from 4 weeks of age 
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to 1 year the effect of birth mode was not apparent. The overlap and tight 
clustering presented by PCoA plots (Fig 4.2) of the infant oral microbiota by birth 
mode is obvious by 6 months and 1 year of age, while the beta diversity between 
samples (Fig 4.1) demonstrates sharing of taxa between the maternal skin and 
vaginal microbiota and the oral microbiota of the infant at week 1, week 4 and 
week 8, with less overlap and less effect of the maternal microbiota with increased 
age (6 months and 1 year).  This early stage impact highlights transfer of maternal 
microbiota, respective to the mode of delivery (CS or SVD), and this was further 
reinforced by the identification of Lactobacillus iners and Propionibacterium 
acnes of vaginal and skin origin in the infants oral microbiota within 1 week of 
birth. While the impact of the maternal vagina and skin are apparent, the maternal 
salivary oral microbiota did not have any significant effect on the infant oral 
microbiota, with no clustering of mother-infant pairs when compared by their oral 
microbiota composition only (Fig 4.8) (Supplementary figure 4.1). We identified 
that there was no impact of the maternal oral microbiota on their own infant oral 
microbial community, as previously demonstrated (Dominguez-Bello et al., 
2010), and also found no direct similarity between the mothers salivary 
microbiota and their infants salivary microbiota, consistent with previous findings 
(Cephas et al., 2011; Chu et al., 2017), reflecting compositional differences 
between the edentulous neonate and the established and mature adult oral 
microbiome.  
 
Previous studies have reported increased diversity associated with SVD delivered 
infants (Boustedt et al., 2015; Lif Holgerson et al., 2011). However, we did not 
identify such diversity difference by alpha diversity measures. While mode of 
delivery and age have both been shown to affect the microbial composition of the 
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infant gut microbiota up 6 months (Hill et al., 2017), this influence was not seen 
in the oral microbiota of the infants from 4 weeks to 6 months of age (Fig. 4.4). 
This supports previous research findings that as the infant ages, the influence of 
mode of delivery on the oral microbiota of the infant diminishes (Boustedt et al., 
2015). We did however demonstrate that the diversity of microbes in the oral 
cavity of the infant decreased slightly with increased age as measured by Chao 
diversity and Shannon diversity, while stability within the oral cavity was 
demonstrated from week 1 to 1 year of age by the remaining alpha diversity 
measures (Phylogenetic and Shannon diversity) (Fig  4.3). While one would 
expect to see increasing diversity with increased age, we found the alpha diversity 
to be relatively stable over time, perhaps symbolising low inter-variation 
differences between the oral microbiota of the infant over time. While the 
diversity did not dramatically change from 1 week to 8 weeks and again to 1 year, 
there were significant compositional changes which signify the role of factors 
such as diet, dentition, salivary flow rate, oral health, siblings etc have to play. 
However, we did observe a lower diversity at all ages in the infant oral microbiota 
compared to the maternal ‘adult’ salivary microbiota, with similar compositional 
differences previously identified between adult and infant salivary microbiome 
(Aas et al., 2008; Crielaard et al., 2011; Foxman et al., 2016; Ling et al., 2013). 
The diversity gap between the mother and infant oral microbiota increased as the 
infants aged, demonstrating closer relatedness at a younger age. Both findings 
highlight that at 1 year of age, the diversity is stable, potentially influenced by a 
myriad of factors (diet, oral health, dental factors, social status, salivary flow rate, 
fluoridation status and education). 
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The infant oral microbiota illustrates tight overlap by beta diversity measures (Fig 
4.1) at 1 week of age to 8 weeks of age, but from 6 months of age the infant oral 
microbiota develops its own distinct composition with a gradual transitioning 
away from this early age taxa (week 1-8), with no overlap or clustering by 1 year 
of age as presented on the PCoA plots (Fig 4.1). This highlights the continued 
development and maturation of the infant oral microbiota with its distinct 
composition, with no influence of birth mode at this age, while other studies 
illustrate that oral microbiota composition can continue to change and develop 
into adulthood (Crielaard et al., 2011).  
 
At phylum level, the infant oral microbiota of infants from week 1 to week 8 was 
dominated by Firmicutes with Streptococcus the predominant genus at week 1 
consistent with previous studies of the oral microbiome of infants (Cephas et al., 
2011) and of children (Z. Ling et al., 2010). Only after 8 weeks does the 
abundance of Firmicutes begin to decrease, from 6 months (60.2%) until 1 year 
(33.7%), while Streptococcus levels gradually decrease in abundance from week 1 
(53.8%) to 1 year of age (23.1%). When Streptococcus levels begin to decrease, 
this is counteracted by increased abundances by 1 year of age with  genera such as 
Neisseria, Porphyromonas, Rothia and Haemophillus, highlighting compositional 
changes within the oral microbiota from the neonatal period into toddlerhood. 
These compositional changes, in particular are most apparent from 6 months of 
age, co-inciding with the average eruption of the first deciduous teeth (typically 
averaging around 4-6 months for lower primary incisors) and the introduction of 
solid foods to the infant. Previous studies have revealed changes in the oral 
microbial composition with eruption of teeth (Aas et al., 2008) and in the infant 
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gut microbiota after introduction of solid foods (Fallani et al., 2011; Bokulich et 
al., 2016). Eruption of teeth increases the surface area for biofim attachment, 
enhancing bacterial attachment and allowing bacterial compositional change. 
Sampling of the infants in this study was done in their own home. However, due 
to personnel constraints we were unable to do dental examinations at each stage of 
sampling. More frequent examinations would have pinpointed the exact timing of 
eruption of the deciduous dentition, which would have benefited this study.  
 
Long term breastfeeding has been linked with increased risk of dental caries 
(Avila et al., 2015; Bahuguna et al., 2013; Kato et al., 2015) and feeding modality 
(breast fed or formula fed) has been shown to have an effect on the oral microbial 
composition of the infant, with increased levels of oral Lactobacillus species in 
breast fed infants (Lif Holgerson et al., 2013; Vestman et al., 2013). We assessed 
whether breast feeding for a minimum of 4 weeks had an effect on the oral 
microbiota of the infant and did not observe any significant effect on the oral 
microbiota of infants born by SVD or CS, or when birth modality breast feeding 
duration was combined (Fig. 4.10). We did however identify species within the 
oral cavity of the newborn at 1 week of age previously found to be associated with 
breastfeeding (Actinomyces gerencseriae) and species more frequently detected in 
the oral cavity of formula fed infants (Granulicatella elegans, Prevotella 
melaninogenica and Neisseria species) (Lif Holgerson et al., 2013), but no impact 
of breastfeeding on the oral microbiota. Perhaps a longer duration of breastfeeding 
may have an impact on the oral microbiota, but all infants in this study were 
breastfed for a minimum of 4 weeks only, some with introduction of mixed-
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feeding (formula and breast) after this stage, and this data was not collected in this 
cohort 
 
5.1.1. Conclusion 
This study is the first longitudinal study to date that we are aware of using culture-
independent methods to analyse the influence of birth mode on the oral microbiota 
of infants from birth at five time points until 1 year of age. We observed the 
influence of birth mode on the oral microbiota of the infant by 1 week of age, and 
both diversity and compositional changes in the oral microbiota of the infant over 
time. We also demonstrated that breast feeding duration did not have a significant 
effect on the oral microbiota of the infant, while sudden compositional changes 
were evident at 6 months and again at 1 year of age, when both teeth begin to 
erupt and solid foods are introduced. Our findings provide a closer insight into the 
oral microbiota development from birth, and the influence of birth mode together 
with the documented changes in diversity and composition will aid us to get a 
better understanding of the long term health impact within the oral cavity for the 
infant, and provide a platform for additional studies to establish how early life 
disturbances can impact the oral health outcome of these infants. 
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5.2. Discussion:  
2. Longitudinal study: Birth to 2 years of age. 
This study documents the oral microbiota changes that occur when the infant 
grows from birth into toddlerhood at 2 years of age, and a continuation of our 
previous analysis of the ORALMET cohort. At 2 years of age, we found that the 
infant oral microbiota was not influenced by birth modality and there is no effect 
of birth mode on the infant oral microbiota except up to 4 weeks of age.  We 
identified taxa of maternal skin and vaginal microbiota origin within the oral 
microbiota of the infant immediately after birth, with some relationship between 
these maternal body sites and the infant oral microbiota up to 8 weeks of age (Fig 
4.11).  These maternal microbes of vaginal and skin origin included Lactobacillus 
iners and Propionibacterium acnes in the infants oral microbiota after birth. The 
maternal salivary oral microbiota however does not have any significant affect on 
the infant oral microbiota at birth or at any age. 
 
The diversity of the oral microbiome has been shown to increase with increased 
age (Könönen et al., 1994; Lif Holgerson et al., 2015), with the salivary 
microbiota demonstrate continued change in the oral microbiota composition until 
adulthood (18 years of age) (Crielaard et al., 2011). We did not detect any 
increased diversity with the increased age from 1 year to 2 years of age. However, 
we noted that the alpha diversity difference at 2 years of age was greater when 
compared to the neonatal period (1 week to 6 months) (p <0.001), than the 
diversity difference when compared to 1 year of age, highlighting less diversity 
differences with increased age. 
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While the alpha diversity within samples demonstrated stability, the beta diversity 
difference between samples at 2 years of age illustrates clear separation, and 
uniqueness (Fig.4.11). We observed continued development and maturation of the 
oral microbiota from the neonatal period and as the infant aged from 1 to 2 years 
of age. The oral cavity is ‘open’ to a wide range of microbes from the surrounding 
environment, sibling influence and is the first entry point to the body with food 
and fluid intake.  All these factors have an impact on the infant oral microbiota 
dynamics and influence a continuous change of microbial composition within the 
oral cavity. The presence of this distinct separation demonstrates that the taxa 
present at 2 years of age are different to that at an earlier age, in particular the 
neonatal period (week 1, week 4, week 8). This microbial composition difference 
at 2 years of age is further supported by clear separation of the year 2 infant oral 
microbiota based on abundances at bacterial genus level on a vertical and 
horizontal dendrogram (Fig. 4.15).  
 
By 3 years of age, the salivary microbiome has been shown to be composed 
mainly of Firmicutes and a higher abundance of Proteobacteria (Crielaard et al., 
2011). We found the oral microbiome at 2 years of age to have decreased 
Firmicute levels. These levels decreased from week 1 (82.3%) to year 2 (21.1%), 
while Proteobacteria levels increased (3.98% at week 1 to 36.7% at year 2). The 
abundances of Bacteroidetes (16.7%-17.7%), Actinobacteria (6.24-6.08%) and 
Fusobacteria (6.58-7.13%) remain consistent between year 1 and year 2. Thus at 
phylum level, from 1 year to year 2 there is evidence of some stability arising in 
the composition at phylum level with less change within the oral cavity of the 
infant. 
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At phylum level there is evidence of stability between groups, the diversity of the 
oral microbiota is becoming more distinct and less diverse. Streptococccus is the 
most abundant genera at 1 week of age in the infant microbiota (53.8%) and there 
is a stepwise decrease Streptococccus levels from week 1 to year 2 of age (11.2%) 
(Figure 4.17).  The initial dominance of Streptococccus at a young age is 
consistent with Streptococcus levels found in previous studies where levels of 
Streptococcus in the salivary microbiota of infants at 5 months was 62.2% 
(Cephas et al., 2011) and at 6 weeks was found to be 60.7% (Chu et al., 2017). 
The low level of Streptococccus at 2 years of age (11.2%) is counterbalanced with 
increased abundances of genera including Haemophilius, Prevotella, Neisseria 
and Fusobacterium.  
 
Ling et al., (Z. Ling et al., 2010) identified similar genera in the oral microbiome 
of children aged 3-6 years, with Streptococcus (25%) and increased levels of 
genera including Neisseria (10.3%), Porphyromonas (3.96%), Rothia (3.68%) and 
Haemophillus (3.87%). In 3-4 year olds, 75% of the salivary microbiota was 
composed of genera including Streptococcus, Prevotella, Neisseria, Rothia, 
Haemophilus, Gemella and Veillonella, highlighting a similar maturation pathway 
the 2 years olds in this study are developing towards (Jiang et al., 2016). Stability 
of the infant gut microbiota reaches an ‘adult-like’ stability by 2-3 years of age 
and we identified that at 2 years of age Streptococccus levels to be at 11.2%. 
Streptococccus levels in the adult salivary microbiota have been shown to be at 
20.4% (Cephas et al., 2011) and 19.68% (Keijser et al., 2008). Our findings  
demonstrate a trend towards and a more adult like microbiota, by the decreasing 
levels of Streptococccus. However, statistically significant differences in diversity 
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and composition between the maternal oral microbiota and the infant oral 
microbiota at 2 years of age were demonstrated, questioning if the stability 
milestone is reached at 2 years. Reinforcing this observation is the finding that the 
maternal salivary microbiota sampled in this cohort was dominated by Firmicutes, 
and much higher abundances of Streptococcus than the infant oral microbiota at 2 
years of age, and thus does not confirm to us that an ‘adult-like’ oral microbiota is 
developing in the infant oral cavity, but reinforces that the infant oral microbiota 
is under constant change at 2 years and perhaps will continue beyond this age. 
 
To identify if the infant oral microbiota continues to mature and diversify,  it 
would be necesary to continue sampling the oral microbial profiles of this cohort 
from 2 years of age to 3 years of age, and to an older age as the child experiences 
development of the deciduous dentition and mixed-dentition phase of eruption. 
Profiling of the oral microbiota to an older age from birth would give us a better 
understanding if the oral cavity microbiota reaches stability or because of the 
exposed open environment of the oral cavity does this ecosystem ever reach such 
stabilty. 
 
Overall we found that as the infant grows from 1 year of age into a toddler at 2 
years of age, there is corresponding development and maturation of the oral 
microbiota, with distinct compositional changes. It is important to study the oral 
microbiota development from birth to an older age, to give us a better 
understanding of the dynamics within this rich ecosystem, and in particular the 
role birth mode has to play. This foundational work will supplement previous 
research that have focused their attention on the oral microbiome of children (e.g. 
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with dental diseases such as caries) and also complement future studies, with the 
ultimate aim to improve and maintain the oral health of children. 
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5.3. Discussion:  
3. Cross Sectional study. 
In this study, we used Illumina MiSeq sequencing to explore the oral microbiota 
of deep dentinal carious lesions and saliva of Irish children affected with S-ECC 
and the salivary microbiota of those that are caries-free. S-ECC is an aggressive 
form of caries, and we analyzed the microbiota of the deep dentinal caries of 
deciduous teeth to determine if the salivary microbiota was a reservoir or source 
of taxa linked with this form of caries.  
Using two well established metrics (Bray Curtis dissimilarity and UniFrac 
distance) we found that the caries dentine microbiota was distinct from that of 
either CFS or CAS, illustrating, when abundance is taken into account, that CAC 
has considerably different proportions of certain high-abundance taxa. However, 
when measured using unweighted UniFrac, which measures presence and absence 
of taxa only, we found that all three groups are distinct, showing that each group 
is different in terms of rare or low-abundance taxa. Of interest was the closer 
microbiota relatedness of CAS to CAC, with the presence of certain CAS outliers 
overlapping with CAC. This suggests that some samples share similar low-
abundance taxa between CAC and CAS or that CAS harbours some taxa which 
may have stimulated the increased caries rate compared to CFS, or there is some 
shedding of taxa from CAC into the CAS. When we implemented a leave-one-out 
strategy with dominant taxa such as Neisseria and Streptococcus, these outliers 
changed position, sometimes clustering within their own group and a few samples 
that clustered within their group in the full dataset became outliers with the 
reduced dataset. When we studied these outliers in detail, we found that these 
samples were not influenced by any metadata, suggesting that factors not 
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accounted for in this study are responsible for unusual taxon composition in a 
subset of samples.  
Focusing on the dominant taxa and their abundance illustrated graphically by 
hierarchical clustering on the heatmap, we identified samples grouped based on 
microbiota similarity, but also of interest was the partial agreement between the 
outliers identifiable in the PCoA plots and in the heatmaps. The identity of these 
outliers could not be readily correlated with patient metadata and when we looked 
in detail at the taxon abundance level, at genus and at family level there is 
splitting of CAC with both the saliva groups (CFS & CAS), with the CFS samples 
clustering mostly together, with some intermixing of both saliva microbiota types. 
There is clear clustering of CAC in branch one to left, with CFS at next branch in 
blue (Fig.4.22, 4.23), with CAS lastly split on a third branch. This is more 
apparent at species level by hierarchical clustering, with less intermixing of both 
salivary microbiota types (Fig.4.24). 
This incomplete separation of samples between saliva groups suggests that the 
salivary microbiota is not specific enough to be used as an identifier for caries risk 
in children.  The oral cavity is an entry point for colonisation of microbial species 
and saliva is a reservoir for a multitude of bacteria, with its microbial and 
nutritional composition being shaped by food intake, reflux, environment and 
other influences (Crielaard et al., 2011; Lazarevic et al., 2010; Nasidze et al., 
2009). In this study, we did not find an association between factors like habitual 
diet, brushing habits or fluid intake with microbiota composition, although it is 
possible these meta data are not sufficiently granular in the FFQ data and patient 
questionnaire. Furthermore, previous studies have shown variability between sites 
in the oral cavity itself, with niches among the tongue, soft and hard palates, 
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supra- and sub-gingival surfaces of teeth and saliva each demonstrating 
microbiota variability (Aas et al., 2005; Dewhirst et al., 2010). The flow rate, 
buffering capacity, and molecules within saliva which can aid attachment of 
bacterial cells, all play a role in both the compositional balance of the oral 
microbiome (Marsh et al., 2016). While some studies have also found an 
association between the microbiota and disease in plaque samples, but not within 
the saliva samples (Huang et al., 2011; Z. Ling et al., 2010) and our findings 
support these findings, with saliva and caries representing two distinct habitats. 
As caries lesions progress and become more severe, the diversity of caries 
microbiota decreases (Gross et al., 2012, 2010; Li et al., 2007). In this study, 
alpha diversity of caries microbiota was lowest, and differences in the diversity of 
the caries samples and saliva samples were significant (p<0.001). However the 
Chao diversity index for CFS was significantly higher than CAS with a p-value of 
<0.05, again supporting the previous data, that when low-abundance or rare taxa 
are given an equal weighting to higher-abundance taxa, differences in diversity 
between the two saliva groups become apparent. This suggests that even at low 
abundance, certain taxa such as the acid-producing lactobacilli can play a strong 
role in caries progression. This highlights an important possibility, that taxon 
abundance of cavity-causing microbes may not be strongly correlated with 
progression of caries; low-abundance taxa at abundance levels that typically do 
not feature in microbiome summary data might be the main indicator of future 
tooth decay because, for instance, a small number of acid-producing or biofilm-
producing species may have a disproportionate impact on oral health. In addition, 
the potential affect that the removal or exclusion of these rare taxa may have on 
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caries prevention and general oral health makes a solid case for their 
identification. 
As caries progresses to a more advanced state, the bacteria that dominate this 
cavity are less diverse, because aciduric organisms have been selected and 
enriched, and we found that the main genera that dominated the CAC lesion were 
Neisseria, Streptococcus and Prevotella, while the species that dominate the 
caries lesion (CAC) include of Streptococcus mutans, Prevotella species, 
Scardovia species and Bifidobacterium dentium. Neisseria, Streptococcus, 
Prevotella and Porphyromonas have all been strongly associated with caries in 
past studies (Aas et al., 2008; Jiang et al., 2013; Li et al., 2007; Munson et al., 
2004; Nasidze et al., 2009; Nyvad et al., 2013; Tanner et al., 2011b). Neisseria 
and  Streptococcus produce acid which lowers the pH of the mouth and leads to 
increased demineralisation of enamel (Gross et al., 2010) while Prevotella has a 
known role in caries progression and endodontic infections (Tanner et al., 2011a; 
Tavares et al., 2011). The high level of Streptococcus mutans in the carious lesion 
is consistent with previous studies, and its presence is a strong indicator for caries 
(Jiang et al., 2013). Streptococcus mutans aids in caries initiation by adhering to 
the enamel, forming a biofilm on the surface and producing acid, and because it is 
aciduric, it can often be part of a more complex community of microorganisms 
working together (Aas et al., 2008; Gross et al., 2010; Lif Holgerson et al., 2015; 
Tanner et al., 2011b), and a risk factor for caries progression (Gross et al., 2012).  
Scardovia is documented as having a role as a cariogenic bacterium involved in 
the later stages of S-ECC (Tanner et al., 2011b). Scardovia wiggsiae is 
significantly associated with S-ECC, based on a culture study of plaque from 
children (Xu et al., 2014), and in adults with caries (Gomar-Vercher et al., 2014). 
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Prevotella species have been shown to play an important role in endodontic 
infections (Tavares et al., 2011), and Prevotella tannerae, Prevotella histicola 
(isolated from human oral mucosa (Z. Ling et al., 2010)) and Alloprevotella 
denticola (Lazarevic et al., 2010; Munson et al., 2004) have all been shown to be 
associated with dental caries. Lactobacillus, which is notably associated with 
caries progression (Aas et al., 2008; Becker et al., 2002; Fabris et al., 2014; Obata 
et al., 2014; Yang et al., 2010) was found at very low levels compared to other 
genera (0.675% (CAC) and 0.031% (CAS)). These low levels were also reported 
in previous studies (Gross et al., 2012, 2010; Nasidze et al., 2009) and this 
interesting finding supports the idea that when certain acid producers are at low 
levels, their acidogenic properties may nevertheless be strong enough to allow 
other acid producers to take their place, such as Neisseria, Selenomonas and 
Streptococcus mitis (Gross et al., 2010). Neisseria species have the ability to 
metabolize glucose to produce lactic acid and this genus was found at high levels 
in CAC (10.29%) and in CAS (16.28%) and may have an active cariogenic role. 
Lactobacillus is found at low levels in endodontic infections with deep caries 
(Hong et al., 2013; Santos et al., 2011). It has also been suggested by Rôças et al. 
that altered Lactobacillus abundance may be due to the change from cariogenic 
microbiota to a microbiota that stimulates progression into pulpal tissue causing 
infection. Shifts in the microbiota composition can be affected by saliva and diet 
to the outermost pulpal layer, while the inner deeper layer has a different 
environment in comparison (Rôças et al., 2016). The replacement of Lactobacillus 
with other taxa could be linked to the degree of pain, duration of pain, length of 
caries destruction, connection with pulp, diet and environmental factors, and this 
fine detail could reveal reasons for the low levels of Lactobacillus in these teeth.  
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Within CFS there are higher levels of Capnocytophaga (10.9%) and Leptotrichia 
(8.1% CFS), and lower levels of Porphyromonas and Neisseria. There is evidence 
to suggest that Capnocytophaga and Leptotrichia are health-associated species 
(Aas et al., 2008; Jiang et al., 2013; Lif Holgerson et al., 2015; Xu et al., 2014) 
and Capnocytophaga has been found at higher levels in caries-free subjects (Gross 
et al., 2010; Jiang et al., 2013; Z. Ling et al., 2010). We found lower levels of 
Porphyromonas (9.5% CAS & 6.6% CFS) and Neisseria (16.3% CAS & 12.6% 
CFS) in CFS compared to CAS.  Some Neisseria species have been shown to play 
a role in acid production (e.g. N. gonorrhoeae and N. meningitidis) (Gross et al., 
2010), while other Neisseria species such as Neisseria flavescens have been 
shown to elicit higher signal of probes when targeted in caries-free children 
(Crielaard et al., 2011) together with the Porphyromonas gram-negative species, 
Porphyromonas catoniae. The association of these species with a caries-free oral 
status has been further supported by Nyvad et al. (Nyvad et al., 2013). We found a 
higher abundance of Porphyromonas catoniae within the CAS (9.5%). Studies 
have reported children with high levels of caries harbouring higher levels of 
Porphyromonas in their saliva (Gomar-Vercher et al., 2014), by culture study 
(Tanner et al., 2011b), and it has been detected in root canals of necrotic 
deciduous teeth (Fabris et al., 2014) and our findings demonstrate  a positive 
association of Porphyromonas with S-ECC. 
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5.3.2. Conclusion 
We conclude that there are distinct differences between the caries microbiota and 
saliva microbiota, with separation of both salivary groups (caries-active and 
caries-free), showing a clear separation when rare taxa are considered. While the 
microbiota diversity in the caries dentinal microbiota is lower than both salivary 
microbiota types, there are clear compositional differences between all groups 
from phylum to species. The taxa present in the dentinal lesions could be potential 
instigators that drive migration of infection to the pulp, while the saliva 
microbiotas in health and disease may be associated with caries-active or caries-
free status in these children. 
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Chapter 6 
 
 
 
 
Conclusions 
 
 
 
 
 
 
 
 
 
 
 
221 
 
The oral microbiome is a rich and dynamic environment, constantly under change, 
being the first point of entry for food and liquids into the body, and an open 
environment to many transient microbes. While the oral cavity is a dynamic 
ecosystem there are also compositional differences in the oral cavity sub niches 
such as the subgingival and supragingival gingivae, hard and soft palate, saliva, 
floor of mouth and between the occlusal fissures of teeth and the smooth surfaces 
of teeth (Dewhirst et al., 2010). There has been a surge in microbiota research 
examining microbiota influence on the health and wellbeing of the human body. 
The influence of birth modality on the infant microbiota is also a research focus 
for many research groups particularly when these effects can persist throughout 
life (Biasucci et al., 2008; Bokulich et al., 2016; Curran et al., 2015; Gregory et 
al., 2015; Huurre et al., 2008). Although there has been increased focus on the 
effect of birth mode on the gut microbiota, there has not been the same attention 
into the effect of birth mode on the oral microbiome (Dominguez-Bello et al., 
2010; Lif Holgerson et al., 2011).  This thesis and ORALMET study aimed to add 
to the data from the limited number of studies investigation the effect of birth 
mode on the oral micrbiome (Dominguez-Bello et al., 2010; Lif Holgerson et al., 
2011) that were presented at the time of designing the study. In particular, this 
study aimed to follow the oral microbiota these neonates from birth through to 
toddler age, which had never been done previously. 
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The Objectives set out at the beginning of the study were to: 
 
Longitudinal/Cohort study  
1) Determine if birth mode (SVD v CS) would have an influence on 
the composition and development of the oral microbiota.  
2) Describe the changes in the oral microbiota from birth to 3 years 
of age among breast fed infants. 
Cross sectional study  
3) Compare the oral microbiota (saliva/dentinal microbiota) of 
children aged less than 5 years with caries (S-ECC) with caries-
free children (saliva). 
We amplified the V4-V5 region and used high-throughput sequencing of 16S 
rRNA amplicons to determine microbiota composition of each sample site 
examined in both studies.   
Longitudinal study: Birth to 1 year of age. 
As mentioned, there have been no longitudinal studies observing the microbial 
changes of the oral microbiome of a neonate from birth as it grows to an older 
age. While there have been few studies investigating the influence of birth mode 
on the oral microbiome (Dominguez-Bello et al., 2010; Lif Holgerson et al., 2011) 
and  studying the microbial composition of the oral microbiome during infancy 
and childhood (Bokulich et al., 2016; Cephas et al., 2011; Chu et al., 2017; 
Foxman et al., 2016; Ling et al., 2013), no study to date that we are aware of has 
followed the same cohort of neonates from birth through infancy into toddlerhood.  
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The main objective of the ORALMET study were to observe the oral microbial 
changes of a neonate from birth until 3 years of age, with particular emphasis of 
the influence of potential microbial transfer of the maternal microbes depending 
on birth modality (CS or SVD). In total, included in our study were 81 saliva 
samples were collected from each mother at birth, together with skin (n=37) and 
vaginal (n=37) samples. At birth 75 neonates were sampled, with follow on of 83 
infants sampled at 1 year of age (total number of samples from birth to 1 year of 
age n=340). We had an initial aim to enrol 100 mothers and their infants (n=50 
CS/ n=50 SVD). The recruitment stage was performed in the public maternity 
department of the CUMH, information leaflets and follow up by telephone was 
performed for over 200 mothers in their second and third trimester. Given the 
unpredictability of pregnancy and in particular the timing of birth, this initial 
phase of recruitment did prove difficult. We achieved a final enrolment of 83 
mothers and their infants and when these final study numbers were compared to 
the previous studies investigating the role of birth mode on the microbiota of the 
infant (Chu et al., 2017), our final numbers were similar, while compared to other 
studies our final study number was very high (Dominguez-Bello et al., 2010).  
Following the microbial changes in the same neonates from birth through infancy 
has given us an insight into the dynamics of the oral cavity even at this early stage 
of life. While the microbiome of the maternal skin and vagina are described, along 
with the maternal salivary microbiome at birth, we see the impact of birth mode 
on the oral microbiome of the neonate at a very early stage, but not beyond, where 
the oral microbiome of the infant continues to develop and change, particularly 
from 6 months of age. Of interest is that the observation that the timing of change 
in the oral microbiome of the infant is from 6 months which coincides with the 
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introduction of solid foods and average eruption time of first deciduous teeth 
(lower incisors). Other factors which could influence the oral microbiome at this 
stage and at 1 year of age are the beginning of crawling and introduction of 
objects and hands into mouth to ease teething symptoms which may also have an 
influence. While these factors all could have a major influence on the oral 
microbiome of the infant, these factors are difficult to measure accurately in such 
a large cohort of infants. We were unable to recall all infants back to the 
Paediatric clinic at each time point (week 4, 8, 6 months and 1 year) due to 
distance, feasibility for parents and costs. I was unable to also call out to the 
homes to complete a full dental examination at each time point of sampling, a and 
collect detailed diet analysis and oral health analysis, which would have 
supplemented the study, and is something, which would benefit further work in 
this field. 
This study does however highlight the role birth mode has to play in the oral 
microbiome of the neonate and that breast feeding does not have a significant role 
in changing the microbial composition of the oral microbiome. We also 
demonstrated the diversity differences within the maternal niches 
(oral/skin/vagina) and how the diversity of the oral microbiome of the infant 
remains relatively stable at an early age, with compositional changes evident and 
still developing up to 1 year of age. This study is the largest cohort study of the 
oral microbiome performed to date, and will provide a solid foundation to drive 
further work in this field. 
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Longitudinal study: Birth to 2 years of age. 
These findings were a continuation of the ORALMET study, including the data 
and findings of the oral microbiome of the infant at 2 years of age (n=42). This 
data was separated from the Year 1 data as this data was separately prepared for 
publication, while the year 2 data will be submitted along with the year 3 data for 
publication when all the bioinformatic data for year 3 is analysed. The year 3 data 
was not included in this thesis due to the timing of collection of samples and the 
return of sequencing data and bioinformatic analysis; therefore I was unable to 
include the data as part of this thesis. 
The oral microbiota of the infant from 1 year of age continues to mature and 
develop at 2 years of age. While an adult like stability has been observed with the 
infant gut microbiota by 2 years of age (Bäckhed et al., 2015; Yatsunenko et al., 
2012), where the gut microbiota has a high diversity, we did not observe such 
dynamics at 2 years within the oral microbiota. We observed a complete change in 
the diversity between samples at 1 week, 1 year to 2 years of age, with complete 
separation of taxa clustering away from the early stages, and the maternal 
microbiota. The compositional changes evident at 2 years of age do not show 
higher diversity, but appears to be similar or slightly lower to an earlier age.  
The average abundance of Streptococcus in the adult salivary microbiota was 
found to be around 20% in two previous studies (Cephas et al., 2011; Keijser et 
al., 2008). We observed that the Streptococcus levels decrease from 53.8% to 
11.2%  from week 1 to 2 years of age. This finding does  support a trend towards 
a more adult like microbiota, but the lower diversity and the compositional 
differences between the maternal ‘adult’ oral microbiota and infant oral 
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microbiota at 2 years of age, suggests that the oral microbiome is under 
continuous change at this age, as previously demonstrated (Crielaard et al., 2011). 
The addition of the year 3 oral microbiota data will add to these findings and 
reinforce if there is any evidence of stabilisation beyond 2 years of age. Because 
there are no longitudinal oral microbiota studies to date from birth, it would be 
interesting to follow these toddlers from 3 years of age, where the majority of 
deciduous teeth would be erupted, through to 6 years of age, when the first 
permanent teeth begin to emerge.  
By following these infants from birth through to 6 years of age and observing the 
oral microbiota changes, it would be constructive to complete dental examinations 
every 6 months along with detailed diet analysis. This would be important, as 
mentioned in Chapter 4, where we compared the oral microbiota of those with S-
ECC and without caries. We then could document and observe  if any microbial 
changes occur before caries presents.  This would give us an insight into any 
subtle microbial changes that may become apparent within the oral cavity that 
may increase the caries risk in these children. A future aim following on from this 
thesis would be to complete this by carrying forward the same cohort group 
enrolled in the ORALMET study to at least 6 years of age and investigating the 
oral microbiota, alongside a more detailed dental examination. 
Our research findings have given a deeper insight into the diversity and dynamics 
of the infant oral cavity, both in health and in disease.  Both our cross-sectional 
study of the carious microbiota of children and the longitudinal development of 
neonates from birth to 2 years of age has given us a platform to work onwards 
with, with an eventual aim to get a better understanding of what drives this 
diversity and dynamical changes in young children. A better understanding of 
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these changes and the action of the microbes within this ecosystem could 
potentially lead to the development of a clinical application to reduce or prevent 
the occurrences of dental diseases in children, in particular before they have a 
chance to develop.   
Cross Sectional Study. 
In chapter four we described the microbiota of deep dentinal lesions of deciduous 
teeth of Irish children affected with S-ECC. We also compared the microbiota of 
the saliva of children with S-ECC to the saliva of children who didn’t present with 
caries at the time of examination and sampling. All children were between the 
ages of 3-5 years of age. Children with active caries were suffering with chronic 
dental diseases and undergoing full general anaesthetic due to the scale of dental 
disease and poor co-operation. While these children were under general 
anaesthetic, samples were taken (dentine and saliva), that otherwise would have 
proven difficult in the dental chair. We used advanced sequencing methods to 
compare the microbiota compositional differences and diversity of taxa between 
all the sampled sites (saliva/dentine), between the two cohorts of children, for the 
first time in Irish children.  
We identified microbiota compositional differences between both groups, with 
species associated with the dentinal lesions such as Streptococcus mutans, 
Prevotella, Bifidobacterium and Scardovia species. The diversity of the salivary 
microbiota was higher than the dentinal microbiota and rare taxa were identified 
in the active dentinal microbiota in these children with S-ECC that warrant further 
investigation. While diet analysis was taken into account in this study (FFQ), the 
influence of other factors such as oral hygiene, plaque levels, measurement of the 
depth of dentinal lesions and if any pulpal involvement was present was not 
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investigated. It is difficult to sample these children and collect information of a 
weekly or daily diet analysis which is a true reflection of the frequency of intake. 
Because the majority of these children only present in pain at the dentist by which 
time caries is already active and chronic. Ideally following a cohort of children 
from birth, before the presence of teeth and into the age of 3-6 years would avoid 
ambiguous data collection (i.e. diet).  
This study does however provide an insight for the first time on the oral 
microbiota of Irish children, where the rates of dental caries in Irish children are 
still high. The identification of microbiota associated with the advanced dentinal 
lesions and microbiota differences in the saliva could be the beginning of future 
work to highlight this persistent problem in Irish children. Further detailed 
analysis using both culture and culture independent techniques of these taxa 
identified in the salivary microbiome and dentinal microbiome would further 
benefit this cross sectional study, with a particular focus on the taxa within the 
advancing front of deep dentinal lesions, where the microbial composition can 
vary considerably to that of occlusal lesions. Together with detailed diet and oral 
hygiene recording, this additional analysis would advance our understanding of 
this rapid progressive disease and support the potential development of 
therapeutics (i.e. with the probiotic potential or  with the aim of arresting the 
advancing lesion), with the overall aim to reduce the destruction of this disease in 
young children.   
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In Conclusion:  
Hypotheses to be tested: 
- There is no difference in the oral microbiome of children 
1. who are delivered by Caesarean section and vaginally: Confirmed 
2. from birth to 3 years of age: Confirmed 
3. with high caries and those who are caries free: Confirmed. 
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Appendix 7.1 Oralmet/Infantmet Questionnaire. Cohort study. Pages 1-3. 
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Appendix 7.2. Oralmet questionnaire. Cross sectional study. Pages 1-5. 
Page 1. 
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Page 2. 
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Page 3. 
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Page 4. 
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Page 5. 
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Appendix 7.3 Food Frequency Questionnaire (FFQ) 
  
M = month W = week D = Day 
ORALMET code:  OM                     
          
Meat, fish, poultry - 
Medium serving (size deck 
of cards) 
Nev
er 
<1 / M 1/M 1/W 2/W 5/W 1/D 2/D 4/D 6+/D 
Beef (roast / steak)                     
Beef: stew                     
Beef burger (1 burger)                     
Pork (roast / chops / 
escalopes) 
                    
Lamb (roast / chops / stew)                     
Chicken or other poultry e.g. 
turkey: roast 
                    
Breaded chicken, chicken 
nuggets, chicken burger 
                    
Bacon / Ham                     
Processed meat (Corned 
beef, Luncheon meats, 
sausages) 
                    
Savoury pies (e.g. meat, 
pork, steak & kidney, 
sausage roll) 
                    
Liver, heart, kidney, paté                     
Fish fried 
(batter/breadcrumbs), baked, 
grilled, fingers/cakes 
                    
White fish, fresh or frozen 
(e.g. cod, haddock, plaice, 
sole) 
                    
Oily fish, fresh or canned 
(e.g. mackerel, kippers, tuna, 
salmon, sardines, herring) 
                    
Shellfish (e.g. crab, prawns, 
mussels) 
                    
Bread and savoury 
biscuits - One slice or one 
biscuit 
Nev
er 
<1 / M 1/M 1/W 2/W 5/W 1/D 2/D 4/D 6+/D 
White bread and rolls 
(including ciabatta & pannini) 
                    
Brown bread and rolls                     
Wholemeal bread and rolls                     
Wheat-free; Rye bread; spelt 
bread (specify) 
                    
Cream crackers, cheese 
biscuits 
                    
Crisp bread, e.g. Ryvita                     
Pancakes, muffins, oatcakes                     
Scone (white)                     
Scone (brown)                     
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Cereals - One medium 
sized bowl 
Nev
er 
<1 / M 1/M 1/W 2/W 5/W 1/D 2/D 4/D 6+/D 
Non-ready to eat - Porridge, 
Readybrek 
                    
High fibre (All Bran/flakes, 
Weetabix, Shredded wheat) 
                    
Cornflakes, Rice Krispies                     
Muesli (e.g. Country Store, 
Aplen) 
                    
Sugar-coated cereals (e.g. 
Frosties, Crunchy nut 
cornflakes) 
                    
Potatoes, rice and pasta - 
Medium serving = a cupful 
Nev
er 
<1 / M 1/M 1/W 2/W 5/W 1/D 2/D 4/D 6+/D 
Boiled, instant or jacket 
potatoes 
                    
Mashed potatoes                     
Chips / Roast potatoes                     
Potato Salad                     
White Rice                     
Brown Rice                     
White/yellow or green pastas 
(e.g. spaghetti, noodles) 
                    
Wholemeal pasta                     
Lasagne (meat based)                     
Lasagne (vegetarian)                     
Pizza                     
Dairy products and fat 
Nev
er 
<1 / M 1/M 1/W 2/W 5/W 1/D 2/D 4/D 6+/D 
Cream (tablespoon)                     
Full-fat yoghurt or Greek 
style yoghurt (125g carton) 
                    
Dairy desserts (125g carton)                     
Cheddar cheese (medium 
serving) 
                    
Low-fat cheddar cheese 
(medium serving) 
                    
Cottage cheese                     
Eggs as boiled, fried, 
scrambled, poached (one) 
                    
Quiche (medium serving)                     
Light salad cream or light 
mayonnaise (tablespoon) 
                    
Salad cream, mayonnaise 
(tablespoon) 
                    
French dressing 
(tablespoon) 
                    
Other salad dressing 
(tablespoon) 
                    
The following on bread or 
vegetables (teaspoon): 
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Butter                      
Lite Butter e.g. Dawn Lite, 
Connacht Gold  
                    
Sunflower margarine e.g. 
Flora  
                    
Low-fat margarine (e.g. 
lowlow) 
                    
Cholesterol Lowering e.g. 
Flora Pro-Active, DairyGold 
Heart 
                    
Cream & Veg. Oil spread 
e.g. Kerrymaid, Dairy Gold  
                    
Olive oil spread e.g. Golden 
Olive  
                    
Fruit - 1 fruit or a medium 
serving (a cupful) 
Nev
er 
<1 / M 1/M 1/W 2/W 5/W 1/D 2/D 4/D 6+/D 
Apples                     
Pears                     
Oranges, satsumas, 
mandarins 
                    
Grapefruit                     
Bananas                     
Grapes                     
Melon                     
Peaches, plums                     
Apricots                     
Strawberries, raspberries, 
kiwi fruit 
                    
Blueberries                     
Tinned fruit (specify)                     
Dried fruit e.g. raisins                     
Frozen fruit (specify)                     
Vegetables (Fresh, frozen, 
tinned) - 2 tablespoons 
Nev
er 
<1 / M 1/M 1/W 2/W 5/W 1/D 2/D 4/D 6+/D 
Carrots                     
Spinach                     
Broccoli, spring greens, kale                     
Brussel sprouts                     
Cabbage                     
Peas                     
Green beans, broad beans, 
runner beans 
                    
Courgettes                     
Cauliflower                     
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Parsnips, turnips                     
Leeks                     
Onions                     
Garlic                     
Mushrooms                     
Sweet peppers                     
Green salad, lettuce                     
Cucumber, celery                     
Tomatoes                     
Sweetcorn                     
Beetroot                     
Coleslaw                     
Baked beans                     
Dried lentils, beans, peas                     
Tofu, soya meat, TVP, 
vegeburger 
                    
Sweets and snacks - 
medium serving 
Nev
er 
<1 / M 1/M 1/W 2/W 5/W 1/D 2/D 4/D 6+/D 
Chocolate coated sweet 
biscuits e.g. digestive (one) 
                    
Plain biscuit e.g. marietta, 
digestives, rich tea (one) 
                    
Cakes e.g. fruit, sponge                     
Buns, pastries e.g. 
croissants, doughnuts 
                    
Fruit pies, tarts, crumbles                     
Sponge puddings                     
Milk puddings e.g. rice, 
custard, trifle 
                    
Ice cream, choc ices, frozen 
desserts 
                    
Chocolates, singles or 
squares 
                    
Sweets, toffees, mints                     
Sugar added to tea coffee, 
cereals (teaspoons) 
                    
Sugar substitute e.g. 
canderel (teaspoon) 
                    
Crisps or other packet 
snacks 
                    
Peanuts or other nuts                     
Soups, sauces and 
spreads 
Nev
er 
<1 / M 1/M 1/W 2/W 5/W 1/D 2/D 4/D 6+/D 
Vegetable soups: 
homemade/fresh (1 bowl) 
                    
Vegetable soups: 
tinned/packet (1 bowl) 
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Meat or cream soups: 
homemade / fresh (1 bowl) 
                    
Meat or cream soups: tinned 
/ packet (1 bowl) 
                    
Sauces e.g. white, cheese, 
gravy (tablespoon) 
                    
Tomato based sauces e.g. 
pasta sauces 
                    
Curry-type sauces                     
Pickles, chutney 
(tablespoon) 
                    
Marmite, Bovril (tablespoon)                     
Jam, marmalade, honey, 
syrup (teaspoon) 
                    
Peanut butter (teaspoon)                     
Drinks 
Nev
er 
<1 / M 1/M 1/W 2/W 5/W 1/D 2/D 4/D 6+/D 
Tea (cup)                     
Herbal tea (cup)                     
Whole milk (cup) - cow, goat, 
soya, rice milk – specify 
                    
Semi-skimmed milk (cup)                     
Coffee instant (cup)                     
Coffee ground (cup)                     
Coffee, decaffeinated (cup)                     
Coffee whitener e.g. Coffee-
mate (teaspoon) 
                    
Cocoa, Hot Chocolate (cup)                     
Horlicks, Ovaltine (cup)                     
Wine (glass)                     
Beer, Larger or Cider (half 
pint) 
                    
Low alcohol / alcohol free 
beer / larger (half pint) 
                    
Port, Sherry, Vermouth, 
liqueurs (glass) 
                    
Spirits e.g. Gin, Whiskey 
(Single measure) 
                    
Low calorie or diet soft fizzy 
drink (glass) 
                    
Fizzy Soft drinks e.g. (Coca 
Cola - Glass) 
                    
Pure fruit drinks e.g. orange 
juice (small glass) 
                    
Fruit squash (small glass)                     
Functional Foods / 
Supplements 
Nev
er 
<1 / M 1/M 1/W 2/W 5/W 1/D 2/D 4/D 6+/D 
Probiotic Yoghurts / cheese / 
milk 
                    
Vitamin supplements 
(details) 
                    
Mineral supplements 
(details) 
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Ready meals 
Nev
er 
<1 / M 1/M 1/W 2/W 5/W 1/D 2/D 4/D 6+/D 
Ready meal (specify)                     
Takeaway (specify)                     
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Appendix 7.4. Ethical approval. 
Ethical approval was obtained from the Cork Teaching Hospitals Clinical 
Research Ethics Committee for the recruitment and sampling of these Cohorts of 
children. Ethical approval reference: ECM 3 (cc) 01/07/14. 
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Appendix 7.5. Oralmet Consent & Information leaflet. 
SUBJECT INFORMATION SHEET 
 
Study Title: The Oral Microbiota of Irish Children and Adults: a baseline 
and longitudinal study in health and disease 
 
Protocol No.:   APC034 
 
Principal Investigator: Dr Paul O’Toole 
 
Co-Investigators: Professor Helen Whelton, Professor Kinirons, Dr.Eimear 
Hurley & Dr Catherine Stanton. 
  
Site of Investigation: Cork University Hospital (CUH), Cork Dental 
School and Hospital, University College Cork 
(UCC), & Teagasc Moorepark Food Research, 
Fermoy, Co. Cork, 
 
Why is this study being run?  
Oral hygiene in children is a key part of ensuring healthy teeth in adulthood. A 
significant number of children in Ireland suffer from pain and sleepless nights 
with toothache.  Because treatment of kids in the dental chair is traumatic, 
children’s teeth that are damaged beyond repair are frequently extracted under 
anaesthetic in hospital. This can lead then to a higher need for orthodontic 
treatment and dental-phobia in the treated kids. 
Tooth damage due to bacteria is called dental caries.  Based on older 
microbiology techniques, the major bacteria related to caries have been identified 
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as oral streptococci, with minor parts played by other bacteria. However, recent 
molecular techniques have shown that some caries can be caused by multiple 
other bacteria. Importantly, whether or not a person develops caries is influenced 
by the total pattern of bacteria in the mouth – the oral microbiota.  
The oral microbiota of Irish babies or children has not been studied using 
molecular techniques. We will study children (in crèches and primary school) by 
taking a saliva sample and determining what bacteria are present associated with 
bad or good teeth. We expect to find differences, and this may help us form a 
‘library’ of information, which we can store, and use to prevent children getting 
these bad, decayed teeth.  We will also investigate the oral microbiota of new-
born babies from birth to age 3.  We will test, as the baby develops and starts 
eating solid foods and cutting teeth, how the bacteria in the mouth also change.  
We will cross-reference this information to the data from older children, to build 
an overlapping picture, from infancy into pre-school kids where the risk of caries 
is greatest.  This will help us identify which bacteria develop to put the child at 
risk of bad teeth, or promote good teeth. 
If you agree to participate in the study you will be asked some general questions 
and eligibility to participate in the study will be determined. 
The visits will take place at the site clinic at Cork University Hospital or Cork 
Dental School and Hospital.  
Two studies will be conducted in parallel. The first study will involve up to 6 
visits over 3 years, at different time intervals. 100 neonates and 100 mothers will 
be involved in the study from birth to 3 years.  
The second study will involve one visit. A sample will be collected while the 
patient is in the Cork University Hospital for a general anaesthetic extraction 
procedure. 100 healthy males and females, under 6 years of age and adults will be 
recruited. 
 
Study Procedure 
You will be advised of the purpose of the study and the procedures which will be 
undertaken.  You will be given a copy of the Subject Information sheet, which 
will explain what is required from you and your child. If interested, you will then 
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be requested to read and sign the Informed Consent form, and receive a signed 
copy.  Your child’s suitability to participate in the study will be checked. 
 
In the first study, participation will involve attending the CUH maternity clinic for 
6 visits over a period of 3 years, at weeks 1, 4, 8 and at 4, 12, 24 and 36 months.  
You will be asked some general questions regarding your baby’s feeding and oral 
hygiene and baby’s weight will be recorded.  A saliva sample will be collected 
from your child and where plaque is present in older infants, a sample will be 
collected.  You, the Mother, will be asked to provide a saliva and plaque sample, 
and a clinical nurse will take a vaginal/skin swab at visit one only. 
You will be asked to avoid feeding your baby 45 minutes before his/her sample 
collection and for you to avoid eating for 4 hours before your sample is collected. 
 
The second study will involve one visit.  If you or your child is scheduled to 
undergo a tooth extraction at the General Anaesthetic clinic in Cork University 
Hospital (CUH), while sedated a saliva and plaque sample will be collected.  In 
addition, a caries sample will be taken immediately from the teeth extracted.   
Saliva and plaque sample will also be collected from children who are caries free 
and have no decayed, missing or filled teeth. 
 
What happens if I start the study and change my mind later?   
You do not have to take part in the study, participation is entirely voluntary. 
Refusal to participate, or discontinuing participation at any time, will involve no 
penalty, loss of benefits or denial of treatment or services by the Cork Teaching 
Hospital or the participating doctor. 
 
Will I experience any unpleasant side effects?    
No side effects will be felt on taking the sample 
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Funding of trial 
There are no cost implications for the Health Services Executive (HSE) or to you. 
The management of patients and investigative tests will comply with current 
standards of care. Cost of research tests will be incurred by the Cork Dental 
School and Hospital and the Alimentary Pharmabiotic Centre, University College 
Cork.   
 
Confidentiality   
All the information gathered from this study will be stored on a computer, paper 
files and will be treated confidentially. You will be identified only by a subject 
number. 
In the event of any publication regarding this study, your identity will not be 
disclosed.  
 
What happens if there is anything I do not understand?   
If there is anything you are not sure about, the Doctor will be happy to explain in 
more detail to yourself or your relatives, guardians (or legal representative if 
required). The study will be fully explained to you before you decide if you want 
to take part.   
 
Dr. Paul O’Toole 
Department of Microbiology & Alimentary Pharmabiotic Centre, University 
College Cork 
Telephone Number:  021 4903997  
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CONSENT BY SUBJECT FOR PARTICIPATION IN A HUMAN 
INTERVENTION STUDY 
 
 
Protocol Number:  APC034 
 
Subject’s Name:  _______________________________ 
 
 
Title of protocol: The Oral Microbiota of Irish Children and Adults: a baseline and 
longitudinal study in health and disease 
 
 
Principal Investigator: Dr.Paul O’Toole 021-4903997 
 
 
Participation in this study is voluntary and you may withdraw at any time for any 
reason 
 
The research project and procedure associated with it have been fully explained to 
me. All experimental procedures have been identified and no guarantees have 
been given about the possible results. I have had the opportunity to ask questions 
concerning any and all aspects of the project and any procedures involved. I am 
aware that participation is voluntary and I may withdraw consent at any time. I am 
aware that my decision not to participate or to withdraw will not restrict my 
access to health care services normally available to me. Confidentiality of records 
concerning my involvement in this project will be maintained in an appropriate 
manner. I understand that the investigators have such insurance as is required by 
law in the event of injury resulting from this research. 
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I, the undersigned, hereby consent to participate as a subject in the above 
described project conducted at the Cork University Hospital and University 
College Cork. I have received a copy of this consent form for my records. I 
understand that if I have any questions concerning this research, I can contact the 
Doctor listed below. If I have further queries concerning my rights in connection 
with the research, I can contact the Clinical Research Ethics Committee of the 
Cork Teaching Hospitals, Lancaster Hall, 6 Little Hanover Street, Cork 
  
After reading the entire consent form, if you have no further questions about 
giving consent, please sign the where indicated. 
      
 
Parent’s/Guardian’s Signature: _____________________   
Date: __________________ 
 dd     mon    yy                 
 
NAME (BLOCK LETTERS):  ____________________Time: _________ 
 
Witness’ Signature:  _______________________________ 
Date: __________         
      dd    mon    yy     
NAME (BLOCK LETTERS)  _________________________ 
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Investigator’s Signature:  _________________________   
Date: __________________       
 dd          mon    yy     
NAME (BLOCK LETTERS)  _________________________ 
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Appendix 7.6. 
Publications & articles under peer review during the course of 
this thesis. 
 
A study of primary teeth restored by intracoronal restorations in children 
participating in an undergraduate teaching programme at Cork University Dental 
School and Hospital, Ireland. 
Authors:  E. Hurley, C. Da Mata, C. Stewart, M. Kinirons 
Published In March 2015 in ‘The European Journal of Paediatric Dentistry 
 
Decisions on repositioning of intruded permanent incisors; a review and case 
presentation. 
Authors:  E. Hurley, C. Stewart. C. Gallagher, M. Kinirons 
Accepted for publication September 2017 in ‘The European Journal of Paediatric 
Dentistry. 
 
Comparison of the salivary and dentinal microbiome of children with severe-early 
childhood caries to the salivary microbiome of caries-free children. 
Authors: Eimear Hurley, Maurice P.J Barrett, Martin Kinirons, Helen Whelton,  
C. Anthony Ryan, Catherine Stanton, Hugh M.B. Harris
  and Paul W. O’Toole. 
Under peer review at ‘BMC Oral Health’. 
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The influence of birth mode and breastfeeding duration on the emerging neonatal 
oral microbiota from birth to 1 year of age, a cohort study. 
Authors: Eimear Hurley, Hugh M.B. Harris, David Mullins, Maurice P.J Barrett, 
Carol Anne O’Shea, Martin Kinirons, Helen Whelton, C. Anthony Ryan, 
Catherine Stanton, Paul W. O’Toole.  
Under peer review at ‘Journal of Dental Research’ 
 
Co-Author on the following: 
Maternal microbiota impact on the gut and oral microbiota of naturally delivered, 
breastfed infants.                 
Authors: Cian J. Hill, Denise B. Lynch, Eimear Hurley, Eugene M. Dempsey, C. 
Anthony Ryan, R. Paul Ross, Catherine Stanton and Paul W. O’Toole. 
This has been submitted to “The Archives of Disease in Childhood, Fetal and 
Neonatal Edition” for peer review. 
 
The oral microbiota in colorectal cancer is distinctive and predictive.  
This has been accepted for publication  to the Journal ‘Gut’ . September 2017. 
Author: Dr. Burkhardt Flemer. 
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Scaffolding 
 
Masons, when they start upon a building, 
Are careful to test out the scaffolding; 
 
Make sure that planks won’t slip at busy points, 
Secure all ladders, tighten bolted joints. 
 
And yet all this comes down when the job’s done 
Showing off walls of sure and solid stone. 
 
So if, my dear, there sometimes seem to be 
Old bridges breaking between you and me 
 
Never fear. We may let the scaffolds fall 
Confident that we have built our wall. 
 
      Seamus Heaney 
 
